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Abstract 
During wakefulness, synapses are strengthened to enable memory formation. Whereas, during 
sleep, weaker connections are ‘pruned’ to help consolidate memories. These synaptic 
alterations are related to cortical oscillations, which are generally faster during wakefulness (30-
80Hz, gamma), and slower during deep sleep (1-4Hz, delta). Synaptic strength is thought to 
decrease during delta rhythms (compared to gamma rhythms). Neuroinflammation can disturb 
these brain rhythms and lead to a decline in cognitive function, which may result from 
aberrations in synaptic plasticity. 
 
To test the laminar and cellular changes in synaptic plasticity during sleep- and wake-related 
oscillations, in vitro electrophysiology and immunofluorescence were employed using acute rat 
neocortical slices. To examine the effect of neuroinflammation on these brain states, systemic 
infection was induced using synthetic analogues of pathogenic bacterial and viral material, and 
a biological parasitic disease model.  
 
The expression of an immediate early gene (IEG) marker of neuronal plasticity (Arc) was higher 
during delta oscillations compared to gamma oscillations and was concentrated to mid-apical 
dendrite bundles from layer V intrinsically bursting cells. These bundles represented cortical 
microcolumns which are known to exhibit synchronous activity, allowing parallel processing of 
information. Increased Arc expression in these columns during delta oscillations may promote 
synaptic rescaling and highlights the role of cortical microcolumns in memory consolidation. 
 
A balance of pro- and anti-inflammatory cytokines was found after short term systemic infection 
which gave way to a predominately pro-inflammatory state when the infection was longer term. 
The oscillatory activity also changed, with a continued decline in gamma power. However, delta 
power increased short term but decreased with a longer infection. The systemic infection had 
no effect on cortical plasticity. These results were corroborated in a mouse model of 
Leishmaniasis and show that systemic infection alters neuronal communication by changes to 
oscillatory activity, but does not change synaptic plasticity levels.  
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Aims and Objectives 
In general, this thesis uses in vitro oscillations generated in neocortical slice preparations of rat 
brain. Using this model system the overarching objectives are to assess the changes in synaptic 
plasticity that occur between different classifications of pharmacologically induced brain 
rhythms and to investigate the effect of neuroinflammation on that interaction. With this in 
mind this thesis outlines experiments that were carried out: 
 
 To generate sleep and wake-related oscillations in neocortical slice preparations and 
assess the effects of those oscillations on neuronal activity and plasticity through 
changes to immediate early gene expression. 
 To localise oscillation related immediate early gene changes across neocortical laminae 
and different cell types. 
 To monitor sleep and wake related oscillations in brain slice preparations after bath 
application of inflammatory agents that mimic bacterial and viral sequences 
(lipopolysaccharide and polyinosinic:cytidylic acid respectively). 
 To raise a systemic immune response using those inflammatory agents that mimic 
bacterial and viral sequences recognised by the peripheral immune system and analyse 
the resulting inflammation in the brain. 
 To compare the effect of the time scale of a mimicked systemic infection on sleep and 
wake-related oscillations generated in brain slice preparations. 
 To evaluate the effect of a real-life systemic infection on sleep and wake related 
oscillations generated in brain slice preparations, and investigate changes to plasticity 
across these oscillations. 
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1.1 The Neocortex 
This thesis focusses on markers of plasticity associated with different patterns of electrical 
activity in the neocortex. The neocortex in humans is the largest part of the cerebral cortex and 
is the most developed in terms of its organisation. It is arranged into six layers (designated by 
Roman numerals I-VI) each with a unique neuronal subtype composition (see Figure 1.1). Twenty 
percent of the neurons of the neocortex are inhibitory interneurons and use y-aminobutyric acid 
(GABA) as their main neurotransmitter. They synapse with proximal pyramidal cells and other 
interneurons to provide the inhibitory balance essential for neuronal oscillations within their 
local neuronal networks (see section 1.2 below) (Dupret et al., 2008; Middleton et al., 2008). 
The majority of the neurons (80%) within the neocortex are excitatory and as such exert a 
depolarising influence on other neurons conferred by the excitatory neurotransmitter glutamate 
(Han and Sestan 2013). Pyramidal cells make up most of the neocortical excitatory cells and can 
span several layers and project between regions allowing long-range connectivity. Thus, they 
are ideally designed to transfer information both within laminae and also between different 
brain areas. Spiny stellate cells are also excitatory but are less widespread, with cell bodies 
primarily restricted to layer IV of primary sensory areas (Costa and Muller, 2014). 
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Whilst communication across the cortex is important, the arrangement of neurons throughout 
the layers suggests that the predominant flow of information is vertically between layers within 
a columnar arrangement. This has been confirmed functionally in the somatosensory cortex 
(Mountcastle et al., 1957), and primary visual cortex (Hubel and Wiesel, 1962). Although not 
necessarily representative of these ‘functional’ columns, a columnar organisation is conserved 
throughout the neocortex and across many species with surprising uniformity in cell number 
and density (Rockel et al., 1980; Carlo and Stevens, 2013). 
 
1.1.1 Intracortical transfer of information through the neocortex 
Sensory inputs, relayed mostly by specific thalamic nuclei, enter cortical columns first at layer IV 
(Bode-Greuel et al., 1987). They are conveyed mainly by parvalbumin immune reactive neurones 
(PIR neurones), however, calbindin immune reactive neurones (CIR) also exist which have 
dispersed projections to superficial layers of the cortex I-III (Jones, 2002). The targets for these 
dispersed projections are presumed to be the apical dendrite of layer V pyramidal cells (Rubio-
Garrido et al., 2009; Bonjean et al., 2012) 
 
The first stage of information processing in the cortex involves the initial receipt of an input from 
the thalamus and its subsequent intracortical projection for the next phase of processing. The 
cells of layer IV (also called ‘first order cells’) receive the majority of the thalamic inputs and are 
known to deal with information from small receptive fields (Hubel and Wiesel, 1962) (Chapin, 
1986). These cells have been shown to predominantly project terminals into layer II/III (also 
known as the supra-granular layer) (Gilbert and Wiesel, 1979) although the axons also descend 
into the white matter with arborisation into layer V/VI.  
 
These projections to layer II/III mostly synapse onto the basal dendrites of layer III pyramidal 
cells (Watts and Thomson, 2005) which are responsible for the second level of neocortical 
processing. It is at the transfer between the first and second levels that sensory information is 
strongly gated so that weaker stimuli cause less firing in layer II/III neurons than the presynaptic 
layer IV cells (Brumberg et al., 1999), whereas firing levels in response to stronger stimuli are 
preserved (Zhu and Connors, 1999). These cells also only respond to more complex stimuli such 
as those including motion or to expanded receptive fields (possibly from the integration of 
several smaller receptive fields from converging layer IV neurons) (Simons, 1978). The layer III 
pyramidal cells’ axons descend all the way through the cortex to layer VI, but only connect to 
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pyramidal cells in layers II/III and V. These cells rarely target layer V regular spiking cells but 
connect much more abundantly with layer V bursting cells (Thomson et al., 2002).  
 
The involvement of layer V bursting cells in the third level of processing, along with their ability 
to receive higher order feedback from their layer I projecting apical dendrites (Rockland and 
Drash, 1996), highlight their importance as a major processing unit in the neocortex. They also 
provide a major output pathway from the cortex, with corticothalamic projections as well as 
projections to other subcortical structures such as the pons (Gao and Zheng, 2004). 
 
The aforementioned studies on the interlaminar network of neurones within the cortical column 
looked at the anatomical projections and arborisation of cells but did not consider the strength 
of the connections between layers (Figure 1.1A). Interlaminar connections can be measured in 
vitro by stimulating a particular layer of the cortex and recording the amplitude of EPSPs in the 
target layer. The prominence of certain interlaminar connections can be estimated finding the 
product of the EPSP amplitude and the probability of locating a synaptic connection between 
cells of the stimulated and target layers. This gives a measure that takes into account the 
strength and the relative number of synaptic connections between layers. Using this method it 
has been shown that intra-laminar connections are particularly strong in layers II, III and IV 
(Lefort et al., 2009). This study also corroborated the evidence (highlighted by anatomical 
investigations) that suggested that the main routes of information flow are between layer IV 
and layer II/III and between layer II/III and layer V cells (Figure 1.1B). This further highlights the 
importance of layer V neurons as an information processing unit in the cortex.  
 
1.1.2 Oscillatory activity in neocortical columns 
The cells of the neocortex are arranged into ca. 0.5mm diameter vertically oriented columns 
with adjacent cells having very similar receptive fields – these are called macro columns. As 
mentioned above, this was originally described by Mountcastle (1957) in the cat somatosensory 
cortex and was found to be conserved in ocular dominance columns of the striate (primary 
visual) cortex (Hubel and Wiesel, 1962). Responses to particular elements of a visual stimulus 
are also dealt with in columns of the inferotemporal cortex, known as ‘feature columns’ 
(Tsunoda et al., 2001). 
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Oscillatory activity occurs in these columns after stimulation with sensory input via the 
thalamus. Experiments on cat visual cortex have shown that oscillatory activity occurs at 40Hz 
after the presentation of a stimulus and the amplitude of the oscillation correlates with the 
closeness in orientation selection of that column (Gray and Singer, 1989). Single cells of the 
target network are also more likely to fire in the negative phase of the oscillation. The 
synchronisation of the activity of cells in dispersed areas of the cortex may allow for the 
coherence of the different features of a stimulus into a single sensory object (Gray et al., 1989). 
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Neurons within certain columns can synchronise their activity with disparate columns, in the 
same and other cortical areas. Long range pyramidal cell projections may be the functional unit 
that allows this to occur. These horizontal axonal arbours were first discovered when tracing 
degeneration of fibres and are important for the visual cortex to code for the relationship 
between spatially distinct, but connected patterns within the visual field (Gray and Singer, 1989). 
 
Evoked potentials in these columns have also been used to understand more about their 
function. It is known that the amplitude of auditory evoked potentials are brain state-specific, 
with the highest amplitudes recorded during deep sleep (Weitzman and Kremen, 1965). 
Differences of this kind are not consistent across the brain and are even altered between cortical 
columns. This means that cortical columns may fluctuate between wake and sleep-like states in 
a manner that is partly independent of the mean, whole brain state - although more columns 
exist in a sleep-like state during whole-brain sleep and vice versa (Rector et al., 2005). This is a 
use-dependent process, with the duration of the sleep-like state (defined by higher amplitude 
evoked potentials) correlating with the duration of the preceding wake-like state within the 
column (Rector et al., 2005). 
 
1.1.3 Intercolumnar communication in the neocortex 
Much of what is known about horizontal connections in the neocortex, has been uncovered by 
lesion studies. These have shown that pyramidal cells in middle layers can extend axons 
horizontally or obliquely between 0.5 – 3mm in distance, up into layer I and II or down into layers 
V and VI (Creutzfeldt et al., 1977). These pyramidal cell axons spread in ‘clumps’ and mostly 
synapse with other pyramidal cells (Kisvarday et al 1986) in the same and other layers (Gilbert 
and Wiesel, 1983). However, the pattern of these horizontal connections varies considerably 
depending on neocortical region and whether the connection is to a higher hierarchical area 
(e.g. primary sensory to association cortex) or a lower one (e.g. frontal cortex to association 
cortex). Regional details are briefly considered below, that focus on the brain regions explored 
in this thesis. These regions were chosen due to their importance in processing sensory 
information which affords high levels of plasticity as well as the existence of optimised protocols 
to model oscillations within these regions in vitro. 
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1.1.4 Primary somatosensory cortex 
The primary somatosensory cortex (S1) is in the post-central gyrus of the human brain. It was 
once considered a single area, but current understanding has it segregated into four functional 
maps related to Brodmann areas 1, 2, 3a and 3b. Excitatory inputs relayed by thalamic nuclei 
(located predominantly in ventrobasal areas) enter S1 mostly at layer VI and trigger the activity 
of cells of this layer, though there are also modulatory inputs to layer II/III (Viaene et al., 2011). 
Inputs are arranged in a topographic map within cortical regions, but the four regions deal with 
different sorts of somatosensory inputs. Area 3b is the primary recipient of touch information 
and projects to Areas 1 and 2 (Kaas et al., 1983) which process with texture and size/shape 
information respectively (Purves et al., 2008). Area 1 and 3b are also known to primarily deal 
with cutaneous information whereas Areas 2 and 3a processing muscle receptor inputs. All of 
these areas further project to other regions of the cortex such as the motor cortex for sensory 
guidance of motor actions and the secondary somatosensory cortex for further sensorimotor 
and polymodal processing (Kaas, 1993). They also project to non-neocortical areas like the 
amygdala and hippocampus to facilitate tactile memory formation (Mishkin, 1979)  
 
1.1.5 Secondary somatosensory cortex 
The secondary somatosensory cortex (S2) includes parts of Brodmann areas 40 and 43. It 
receives input from S1 (above) and less specifically from matrix thalamic nuclei. In response to 
nociceptive stimuli, parallel activity in both S1 and S2 occurs, however the secondary 
somatosensory cortex unlike its primary counterpart, responds to stimuli bilaterally (Ploner et 
al., 1999). It is thought that S2 has a role in higher order processing of tactile information, 
particularly with relevance for working memory and attention. Higher fMRI activation of S2 than 
S1 was seen when human subjects focussed attention on a stimulated area (Hämäläinen et al., 
2002). This finding is corroborated by increasing cell firing (Hsiao et al., 1993) and the amount 
of synchronous activity (Steinmetz et al., 2000) in S2 also related to attention.  
 
Despite its importance in somatosensory processing, different sub-regions of S2 have been 
shown to respond to multisensory inputs (Brett-Green et al., 2004). This has been suggested to 
involve polymodal transition zones between S2 and adjacent regions responsible for the 
processing of other modalities of uni-sensory information (Wallace et al., 2004), (Menzel and 
Barth, 2005). This further suggests that S2 may have as much a role in sensory integration as it 
does in the processing of somatosensory information from S1. 
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1.1.6 Primary auditory cortex 
The primary auditory cortex (Brodmann areas 41 and 42) exists in Heschl’s gyrus of the temporal 
lobe. It deals with the conscious perception of sound. This is evident when lesions of this area 
result in people stating they are deaf while still retaining reflexive responses to sound. These 
reflexive responses originate in brainstem and midbrain areas (Cavinato et al., 2012). Auditory 
information from the cochlea is transferred to the primary auditory cortex, first through the 
inferior colliculus and then through the medial geniculate nucleus in the thalamus. The primary 
auditory cortex is organised into a tonotopic map based on the cochlear response. The cochlea 
separates an auditory stimulus by frequency in its own tonotopic map, that organisation of 
frequency information is conserved in the primary auditory cortex (Lauter et al., 1985; 
Humphries et al., 2010). As well as processing tonal information, it binds elements of complex 
sounds together, so they are perceived as a single entity. The auditory cortex also processes 
more abstract elements of the auditory landscape such as echoes and background noise 
(Chechik and Nelken, 2012).  
 
1.2 Neural Oscillations 
1.2.1 Recording the electrical activity of the human brain 
The electrical activity of large populations of millions of neurons often organises into oscillations, 
particularly in receipt of sensory information (1.1.2 above). These oscillations can occur in local 
sites in the brain or involve long distant synchronisation in the timing of electrical activity across 
dispersed brain areas. The oscillatory activity results from the recruitment of networks of 
neurons of different types whose firing temporally summates to form rhythmic fluctuations in 
the potential difference between different locations in the extracellular environment. This 
electrical activity was first recorded using a technique called electroencephalography (EEG), 
developed initially by William Caton (1875) and first used in human subjects by Hans Berger 
(1929). EEG uses electrodes placed on the scalp to remotely monitor neuronal population-
generated voltage fluctuations through the scalp and skull. This technique readily demonstrates 
oscillations, or rhythms, as perhaps the most obvious feature of brain electrical activity. 
 
The first rhythm observed in humans by Berger is now known as the alpha oscillation. It defines 
electrical oscillations of a frequency between 8-12 Hz, and Berger noticed how it dominated the 
visual cortex EEG recordings when the patient’s eyes were closed. This was replaced by the beta 
rhythm (12 – 30Hz) when the patient opened their eyes – a process he called ‘alpha blockade’ 
(Berger, 1929). 
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Since then, further connections between EEG oscillations and the subjects’ sensory, cognitive, 
and behavioural state have been widely studied. In general, the electrical oscillations are slowest 
during sleep and increase in frequency with the state of arousal (see Figure 1.2). The slowest, 
'delta' waves (1-4Hz) are apparent during deep sleep. This stage is also called non-rapid eye 
movement sleep (NREM sleep) or slow wave sleep (SWS). Theta frequency oscillations (4-8Hz) 
are prevalent during the stage known as rapid eye movement (REM) or paradoxical sleep. Two 
types of electrophysiological events also occur during sleep. Large very slow events called k-
complexes occur during NREM sleep in response to external stimuli and are thought to aid in 
suppressing cortical arousal (Cash et al., 2009), and are also thought to play a role in memory 
consolidation and synaptic plasticity (Tononi and Cirelli, 2006). Similar arousal suppression 
(particularly auditory) has been shown to be a function of fast transient bursting events called 
sleep spindles (Dang-Vu et al., 2010). They have also been correlated with memory performance 
(Holz et al., 2012).  
 
The theta and delta oscillations that occur during sleep have low metabolic demand (Madsen 
and Vorstrup, 1991; Maquet, 1997) compared to the faster oscillations associated with 
wakefulness (such as gamma, 30-80Hz) (Nishida et al., 2008), and are even suggested to be 
restorative to neurons and their connections (Eugene and Masiak, 2015). This highlights the 
payoff between the ability to transfer information and process sensory input quickly (as occurs 
during wakefulness using higher frequency oscillations), with the ability for the brain to keep its 
metabolic demand satisfied (Tononi and Cirelli, 2006). 
 
Although the initial discovery of neuronal oscillations involved the EEG technique, there are 
many other techniques by which these phenomena can be studied. Electrocorticography (ECoG) 
is an invasive version of EEG, which involves recording from the pial surface of the brain itself 
and is therefore only usually carried out during neurosurgical operations (Khodagholy et al., 
2016). Magnetoencephalography (MEG) is similar to EEG in that recordings are made non-
invasively, but it measures changes in the magnetic field caused by the activity of neurons rather 
than the voltage changes constituting the electric field (Baillet, 2017). Both ECoG and MEG offer 
recordings with better spatial localisation than EEG, but at the cost of their invasiveness and 
expense respectively. These techniques, in conjunction with the subject’s performance during 
specific cognitive tasks, have allowed the discovery of the processes and brain structures 
involved in many areas of cognition and sensory processing. This thesis concerns itself only with 
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the gamma/beta and delta EEG oscillations as markers of wakefulness and NREM sleep 
respectively, but many far more detailed correlations between oscillations and brain function 
have arisen in the last 20-30 years, including sensory perception and binding, attention and sleep 
(Singer, 1993; Kahana, 2006; Wang, 2010; Jutras and Buffalo, 2014). 
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1.2.2 Recording oscillatory activity in vivo 
To understand the mechanisms involved in generating and maintaining cortical oscillations, 
animals have often been used. In vivo recordings from mammalian brains (mostly rats, mice 
monkeys and cats) have been useful in this respect. In general, electrodes are placed within 
specific brain structures by stereotaxic surgery on living animals and can record the local 
population, single cellular and even subcellular (e.g. dendritic) activity. Through this method, 
activity can be measured during different brain states and can be related to the functional 
behaviours seen in the animal. This can also be applied to observe changes in disease models to 
increase the understanding of the mechanisms behind the pathology and the effect of 
pharmacological manipulations to recover normal function. Whilst in vivo studies have been 
very useful, they also have their disadvantages. Accurate electrode placement is challenging and 
once placed the electrode can shift due to the general movement of the animal, blood flow, or 
breathing - however, the technology in this regard is improving rapidly. There is also limited 
scope in the ability to manipulate the activity of the networks of cells involved. For these 
reasons, the electrophysiological studies in this thesis employed recordings from brain tissue in 
vitro. 
 
1.2.3 Recording oscillations in vitro 
In vitro electrophysiology eliminates many of the above shortfalls of in vivo studies by allowing 
the isolation of neuronal networks, whilst maintaining them in a viable electrically active state 
in slices of neural tissue. This is achieved at the expense of being able to interrogate relationships 
between electrical brain activity and behaviour. However, specific regions of the brain can be 
isolated, and sections can be made from them that can be maintained for many hours. This 
isolation allows absolute certainty regarding the regional origin of any activity seen and 
facilitates a controlled manipulation of electrical excitability and overall neuromodulatory state 
without complexity from unknown variables such as spontaneous activity from multiple afferent 
connections e.g. from sensory stimuli, brainstem and even ‘top-down’ influences from other 
brain areas. 
 
It also allows for more precise electrode placement and makes intracellular recording 
experiments much more technically manageable. However, without afferents and efferent 
connections, there is no sensory input or communication with brain regions that are absent from 
the slice and therefore little to drive spontaneous electrical activity. Therefore, electrical 
stimulation or pharmacological manipulation of the isolated networks, maintained within the 
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slice, must be carried out to mimic the input those networks would normally receive. 
Furthermore, the ionic composition of the artificial cerebrospinal fluid (ACSF) used to maintain 
the slice can be changed to further investigate a role for cellular and synaptic mechanisms 
underlying certain electrical activities. This then provides a basis by which to probe the 
mechanisms behind the oscillatory activity of the brain and study its changes in health and 
disease. What is already known about these mechanisms, and how they may relate to brain 
plasticity is introduced below. 
 
1.2.4 Gamma Oscillations 
The work in this thesis uses a model of gamma oscillations as an experimental model 
representation of cortical dynamics associated with sensory perception during wakefulness. 
Gamma oscillations were one of the first oscillatory conditions to be modelled in vitro. They are 
fairly ubiquitous in most behavioural states, from wakefulness to deep sleep, but are particularly 
prevalent during primary sensory processing during wakefulness (Gray and Singer, 1989). The 
synchronous activity of presynaptic neurons at gamma frequency increases post-synaptic 
responses (especially on convergent targets) and allows for more efficient propagation of 
sensory information. This process also aids in attentional processing (Magazzini and Singh, 
2018), working memory (Lundqvist et al., 2016) and contributes to de novo memory formation 
in the hippocampus (Axmacher et al., 2006; Sederberg et al., 2007; van Vugt et al., 2010).  
 
The importance of gamma oscillations has been highlighted by studies which have shown that 
there is a correlation between the firing rate of cortical neurons and the amplitude of gamma 
band activity in the local field (Ray et al., 2008). In fact, the timing of cell firing during gamma 
oscillations is critical as it allows the segregation of cells that carry information of the salient 
stimuli (and thus fire in time with the gamma oscillation) from cells that carry other information 
(Engel and Singer, 2001). From this, it is apparent that the relationship between gamma-band 
synchrony between regions and the timing of neuronal firing contributes to the processing of 
sensory information and also forms the basis of short-term memory (Engel et al., 2001; Kaiser 
and Lutzenberger, 2005).  
 
It is not surprising then that gamma oscillations have also been shown to be important in visual 
processing (Henrie and Shapley, 2005), auditory processing (Haenschel et al., 2000), olfaction 
(Adrian, 1942), somatosensory perception (Rossiter et al., 2013)  and nociception (Gross, 2007).  
Gamma oscillations are not just critical for processing sensory information from a single source 
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but also for perceptual binding (Tallon-Baudry and Bertrand, 1999). To make sense of the world 
we need to be able to combine individual sensory items into a unified neural representation of 
the sensory object as a whole. Perceptual binding (particularly visual perception) allows us to 
take different features - such as the lines, faces, angles, and depth required to perceive a table 
– and combine them into a single sensory object. This is also important across senses 
(particularly between seeing and hearing) for example in the combination of the visual 
movement of a speakers face with the auditory processing of their speech (Stevenson et al., 
2014; Lin et al., 2015).  
 
1.2.4.1 Mechanisms of gamma – ING 
There are several mechanisms describing how gamma oscillations are generated (see Figure 
1.3). The most basic (in terms of network simplicity) of these mechanisms is interneuron 
network gamma (ING).  
 
ING describes a mechanism of gamma band network activity in which interconnected 
interneurons alone are capable of generating the population rhythm. This was originally shown 
by eliciting 40Hz oscillations in the cornu ammonis area 1 (CA1) region of the hippocampus with 
trains of electrical stimulation that activate metabotropic glutamate receptors (mGluR) or 
through direct mGluR activation by an agonist (Whittington et al., 1995). This mGluR activation 
increases interneuron depolarisation by reducing K+ currents through secondary messenger 
signal activity on K+ channels (Miles and Poncer, 1993). This was shown to be independent of 
pyramidal excitation as the 40Hz rhythms were conserved the after the blockage of glutamate 
receptors (NMDAr, AMPAr and kainate receptors) (Whittington et al., 1995).  
 
Depolarisation of one interneuron generates a train of action potentials whose frequency is 
dictated by the amount of depolarisation and the duration of the after-hyperpolarisation 
potential (or refractory period). However, with interconnected interneurons, the action 
potentials from the first interneuron generate IPSPs in the second, which silences that 
interneurons activity until the IPSP is over. This means that the second interneuron is most likely 
to fire in tandem with the first. It also means that the oscillation is possible due to the 
interneurons’ ability to recover from inhibition with enough tonic depolarisation (by mGluR 
activation) to fire again. Through this mechanism, each interneuron entrains others nearby and 
interneuron network gamma oscillations are generated (Whittington et al., 2000). 
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ING is only possible due to the short range of projections from the interneurons involved (like 
those in CA1). However, it unlikely to be a conserved mechanism in the cortex due to the long-
distance synchronisation of gamma oscillations readily observed in many conditions. 
Furthermore, the physiological relevance of ING is dubious due to the need to isolate networks 
of interneurons from excitatory cell influence and is only possible experimentally through the 
blockage of NMDA and AMPA activity (Whittington et al., 1995). It is unlikely that excitatory cells 
play no part in gamma oscillations due to their dense connectivity with interneurons and the 
fact that hippocampal and neocortical afferents activate both excitatory and inhibitory cells 
during in vivo gamma oscillations (Burchell et al., 1998). 
 
1.2.4.2 Mechanism of gamma – PING 
To be more relevant to the conditions of the brain in vivo, the reciprocal influence of excitatory 
neurons need to be included in with the interneuron network activity. Pyramidal-interneuron 
network gamma (PING) describes this interplay (Traub et al., 1997). Metabotropic receptor 
activation (mGluR and mAChR) recruits pyramidal cells (as well as other interneurons) to the 
network (Whittington et al., 1997) and because pyramidal cells recover from inhibition before 
interneurons, they provide phasic excitation and cause the interneurons to fire again 
(Whittington et al., 2000).  
 
Therefore, as the pyramidal cells fire, their EPSPs cause the activation of fast spiking (FS) 
interneurons (primarily by glutamatergic neurotransmission and action via AMPA receptors). 
The interneuron output then causes the inhibition of other interneurons (the ING mechanism 
above) as well as the reciprocal inhibition of the locally connected pyramidal neurons. This 
process has a decay, which then allows the pyramidal neurons to fire again and thus generates 
rhythmic oscillations at gamma frequency (Whittington et al., 2011). Each interneuron may have 
reciprocal innervation with nearly 1000 different pyramidal cells (Halasy et al., 1996), 
convergence and divergence that highlights the importance of interneurons in the generation 
of the gamma rhythm and the synchronisation of pyramidal cells in the network (Whittington et 
al., 2000). 
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1.2.4.3 Mechanisms of gamma oscillations - Persistent gamma oscillations 
Although the PING model provides the basis for how a gamma rhythm may work in the cortex, 
experimentally it only exists for brief periods of time following glutamate pressure injection 
(Whittington et al., 1998), tetanic stimulation (Whittington et al., 1997) and potassium 
concentration increases (LeBeau et al., 2002). Though PING may be related to certain in vivo 
states, the persistent gamma oscillations seen in vivo and in vitro require an adaptation of the 
model to explain their mechanism. The fundamental conceptual problem with the PING model 
is that it involves the somatic spiking of pyramidal cells, which has only been seen to occur at 1-
4Hz during persistent gamma (Fisahn et al., 1998; Chapman and Lacaille, 1999; Gillies et al., 
2002). Spiking at this frequency range is, at least experimentally, insufficient alone to provide 
the excitatory drive for a persistent rhythm (Whittington and Traub, 2003), even with the huge 
convergence of pyramidal cells onto single interneurons (Gulyas et al., 1999). It would seem, 
that for persistent gamma oscillations to occur another form of input is needed. This comes from 
fast rhythmic bursting (FRB) neurons which spike multiple times per wave of the gamma 
oscillation and require the gap junctions that exist between these and other pyramidal neurons 
to broadcast this additional spiking throughout an electrically connected network of axons 
(Cunningham et al., 2004). 
 
Stable persistent gamma oscillations can be generated in acute slices of rat brain by the bath 
application of carbachol (CCH), an agonist of both muscarinic and nicotinic acetylcholine 
receptors (Fisahn et al., 1998). Whilst carbachol has been shown to generate robust 
hippocampal gamma oscillations, it’s the induction of cortical gamma oscillations is less 
successful (Dickson and Alonso, 1997; Gloveli et al., 1999). Kainic acid (kainic acid, KA), an 
exogenous ligand for the glutamate-sensitive excitatory kainate receptors is even more reliable 
as a manipulation to induce persistent gamma oscillations. This has led to well characterised in 
vitro oscillation models - believed to reliably represent the in vivo oscillation - in the 
hippocampus (Traub et al., 1996), entorhinal cortex (Cunningham et al., 2003), primary auditory 
cortex (Ainsworth et al., 2011) and secondary somatosensory cortex, S2 (Roopun et al., 2008). 
This thesis, therefore, used kainate application to brain slices containing auditory and secondary 
somatosensory cortex to generate gamma oscillations as an in vitro model of an active, awake 
cortex. 
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1.2.4.4 Features of auditory gamma in vitro. 
In the primary auditory cortex (Au1) the gamma rhythm can be generated by bath application 
of 400nM kainate, where the power of the oscillation is highest in layer III (Cunningham et al., 
2004). There is also a kainate concentration-dependent frequency split in the auditory gamma 
oscillation with bath concentrations over 600nM. The faster gamma oscillation (known as γ2) at 
50-80Hz originates from layer IV whereas the slower gamma (γ1) is generated from layers II/III 
(Ainsworth et al., 2011).  Layer V synchronises with layer II/III in low gamma and with layer IV at 
the kainate concentration at which the layers frequencies split. This suggests that differences by 
subject and task of the in vivo rhythm in this area may be related to the strength of the auditory 
input to the cortex, which is mimicked in vitro by the kainate concentration. As we wished to 
model background gamma rhythms we used lower concentrations of kainite, where only the 
slower rhythm was seen. 
 
1.2.4.5 Features of S2 gamma oscillations in vitro 
In the secondary somatosensory cortex (S2) a different frequency split is seen similar to that of 
the auditory cortex. In superficial layers II/III a gamma rhythm exists at around 40Hz whereas in 
layer V the oscillation is in the β2 range (20-30 Hz). These oscillations are maintained after a cut 
is made in layer IV to separate superficial and deeper layers (Roopun et al., 2006). Additionally, 
the power of both oscillations increases after the cut and could be due to destructive 
interference between the two rhythms in the intact slice. The beta rhythm may recruit cells in 
the gamma generators’ layer (and vice versa) and thus the number of cells contributing to each 
rhythm in their respective layers is decreased, which has a detrimental effect on oscillation 
power. 
 
The dual rhythms seen in these cortices (Au1 and S2) are consistent with the idea that the 
sensory information entering the cortex at layer IV can be transferred to both superficial and 
deep layers (Thomson and Bannister, 2003). As superficial layers are known to have strong 
intralaminar connections with other regions (Gilbert and Wiesel, 1979; Lefort et al., 2009), this 
pathway may allow for perceptual binding (discussed above) to create a neural representation 
of the somatosensory perception of an object (combining size, shape and texture). Deeper layers 
project to subcortical regions, such as the thalamus, which controls the response to the stimulus, 
which is especially important in the feedback to control motor actions (Kaas, 1993).  
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1.2.4.6 Multimodal nature of auditory cortex and secondary somatosensory cortex. 
The auditory cortex and somatosensory cortex were both thought to be involved with the 
processing of unimodal sensory information, however studies have since suggested not only 
synchronous activity between these two areas of the neocortex but also that they may encode 
multimodal sensations rather than just dealing with discretely different modes of sensory input 
(some of this with respect to S2 is introduced above). 
 
This has been shown in human fMRI with certain areas of the auditory cortex responding to 
somatosensory input as well as auditory input and subsequently integrating these two inputs 
(Foxe et al., 2002). Also, the responses to joint inputs have been seen to sum to more than 
oscillations resulting from single sensory cues (Ro et al., 2013). 
 
Structurally the auditory cortex has also been found to have connections to the secondary 
somatosensory cortex in humans. These ipsilateral white matter tracts allow the interaction 
between somatosensory and auditory sensory inputs in which sounds can elicit or increase 
tactile perception (Ro et al., 2009). Abnormalities in these connections are known to be present 
in auditory-tactile synaesthesia (Beauchamp and Ro, 2008). 
 
1.2.4.7 Gamma oscillations and plasticity. 
Several lines of evidence link the generation of gamma rhythms to neuronal network plasticity. 
The synchrony of activity between areas of the cortex, mediated by gamma-band frequencies, 
have been linked to memory, with rhinal-hippocampal gamma synchrony underlying successful 
(but not failed) memory formation tasks in humans (Fell et al., 2001). Synchrony has also been 
shown in the rat brain to be generated via fast gamma oscillations between the entorhinal cortex 
and CA1 which underlies the mnemonic encoding of position in space, and in slow gamma 
between CA1 and CA3 for information storage (Colgin et al., 2009b). A reason for the 
prominence of gamma oscillations in the communication between regions, encoding of 
information and memory, could be because the timing of excitatory postsynaptic spikes required 
for synaptic plasticity lies within the gamma range (Bi and Poo, 1998). Plasticity afforded by 
synchronous gamma rhythms has been shown to potentiate excitatory synaptic connections 
between principal cells, leading to changes in the neuronal activity of the hippocampus 
(Whittington et al., 1997) and neocortex (Roopun et al., 2008).  
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The above studies on synchrony between regions in the cortex and the transfer of information 
strongly suggest that synaptic plasticity may be a consequence of the generation of gamma 
rhythms. But what relation do gamma rhythms have to such synaptic plasticity? 
 
Gamma oscillations in neuronal membrane potentials have been suggested to be the 
mechanism by which plasticity can be modulated. One finding that supports this mechanism is 
that layer II/III pyramidal cells undergo LTP or LTD (in the form of changes in EPSP amplitude) 
depending on the phase of the EPSP in relation to the membrane potential oscillation (Wespatat 
et al., 2004). If these cells are part of the network that creates gamma oscillations in the local 
field, they may link gamma rhythms and plasticity via control of neuronal output timings. 
Moreover, repeated stimulation of layer 4 (causing ascending cortical activation to more 
superficial layers) with the specific application of glutamate 1 hour apart can cause plasticity 
which alters gamma oscillation dynamics. After repeated stimulation, there was an increase in 
the power of the oscillation, as well as superficial enhancement and deeper layer suppression 
of spike firing frequencies and their timing to the field oscillation (Ainsworth et al., 2016). These 
processes are thought to be important for attentional modulation and short-term memory. 
Another way of answering the question is to look at gamma rhythms related to memory - an 
outcome of plasticity. This approach has shown that the spectral power of gamma-band 
oscillations in the auditory cortex appears to be predictive of the formation of an associative 
(auditory fear conditioning) long-term memory (Headley and Weinberger, 2011). 
 
From the above evidence, it appears that gamma rhythms play a role in the formation of new 
memories. However, this alone is usually not enough to generate life-long memories. The 
formation of new memories needs to be ‘consolidated’ somehow. Current theories suggest this 
is done during sleep, so we next consider sleep-related cortical dynamics.  
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1.2.5 Delta Oscillations 
This thesis uses an in vitro model of delta rhythms to represent the cortical dynamic state during 
sleep. During deep sleep (NREM stages 3 and 4) the brain exhibits slow wave activity (SWA), 
which is dominated by delta oscillations (1-4Hz) in the EEG. Oscillations in this band are believed 
to play a role in synaptic homeostasis and memory consolidation vital for long-term learning in 
humans (Huber et al., 2004; Walker, 2009) and have been shown to be amplified during sleep in 
rats in specific brain regions related to a learning task during prior wakefulness (Hanlon et al., 
2009).  
 
Delta waves were once believed to be only physiologically relevant to sleep, and their presence 
during wakefulness was considered a response to brain injury or pathology (see section 1.4 
below). However, there has also been emerging evidence for the impact of wake state delta 
rhythms on normal attentional processing, and the inhibition of sensory input that would 
interfere with the concentration required to carry out a task (Harmony et al., 1996). It is possible 
this is a similar mechanism involved in the functional separation of the whole brain from sensory 
input during sleep (Alper et al., 2006). Contrasting this idea, experiments have shown that whilst 
there is a positive correlation between delta rhythms and metabolism during wakefulness, the 
relationship is negative during sleep  (Maquet, 1997). This disparity may suggest a functional 
difference between physiological waking delta oscillations and those seen during sleep that is 
beyond the scope of this thesis. 
 
1.2.5.1 Mechanisms of delta oscillations 
Delta oscillations are believed to have at least two components to their generation – one 
neocortical, one thalamic. In the thalamus, delta rhythms are generated after neuromodulatory 
afferent changes from brain stem nuclei (McCormick, 1992; Varela and Sherman, 2009). These 
brainstem nuclei are responsible for cholinergic and aminergic signalling (dopamine, histamine, 
noradrenaline and serotonin) in the brain and make up the reticular activating system (RAS) 
which controls arousal and sleep. Cholinergic neurons within the RAS promote cortical activation 
via the thalamus, whereas as the activity of brainstem aminergic nuclei is relayed through the 
hypothalamus. During sleep, neurons in the reticular activating system have a lower firing rate 
(due to inhibition by GABAergic neurons of the preoptic area). This leads to a reduction in 
neuronal activity propagated to thalamocortical neurons.  
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Hyperpolarisation of thalamocortical cells by the reticular activating system generates low 
threshold spiking (LTS) at 1-2Hz. The delay between periods of this activity occurs due to the 
time courses of intrinsic conductances expressed by thalamocortical (TC) neurons. This includes 
the activation and inactivation of the hyperpolarisation-activated (Ih) current and its interaction 
with the low threshold calcium (IT) current which occurs after LTS (Soltesz et al., 1991; Brown et 
al., 2012) as well as the delayed rectifier current (IK) (Emri et al., 2000). In fact, the ablation of 
the Ih current (by ZD7288 application abolished TC delta activity) and an increase in Ih also 
increases this oscillatory activity (Hughes et al., 1998). Furthermore, this thalamic activity can 
be synchronised by the inhibitory activity of reticular (RE) cells that hyperpolarises TC cells at a 
membrane potential at which delta frequency LTS occur (Steriade et al., 1991).  
 
However, the importance of the thalamus for conferring and organising oscillations within the 
cortex is debated. The sheer extent of the thalamocortical projections could allow for the 
cortical delta rhythm to merely be the propagation of the thalamic oscillation. However, in vivo 
experiments using surgical procedures to isolate the cortex have still shown the presence of 0.1-
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4 Hz oscillations, even without thalamic inputs (Kellaway et al., 1966; Timofeev et al., 2000).  
Indeed, some cortical forms of delta rhythm have been shown to be reliant intrinsic properties 
of cortical neurons and are reflected in thalamocortical neurons, rather than the other way 
around (Amzica and Steriade, 1998; Fell et al., 2002). It has also been suggested that during sleep 
different cortical areas locally generate delta rhythms in a use-dependent manner (Vassalli and 
Dijk, 2009), a feature that has also been in awake animals. (Vyazovskiy et al., 2011). The 
association areas of frontal cortex and parietal cortex are the predominant proposed delta 
rhythm generators in human cortex during sleep (Ioannides et al., 2009), and each cortical 
region may have its own local delta rhythm generator (Mormann et al., 2008) interacting with 
the thalamic generators (described above). This occurs through excitatory glutamatergic 
corticothalamic projections to thalamocortical neurons or reticular neurons. The inhibitory relay 
through GABAergic reticular neurons to thalamocortical neurons overcomes the direct 
excitatory feedback (Steriade, 2003). 
 
1.2.5.2 In vitro Delta Oscillations 
In vitro preparations have also shown the ability of the isolated neocortex to generate delta 
oscillations. This requires using a combination of very low levels of the cholinergic agonist 
Carbachol (10% that used for in vitro gamma oscillations) and a dopaminergic (D1R) antagonist 
SCH23990 to mimic the low dopaminergic tone seen during sleep (Watson et al., 2010) to 
generate a burst firing pattern from intrinsically bursting (IB) cells in an NMDAR dependent 
manner (Traub et al., 2017)  . The periodicity of the delta rhythms is determined by the duration 
of the after-hyperpolarisation potentials (AHP) of IB cells. The AHPs reflect the inhibitory GABAB 
currents which occur in IB cells and are caused by GABA signalling from neurogliaform cells.  
They cause a refractory period in which the IB cells are hyperpolarised, preventing their firing 
until the AHP event is over. Layer V regular spiking (RS) neurons are also involved; spiking only 
a few times per delta period causing (Carracedo et al., 2013). This sparse spiking correlates with 
EPSPs (~2 per delta period) in layer 2/3 which are thought to converge to facilitate the excitation 
of burst firing of layer V IBs (Kampa et al., 2006).  
 
Much of what is known about the mechanism of the delta rhythms was studied in the secondary 
somatosensory cortex as it is known to generate strong delta rhythms in rodents – where it 
forms part of the parietal cortex -  (Carracedo et al., 2013) and in humans (Ioannides et al., 2009). 
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1.2.5.3 Delta activity and memory consolidation  
One of the putative functions of delta oscillations is the consolidation of memories. 
Consolidation is the process whereby a memory trace, which is the neuronal representation of 
a recently encoded memory, is stabilised and reinforced. It is a two-part process, with both roles 
requiring different cortical dynamics. Synaptic consolidation, which occurs during REM sleep 
(Diekelmann and Born, 2010) (and is thus associated with the theta rhythms) is the process 
whereby the circuit in which the memory trace exists is strengthened, through molecular 
mechanisms to increase synaptic efficacy. To transfer the memory held in short term circuits to 
long-term memory, the process of ‘systems consolidation’ occurs (Dudai and Eisenberg, 2004). 
Systems consolidation is thought to consist of many waves of synaptic consolidation that 
reorganise the representation of a long term memory to dispersed neuronal networks and can 
occur over a period of months (Dudai et al., 2015). This process happens during SWS when 
acetylcholine levels are at their lowest (Gais and Born, 2004).  
 
During wakefulness, high levels of acetylcholine have been shown to decrease EPSPs in the 
feedback pathway from CA3 to CA1 and entorhinal cortex (Rovira et al., 1983; Herreras et al., 
1988). This process is known as excitatory feedback suppression and is mediated by high levels 
of acetylcholine. This limits the spread of information to hippocampal circuits and prevents their 
interference with memory traces in the cortex. Oppositely, reduced levels of acetylcholine 
during sleep prevents feedback suppression to allow the transfer of information through the 
hippocampus to the entorhinal cortex and association cortex to allows the consolidation of 
memory (Hasselmo, 1999). Although delta oscillations are prevalent during SWS and are known 
to be associated with low cholinergic tone, little is known about their contribution to this 
mechanism of memory consolidation.  
 
1.2.5.4 Delta activity and plasticity  
Delta band activity is known to increase during sleep with the amount of time spent awake; 
particularly in areas related to the sensory modality of experience during prior wakefulness 
(Kattler et al., 1994; Huber et al., 2004; Miyamoto and Murayama, 2016). Some theorise that 
this is a restorative response to the neuronal fatigue built up by greater firing rates during 
wakefulness, (Rechtschaffen, 1998; Vyazovskiy and Harris, 2013). To test this theory 
optogenetics have been used. This uses the delivery of a viral vector to allow local populations 
of neurons to be stimulated to fire after the delivery of a light pulse. Rodriguez et al. (2016)   
compared mice that displayed wake-like tonic firing in the frontal cortex when optogenetically 
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stimulated (during each NREM cycle occurring in the previous 6 hours), with mice that had been 
sleep deprived for 6 hours by the placement of a novel object in their cage whenever they 
appeared to be inactive. After treatment conditions, mice were allowed to sleep and their SWA 
was monitored. It was shown that an increase in the amplitude of SWA only occurs during sleep 
deprivation and the frequency of ‘off’ periods of the oscillation increased in correlation with 
neuronal activity during prior wakefulness. No such changes were seen in the optogenetic 
stimulated mice. This suggests that the response in SWA is to increases in synaptic strength 
during wakefulness rather than just a blanket increase in neuronal activity. It may, therefore, 
follow that SWA is required for the renormalisation of synaptic strength accrued during 
wakefulness to relieve the metabolic demand. 
 
This is the proposed process at the core of the synaptic homeostasis hypothesis (SHY). This 
theory suggests that during the wake state there is a net strengthening of synapses in the brain, 
as a result of the sensory processing and learning that occurs. This leads to a cellular need for 
space in which to build additional synaptic connections and more energy to strengthen them 
and maintain them, however, both of these demands are limited. It is suggested that sleep is 
required to generally normalise these synaptic connections, by globally decreasing synaptic 
strength so that the process of synaptic strengthening can continue again the following day 
(Tononi and Cirelli, 2014).  
 
The idea that there is a general decrease in synaptic strength during sleep is corroborated by 
structural, molecular and electrophysiological evidence.  There has been shown to a net loss in 
number and size of synaptic spines during sleep in Drosophila (Bushey et al., 2011) and mice 
(Maret et al., 2011). The number of excitatory AMPA receptors is known to be increased during 
wakefulness and decreased in sleep (molecular markers of synaptic strength) (Vyazovskiy et al., 
2008; Lante et al., 2011). Furthermore, sleep also leads to decreased cortical firing rates 
(Vyazovskiy et al., 2009). 
 
An expansion on the theory also exists suggesting that the decrease in synaptic strength does 
not affect all synapses, but those which are stronger (with larger spines) are unaffected which 
improves the increase signal to noise ratio of those synaptic connections. Looking at the physical 
connections between dendritic spines and axon terminals - called the axon spine interface (ASI) 
- by electron microscopy has shown that there is a shrinkage of 18% in the area of contact at the 
ASI during sleep (de Vivo et al., 2017). This also correlated to the size of the dendritic spines, 
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with the largest 20% of spines being spared. There has also been shown to be a net loss of 
synaptic spines during sleep (Maret et al., 2011), although it is not clear as to whether it is the 
smaller spines that are lost.  
 
Further to these structural changes, electrical changes at the synapse and at the neuronal level 
occur during sleep. In general, the firing rates of neurones are decreased during sleep in the 
cortex (Vyazovskiy et al., 2009; Watson et al., 2016) and hippocampus (Miyawaki and Diba, 
2016). Additionally, the general efficacy of cortico-cortical synapses has been shown to be 
decreased after sleep (Vyazovskiy et al., 2008). However looking at individual neurons, it was 
found that their firing rates during sleep are equalised from initially higher or lower rates 
(Watson et al., 2016). These changes - along with the divergent changes in synaptic size and 
contact highlighted by de Vivo et al. (2017) suggest that homeostatic rescaling during sleep is 
more complex than the global downscaling of synapses. It appears that different processes occur 
at synapses depending on their strength, to increase the ‘signal-to-noise’ ratio (rather than 
maintain it as suggested in the general downscaling hypothesis). 
 
Molecular changes at the synapse have been implicated in this synaptic scaling during sleep. 
Along with the decrease in spines size, the internalisation and dephosphorylation of 
glutamatergic AMPA receptors in specific synapses occurs during sleep (Diering et al., 2017). The 
decrease in postsynaptic AMPA receptor number reduces the number of cations entering 
through the associated ion channels after glutamate binding, and thus decreases the size of 
EPSPs propagated across the synapse as the postsynaptic membrane (Luscher et al., 1999). The 
ability of spines to regulate their synaptic homeostasis in response to local activity (through this 
AMPA receptor endocytosis) requires the activity of the immediate early gene Arc (Béïque et al., 
2011), which is discussed further below and is a focus of this thesis.   
 
A further link between AMPA receptor internalisation and sleep is through adenosine signalling.   
Adenosine receptor activation is known to cause the internalisation of AMPA receptors (Chen et 
al., 2016). Furthermore, the accumulation of adenosine during wakefulness is known to lead to 
the inhibition of the aminergic systems of the reticular activating system (see Chapter 1.2.4.1 
and Figure 1.4) otherwise promote wakefulness and activate the cortex after conscious 
disconnection during sleep. Adenosine accumulation causes the disinhibition of GABAergic 
neurones of the ventrolateral preoptic area which in turn causes the inhibition of aminergic and 
cholinergic nuclei of the reticular activating system to promote sleep (Pace-Schott and Hobson, 
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2002). Adenosine also directly facilitates SWA in thalamocortical neurons (Pape, 1992). It is likely 
that synaptic plasticity through NMDAR activation would lead to an increase in adenosine 
concentrations in thalamocortical circuits and thus subsequently increases SWA (Bjorness and 
Greene, 2009), as NMDAR activation is known to increase adenosine concentrations in 
brainstem cholinergic nuclei (Brambilla et al., 2005).  
 
The cholinergic system plays an important role in the presence of SWA. Increased cholinergic 
tone to levels associated with wakefulness inhibits SWA in cortical neurons (Marrosu et al., 
1995), and is managed by adenosine-1 receptor (A1Rs) activation which inhibits acetylcholine 
release from tegmental nuclei and the nucleus basalis of Meynert to decrease arousal (Porkka-
Heiskanen et al., 1997).  
 
Dopamine is also crucial in controlling the sleep-wake cycle, with dopaminergic cells in the 
ventral tegmental areas responsible for controlling arousal (Monti and Jantos, 2008). Stimulants 
that increase dopamine signalling either through the KO of the dopamine transporter (Wisor et 
al., 2001) or through the exogenous activation of dopamine receptors (Isaac and Berridge, 2003) 
all serve to promote wakefulness. Whereas the antagonism of the receptors has the opposite 
effect (Monti et al., 1990). Antagonism of hippocampal D1 receptors has also been shown to 
have a negative effect on the persistence of fear memory (Rossato et al., 2009), which may point 
at a role of low dopamine in the processed of depotentiation needed for synaptic rescaling.  
 
1.3 Immediate early genes (IEGs) 
To quantify activity and plasticity levels associated with wake and sleep rhythms this thesis uses 
immediate early genes as markers. Immediate early genes (IEGs) are the first genetic response 
to cellular signals and their transcription is rapidly induced (in as little as 15 minutes) in response 
to a wide variety of stimuli (Hu et al., 1994). Many IEGs are transcription factors and as such are 
involved in triggering a cascade of activation that leads to the downstream expression of further 
genes and cellular effects. These effects relate to the classes to which the IEG belongs, with 
some (regulatory transcription factors) exerting a wide cellular effect through the genes they 
activate, whereas others have a more focussed role in specific cellular processes (Guzowski et 
al., 2001). The experiments performed here used 2 IEGs as activity/plasticity markers: c-fos and 
Arc. 
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1.3.1 C-fos - Finkel–Biskis–Jinkins osteogenic sarcoma homologue 
C-fos is a member of the Fos family of transcription factors. It was originally discovered as a 
proto-oncogene and is the mammalian homolog of the Finkel-Biskis-Jinkins osteogenic sarcoma 
virus gene that was found in mouse tumours (Finkel et al., 1966). It is now known to be an 
immediate early gene due to its rapid transcriptional induction and has been used as a marker 
for recent neuronal activation (Morgan and Curran, 1989; Hoffman et al., 1993).  
 
The c-fos protein contains a region common to many transcription factors, known as the leucine 
zipper. It is so called as every seventh amino acid in its sequence is a leucine residue. This zipper 
allows the heterodimerisation of c-Fos protein with Jun family proteins such as c-Jun – a product 
of another immediate early gene (Gentz et al., 1989; Turner and Tjian, 1989). This heterodimer 
forms the protein complex known as AP-1 (Activator Protein 1) that acts as a transcription factor 
involved in many cellular processes. The c-Jun protein can also homodimerize in the absence of 
c-Fos, but in this form, its binding affinity for DNA is 25 times less that of the AP-1 complex 
(Halazonetis et al., 1988). 
 
1.3.1.1 C-fos as a marker of neuronal activation 
The low expression of c-fos in basal conditions allows its transcription and translation to be 
accurately monitored. As c-fos is an immediate early gene, the time-scale of its upregulation is 
relatively fast, with c-fos mRNA levels peaking after 30 minutes and protein expression being 
elevated from 60 minutes after the induction stimulus (Morgan et al., 1987).  
 
Early studies that examined the activity-dependent expression of c-fos did not look at single 
neurons but at changes in expression in neuronal populations in response to a wide variety of 
stimuli. These studies showed c-fos expression could be induced in certain brain areas in 
response to: noxious sensory stimulation (Hunt et al., 1987; Coggeshall, 2005) sciatic nerve 
stimulation (Bojovic et al., 2015), dehydration (Carter and Murphy, 1990) myocardial  infarction 
(Ahn et al., 2015), seizure (Morgan et al., 1987), (Smeyne et al., 1992), instrumental learning 
(Svarnik et al., 2005), novel environment exposure (VanElzakker et al., 2008) and various 
stressors  (Chowdhury et al., 2000; Ubeda-Contreras et al., 2018). 
 
To understand the mechanism behind c-fos induction, it is important to see how c-fos 
upregulation occurs in single cells. It is now known that c-fos expression can be induced in 
neurons by membrane depolarisation, as well as brain-derived neurotrophic factor (BDNF) 
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signalling and Forskolin application (i.e. increased cAMP levels) (Joo et al., 2016). These stimuli 
induce c-fos gene expression through the activation of the transcription factors CREB and SRF 
by protein kinases, such as Ca2+/calmodulin-dependent protein kinases, MAP kinases and protein 
kinase A (West and Greenberg, 2011).  Furthermore, from experiments using Channelrhodopsin-
2 transfected pyramidal hippocampal cells, trains of action potentials were stimulated, firing 
spikes in response to light pulses. Stimulation in this way increased in the expression of c-Fos 
protein in single neurons in an NMDA and AMPA receptor-independent manner; though it 
required the activity of the sodium channels (Schoenenberger et al., 2009).  This suggests that 
neuronal output (action potentials) alone are sufficient to upregulate c-fos expression. 
 
The situation becomes a little more complex when it is considered that generation of antidromic 
action potentials causes an insignificant increase in c-fos mRNA levels in magnocellular neurons 
of the hypothalamus, compared to muscarinic acetylcholine activation by carbachol (Luckman 
et al., 1994). Whether this discrepancy is due to the cell types involved, or different stimulation 
regimes, is uncertain. It does suggest however that c-fos expression may be specific to 
orthodromic action potentials alone, a factor that may influence its use as a marker for activity 
during persistent gamma rhythms (see above). 
 
Further evidence also suggests that the mechanism of neuronal c-fos induction is more 
complicated than a straightforward orthodromic action potential leading to c-fos transcription 
relationship. At least in terms of the amount of expression, it has been shown that under seizure 
stimulation the number of action potentials is not correlated with the magnitude of c-fos 
induction (Labiner et al., 1993). There is also no direct correlation between the percentage of c-
Fos-positive neurons and percentage of active neurons (Svarnik et al., 2005). This is emphasised 
by Kovacs (2008) who points out that if depolarisation alone were sufficient to induce the 
expression of c-fos, then under basal conditions there would be robust staining in millions of 
cells throughout the brain, which is not the case. 
 
In addition, c-fos expression has been shown to exhibit a high degree of region-specificity. For 
example, in an appetitive reaching task, the motor cortex showed no induction of c-Fos protein, 
whereas the retro-splenial cortex (involved in ‘learning’ the task) showed a significant increase 
(Svarnik et al., 2005). During different stress conditions, different patterns of up and 
downregulation of c-Fos expression are seen within different regions of the brain related to the 
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intensity of the stress and also qualitative aspects of the stressor (Chowdhury et al., 2000; 
Ubeda-Contreras et al., 2018).  
 
Therefore, it seems that c-fos is induced not by the simple firing of action potentials in existing 
patterns, but to changed patterns of neuronal activity (Svarnik et al., 2013). This may explain 
why stimulation of unusual brain activity (e.g. evoked seizures) and behavioural tasks that 
involve the activation of new circuits induce c-fos expression.  
 
This is particularly true for a novel experience (VanElzakker et al., 2008), visual stimulation 
(Rosen et al., 1992)  and learning (Anokhin et al., 1991; Kleim et al., 1996) where the induction 
of c-fos expression was seen to be specifically increased in cortical areas related to the task. This 
increase was not seen in control animals or those repeating already learned behaviour.  
 
1.3.1.2 C-fos and memory 
The above evidence suggests that c-fos expression may be related to the formation of memory 
and its persistence. This has also been more directly tested, with evidence showing that delayed 
expression of c-fos mRNA is necessary for the persistence of a long-term memory trace that 
would have otherwise have decayed (Katche et al., 2010).  
 
Looking more in depth at the mechanism to link learning and memory to c-fos expression, it has 
been shown that using chemical and electrical methods that induce synaptic plasticity - through 
long-term potentiation (LTP) - cause increases in c-Fos protein (Abraham et al., 1991). However, 
the amount of LTP evoked by this method does not correlate with the extent of c-fos induction 
(Dragunow et al., 1989). This suggests that either there is a non-linear relationship between LTP 
induction and c-fos expression, or it may be neuronal activation and not the potentiation of the 
synapse that causes the c-fos upregulation. Brain-specific c-fos knockout mice have been used 
to directly interrogate the role of c-fos in plasticity and memory. Using the Cre/LoxP system to 
ablate c-fos expression in nestin-expressing cells, Fleischmann et al. (2003) showed that 
knockout of c-fos from the CNS led to impaired spatial memory and a concurrent decrease in 
LTP between CA1 and CA3 regions of the hippocampus. 
 
Although these studies all link changes in the levels of c-Fos directly and indirectly to synaptic 
plasticity, they do not suggest the mechanism of molecular involvement of c-Fos in this process. 
C-Fos likely acts through AP-1 in the process of synaptic plasticity. AP-1 regulates the expression 
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of plasticity-associated genes (Eagle et al., 2016) including BDNF (Tuvikene et al., 2016) and cyclic 
AMP response-element-binding protein (Sanyal et al., 2002). AS induced BDNF and CREB can 
further activate transcription to regulate synaptic strength and number, AP-1 mediated gene 
expression appears to act via positive feedback loops to influence synaptic plasticity. 
 
1.3.2 Arc - Activity-related cytoskeleton-associated protein  
Another immediate early gene, with a more direct link to synaptic plasticity, is the activity-
regulated cytoskeleton-associated protein, Arc (also known as Arg3.1). Most immediate early 
gene products are translated in the cell body where they remain to mediate their cellular actions 
(Wallace et al., 1998). Arc is a neuron-specific IEG and its expression is regulated at the level of 
transcription, mRNA trafficking and protein translation. Synaptic activity not only induces Arc 
mRNA but also triggers the trafficking of Arc mRNA to dendrites where it is subsequently locally 
translated (Steward et al., 1998). Its increased expression has been related directly to learning 
and memory and has been shown to participate in several different forms of synaptic plasticity.  
 
1.3.2.1 Arc and long-term potentiation 
Early studies on Arc induction showed that Arc mRNA and Arc protein were seen to be increased 
for up to 4hrs by high-frequency stimulation (400Hz); known to induce LTP (Lyford et al., 1995). 
This increase was blocked by pre-treatment with the NMDA receptor antagonist MK801, which 
suggested that NMDA receptor-dependent signalling cascades are, at least in part, responsible 
for the increase in Arc mRNA (Link et al., 1995). The role of Arc in LTP was found to be related to 
its involvement in the stabilisation and growth of filamentous actin in the synaptic cytoskeleton 
(Guzowski et al., 2000; Messaoudi et al., 2007).  
 
Arc expression can also be induced chemically (with BDNF, bicuculline or glutamate) rather than 
with electrical stimulation, in an NMDAR dependent manner. Whilst NMDA receptor activation 
induces Arc expression the activation of AMPA receptors have been shown to inhibit Arc 
expression. Rao et al. (2006) showed that the inhibition of AMPA receptors with NBQX and GYKI 
52466 had the opposite effect, increasing both basal and BDNF-induced Arc expression. This 
suggests that Arc expression is balanced by NMDAR and AMPAR activation. 
 
The knockout of Arc impairs spatial learning (Managò et al., 2016), fear conditioning (Gouty-
Colomer et al., 2016) and taste aversion (Plath et al., 2006), due to impaired long-term memory 
related to late-phase LTP. This occurs despite intact short-term memory and increased early 
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phase LTP (Plath et al., 2006). Using antisense oligonucleotides to inhibit Arc protein expression 
leads to impaired maintenance of LTP but does not affect its induction (Guzowski et al., 2000; 
Messaoudi et al., 2007). It also appears that inhibition of such maintenance of LTP impairs 
memory consolidation (Guzowski et al., 2000; Bramham et al., 2010).  
 
1.3.2.2 Arc and Long-Term Depression 
Although the process of memory consolidation requires the strengthening of more important 
memories, forgetting things that are trivial or unimportant is also crucial. This would require the 
weakening of synaptic strength which occurs in by a process called long-term depression (LTD) 
(Tononi and Cirelli, 2014). In this process, metabotropic glutamate receptors (mGluR) can reduce 
synaptic strength between neurons through mGluR dependent-LTD (Lüscher and Huber, 2010). 
One of the key mechanisms that underpin this, which Arc plays a role in, is the rapid endocytosis 
of AMPA receptors from the post-synaptic membrane (Wall and Correa, 2018). This, in turn, 
reduces the post-synaptic response to glutamate release. This is likely to be an important factor 
in the process of memory consolidation during sleep, since AMPA receptors in synapto-
neurosomes (isolated synaptic vesicles and terminals from brain homogenate) have been shown 
to be decreased in rat brains at the end of the rest phase (when 75% of the previous dark phase 
was spent awake) compared to the active phase (when 75% of the light phase was spent asleep)  
(Vyazovskiy et al., 2008). 
 
Arc enables AMPAR endocytosis through its interaction with two endocytic proteins endophilin 
and dynamin that bring AMPA receptors into endosomes where they are recycled, lysed or 
trafficked to the nucleus (Chowdhury et al., 2006; Rial Verde et al., 2006; Shepherd et al., 2006). 
This process is crucial in the rescaling of synapses during sleep (Diering et al., 2017) and is crucial 
for the maintenance of synaptic homeostasis and memory consolidation. This mGluR-LTD can 
be induced electrically with low-frequency stimulation (LFS) or pharmacologically using 
dihydroxyphenyl-glycine (DHPG) as an exogenous agonist for the mGluR-1 and 5 (Waung et al., 
2008). Blocking Arc gene expression inhibits the induction of LTD by either method (Park et al., 
2008). 
 
1.3.3 General IEG changes during different brain states 
The expression of IEGs in the brain been compared between sleep and wakefulness by cDNA 
microarray. C-fos (Cirelli and Tononi, 1999) and Arc (Cirelli and Tononi, 2000b) mRNA levels were 
increased in all layers of the cortex after 3 hours of spontaneous wakefulness (SW – where the 
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animals spent >75% of the last 3 hours awake) compared to spontaneous sleep (SS – animals 
spent >75% of the last 3 hours asleep). There was no significant difference between 3 hours SW 
and 3 hours sleep deprivation (SD – by stroking with a paintbrush once animals appeared 
drowsy), and after 24 hours SD the IEG expression was lower still (Cirelli et al., 1995). These 
comparison studies were carried out on wide regions of the brain rather than specific areas, so 
the increases are general during the awake state compared to sleep, which would point to a 
general decrease in synaptic strength during sleep. This contrasts with other studies looking at 
regional changes to immediate early gene levels during post-learning sleep.  
 
1.3.4 Regional IEG changes across brains states  
Regional differences in IEG expression have been related to synaptic plasticity and IEG 
expression is increased in certain areas of the brain as a result of learning tasks in rats and mice. 
During REM sleep, animals recently exposed to a visually enriched environment showed a 
significant increase in the expression of the plasticity-related gene IEG zif268 in the cortex and 
hippocampus during subsequent REM sleep (Ribeiro et al., 1999). Further to this, there is a 
positive correlation between the amplitude of spindle firing events (which exist in the transition 
between REM and SWS) and the level of IEGs such as Arc (Ribeiro et al., 2007). Other studies 
have shown a link between zif268 and consolidation of fear conditioning memories in the 
hippocampus (Lee et al., 2004), which seems to point at a role of sleep and the long-term 
preservation of memories. These studies suggest a relationship between certain brain states and 
synaptic plasticity. Since neural oscillations vary during different brain states too, it is thought 
that they may have a part to play in this memory formation and plasticity.  
 
This is reinforced by findings that link the expression of c-Fos (an IEG marker for ‘new’ patterns 
of cellular activation, see above) and Arc (an IEG core to mechanisms of neural plasticity) with 
task-related sleep slow wave activity (SWA). In mice performing a unilateral reaching task, there 
was an increase in SWA in the learned hemisphere. This was seen in conjunction with an increase 
in Arc and c-Fos protein levels (Hanlon et al., 2009). The relationship between REM sleep and 
memory consolidation has also been investigated as REM is the sleep stage that is classically 
associated with theta frequency oscillations. These theta oscillations are thought to induce 
synaptic memory in the form of late LTP in the hippocampal CA1 region (Huang and Kandel, 
2005). 
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1.4 Neuroinflammation 
Neuroinflammation is the normal response of the immune system of the CNS to the presence of 
foreign material and damaged endogenous cells that may prove harmful to the surrounding 
nervous tissue. Associations have been discovered between neuroinflammation and altered 
sleep patterns (Mullington et al., 2010). The cause and effect of these associations appear to go 
both ways, with sleep loss in humans inducing increases in proinflammatory markers in the 
blood inflammatory (Vgontzas et al., 2004; Irwin et al., 2008) and infusion of proinflammatory 
cytokines promoting sleep in animals (Krueger et al., 1984). Furthermore, the immune challenge 
in humans prior to sleep reduces the duration of REM sleep, but increase the time spent in NREM 
sleep with no effect of oscillatory amplitude (Pollmacher et al., 1993). However if the 
inflammatory challenge occurs during sleep there is no alteration in the duration of any sleep 
stage but increases in delta and theta power during NREM sleep are seen (Haack et al., 2001).  
 
There have also been many studies to look at the relationship between inflammation and 
cognitive function. Neuroinflammation had been associated with deficits in attention (Holden 
et al., 2008), working memory (Buchanan et al., 2008),  contextual fear memory (Barrientos et 
al., 2009a)  episodic and spatial memory (d’Avila et al., 2018) and  object recognition memory 
(Hirshler et al., 2010) in animals. Similar associations have been seen in humans with increases 
in inflammatory markers associated with mild cognitive impairment (Magaki et al., 2007), 
decline in verbal and non-verbal memory (Reichenberg et al., 2001) as well as specific cognitive 
tests after stroke (Rothenburg et al., 2010) and normal ageing (Dik et al., 2005; Simen et al., 
2011). Therefore neuroinflammation is considered in this thesis as a potential means to perturb 
the pattern of cortical dynamics and subsequently change IEG markers. These are quantified in 
the early sections of this thesis.  
 
The inflammatory environment can be triggered in the brain after a physical, pathogenic, toxic, 
or autoimmune insult. Whilst most disease-relevant cases relate to chronic neuroinflammation, 
it can also occur acutely, most commonly related to a physical brain injury sustained during 
contact sports. Neuroinflammation may also manifest aberrantly, where the response to the 
above insults is excessive. In these cases, the normal, healthy aspects of neuroinflammation can 
become part of primary pathology. Whilst the peripheral immune system is responsible for 
initiating an inflammatory response to fight infection and remove foreign agents, under normal 
conditions peripheral immune cells are restricted from entering CNS tissues by the blood-brain 
barrier (BBB). However, in the case of brain trauma or disease conditions infiltration may occur. 
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Thus, any study of neuroinflammation secondary to systemic infection (or model thereof) needs 
to consider the BBB. 
 
1.4.1 The blood-brain barrier 
The blood-brain barrier (BBB) is a unique feature of the microvasculature of the CNS. It prevents 
the passage of larger objects and molecules (such as bacteria) from the circulation into the CSF 
whilst allowing the movement of smaller homeostatic molecules necessary for the maintenance 
of the CNS tissue. The BBB is mainly formed by specialised endothelial cells (ECs) that are 39% 
thinner than ECs in other tissues. This allows faster diffusion of water, gases and lipid-soluble 
molecules to provide nutrients more easily for the highly metabolically active CNS tissue 
(Coomber and Stewart, 1985). The ECs of the CNS are uniquely held together by tight junctions 
that limit the paracellular flow of solutes between the blood and the extracellular environment 
of the CNS (Brightman and Reese, 1969).  
 
Transcellular movement across the BBB ECs occurs through several systems. Gases (O2 and CO2) 
and smaller polar molecules can diffuse across easily across the BBB. The passive movement of 
ions and smaller molecules occurs through channels, whilst active transport of molecules also 
occurs across the BBB, which expresses high levels of the glucose transporter (GLUT1) (Boado et 
al., 1994) and amino acid transporter (LAT1) (Boado et al., 1999). Larger molecules are carried 
across the blood-brain barrier in vesicles and it is this transcytosis that is also of high importance 
for the delivery route of drugs across the BBB (Andreone et al., 2017).  
 
Other cells and structures support the BBB. Astrocytes ensheath blood vessels and neurons and 
provide communication between neurons and contractile pericytes (PCs) to allow changes in 
blood flow (through alterations in vascular diameter). This allows the provision of a nutrient 
supply to be tailored to the tissue's requirement, often in accordance with neuronal activity 
(Gordon et al., 2011).  A basement membrane is also provided by PCs and ECs to provide 
structural integrity to the neurovascular system. 
 
Although the blood-brain barrier is designed to isolate the brain from the inflammatory 
environment of the body, a systemic infection can still affect the CNS. This can occur through 
several means: using the BBBs para- or transcellular mechanisms for the transport of 
inflammatory signalling molecules or through immune cells; entry by the disruption of the blood-
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brain barrier or through the circumventricular organs; or through the peripheral activation of 
the autonomic nervous system sending signals to the brains (Varatharaj and Galea, 2017).  
 
1.4.2 Microglia 
The blood-brain barrier keeps the CNS isolated from pathogens that may be present in the 
peripheral circulatory system, however, this also means that it is separated from the peripheral 
immune system. Therefore, the CNS has specialised resident immune cells called microglia, 
which are responsible for the coordination of the brain’s immune response. Infections in the 
CNS occur infrequently however and recently studies have found microglia have a wide range of 
other roles in neuroprotection (Vinet et al., 2012) and in the pruning of neuronal processes and 
synapses (Paolicelli et al., 2011).  
 
Microglia are derived from myeloid progenitor cells in the embryonic yolk sac during 
development (Ginhoux et al., 2010). The maintenance of the microglia population post-
development primarily involves self-replication in the CNS rather than replenishment from the 
circulation (Ajami et al., 2007) as is the case with other tissue-resident macrophages such as 
Kupffer cells in the liver (Hashimoto et al., 2013). 
 
Microglia exhibit two main functional morphological states in the brain. In the healthy brain, 
they are found in a ‘resting state’ - these microglia have a ramified morphology with small cell 
bodies and many-branched processes. Despite being ‘at rest’, ramified microglia are in fact very 
active as their projections survey their microenvironment for damage or pathogenic signals 
(Nimmerjahn et al., 2005). 
 
Microglia can be activated by TLRs (Toll-like receptors), which are pattern recognition receptors 
that detect certain sequences in pathogens, known as pathogen-associated molecular patterns 
(PAMPs) types. There are 9 subtypes of TLRs found in the human brain (Bsibsi et al., 2002) which 
recognise and initiate immune responses to different pathogens. They also respond to the 
presence of pro-inflammatory cytokines (Hanisch, 2002), apoptotic and necrosis signals 
(Burguillos et al., 2011), lipopolysaccharides (Chen et al., 2012) and viral RNA (Zhu et al., 2016). 
Microglia are also very sensitive to increases in extracellular potassium  (Gehrmann et al., 1995) 
which occurs after the rupture of neurons.  
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Upon activation, microglia begin proliferation (Gómez-Nicola et al., 2013) and begin to change 
morphology. This involves the retraction of the branches used to detect the pathogenic signals 
and an increase in motility, migrating to the site of injury where they can phagocytose the 
foreign material. They also begin feedforward signalling mechanisms whereby they release 
proinflammatory cytokines to activate more microglia, perpetuating the innate immune 
response.  
 
1.4.3 Cytokines and chemokines 
Cytokines are very important signalling molecules between cells and differ from hormones in 
that their circulating concentrations are more variable and are released and used by a large 
range of cell types. These include macrophages, microglia, B cells, T cells, mast cells, neutrophils, 
basophils and eosinophils. Different cytokines can be released by different cell types and can 
also act on cell types, often with multiple cytokine subtypes have similar functions (Zhang and 
An, 2007).   Neuroinflammation is induced and propagated by a subset of these cytokines known 
to be pro-inflammatory. They play roles in recruiting microglia to limit the damaging effect of 
pathogens and necrotic/apoptotic cellular material (Kim et al., 2016). As well as cytokines that 
perpetuate the inflammatory response, there are also anti-inflammatory cytokines that 
modulate the response. This anti-inflammatory, negative feedback helps reinstate the 
homeostasis of the brain (Opal and DePalo, 2000).  Chemokines are also at work during 
inflammation to act as chemo-attractants for immune cells like microglia (Ransohoff et al., 
2007). They are a critical component of the neuroinflammatory response so are considered 
separately below. 
 
1.4.3.1 Tumor Necrosis Factor Alpha (TNFα) 
TNFα has emerged as one of the most important proinflammatory cytokines in mediating a 
suitable and sufficient inflammatory response to pathogen or damage. TNFα has been shown to 
be produced by many cells including neurones and other immune cells such as neutrophils, 
eosinophils, CD4+ T cells and natural killer cells (Gahring et al., 1996). In the CNS, microglia are 
the predominant producers of TNFα (Gregersen et al., 2000) and therefore are likely to work in 
an autocrine (self-stimulating) positive feedback loop (Kuno et al., 2005). They are also driven 
by its release to begin phagocytosing material, particularly neurons (Neniskyte et al., 2014). 
TNFα is in part responsible for the chronic pathological activation of microglia that is common 
in neurodegenerative disorders such as Alzheimer’s (Combs et al., 2001) and Parkinson’s disease 
(Barcia et al., 2011) 
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Cultured TNFα null microglia that are activated by lipopolysaccharide treatment have been 
shown to secrete lower levels of several other cytokines (IL- 1β, IL-6, IL-10 and IL-12) suggesting 
that TNFα is also important in propagating the inflammatory cascade (Harms et al., 2012). It is 
also known that a deficiency in TNFα causes a decrease in the activation of microglia (Sriram et 
al., 2006).  
 
One of the signalling pathways through which TNFα is released is through metabotropic 
glutamate receptors present on microglia. mGluR2 activation induces neurotoxicity through the 
enhanced release of TNFα and downstream activation of the apoptotic pathway protein caspase 
3 (Taylor et al., 2005). Interestingly activation of microglia is decreased after activation of 
mGluR3, which thus has an opposite, neuroprotective effect compared to mGluR2  (Taylor et al., 
2003).  
 
1.4.3.2 Interleukins 
Interleukins are also important signalling cytokines in the inflammatory response, and there are 
pro- and anti-inflammatory subtypes meaning they are involved in the initiation and regulation 
of the immune response. The main proinflammatory interleukins are IL-6, IL-1α and IL-1β. The 
latter two are the two most studied of the 11 cytokines in the IL-1 subfamily and they possess 
the strongest proinflammatory effect (Dinarello, 2011). They bind to IL-1R1 (the IL-1 Receptor 
type 1) which causes the activation of the myeloid differentiation primary response 88 (MYD88) 
pathway (Weber et al., 2010).  This can also activate other key proinflammatory cytokines TNFα 
and IL-6 (Oppenheim et al., 1989).  
 
It is assumed that IL-1α and β have redundant effects as they can both bind to the same receptor 
however it has been shown they more often act in important independent roles. IL-1α can signal 
to the innate immune system through its action as a damage-associated molecular pattern 
signalling molecule. This highlights its importance in the stimulation of an inflammatory 
response in conditions devoid of infection such as brain injury or stroke (Luheshi et al., 2011). 
IL-1β release can then be stimulated by IL-1a. This then allows the perpetuation of the immune 
response through the activation of microglia (Monif et al., 2016). 
 
IL-6 is another proinflammatory interleukin, which has been shown to be expressed by microglia 
and astrocytes (Frei et al., 1989). It can also be expressed by neurons, an induction that is 
stimulated by IL-1β and TNFα (Ringheim et al., 1995), or even the depolarisation of neurons 
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(Sallmann et al., 2000).  These cytokine signalling molecules may transfer systemic inflammation 
to the CNS due to their ability to cross the BBB (Banks et al., 1995). 
 
Of the anti-inflammatory interleukins, IL-13 and IL-4 are particularly important as they work 
together to exert their neuroprotective effects. The genes encoding for IL-13 and IL-4  are at 
similar loci on chromosome 5 and their receptors exist in a complex through which they exert 
their anti-inflammatory effects (Rael and Lockey, 2011).  Once the receptor complex is activated 
it causes the activation (through phosphorylation of the transcription factor STAT6) of anti-
apoptotic genes (Ohmori and Hamilton, 1998). IL-4 and 13 signalling also cause the inhibition of 
inflammatory cytokine production (Minty et al., 1993). This is through a change to the microglial 
expression of other cytokines: decreasing TNF and increasing insulin-like growth factor 1 (IGF-1) 
(Butovsky et al., 2005). IL-4 also acts on astrocytes inhibiting their activation and reactive oxygen 
species production and inducing NGF to release all of which are immunosuppressive effects 
(Brodie et al., 1998).  
 
1.4.3.3 Chemokines 
Chemokines are a family of chemotactic peptides involved in the inflammatory response. They 
are divided into four main classes (CXC, CC, CX3C and XC), which are linked to the nomenclature 
describing the chemical structure of their receptors (CC chemokines bind to CC receptors). The 
chemokines themselves are named I  recognition of the amino acid chain of the N-terminus of 
their structure, be it with two adjacent cysteine residues (CC) or with up to three amino acids 
between these cysteine residues (CX3C) (Lata and Raghava, 2009). There are 48 chemokines 
across these groups but only 19 receptors (Zlotnik and Yoshie, 2012), suggesting a complex 
ligand-receptor relationship. Indeed some chemokine-receptor relationships are exclusive, 
whereas other receptors have up to 10 ligands (Ransohoff, 2009).  
 
Chemokines exert their effects through these G-protein coupled receptors (Murphy, 1994) 
whose binding leads to the release of calcium from intracellular stores which activates MAP 
kinases. One of the major effects this mechanism plays a role in is the mediation of chemotactic 
effects (Murdoch and Finn, 2000). This chemotaxis is caused by the chemoattractant nature of 
chemokines which cause cells to follow increased concentrations of the chemokine to its source. 
It has been shown that in response to even a small chemoattractant gradient, neutrophil cells 
can amplify the asymmetry by upregulating the polymerisation of actin preferentially at the 
leading edge of the cell (Weiner et al., 1999). This occurs through the increased signalling of 
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receptors and downstream protein kinase upregulation (Servant et al., 2000) as receptors have 
been shown to be evenly distributed throughout the membrane of neutrophils (Servant et al., 
1999).  
 
Functionally chemokines are split into two groups. Homeostatic chemokines are constitutively 
expressed in certain tissues or cells to exert roles in cell migration (particularly leukocytes) for 
the development and maintenance of cells and tissues. Inflammatory chemokines are only seen 
in meaningful concentrations during infection or injury to attract leukocytes and other immune 
cells to the site of damage. There appears to be much more cross-talk between inflammatory 
chemokines and as such some of their receptors and ligands have been labelled as redundant, 
however, this is controversial (Schall and Proudfoot, 2011). 
 
Some chemokines are also involved in the chemotaxis of microglia to the site of inflammation. 
Such chemokines like Fractalkine (CX3CL1) are mainly expressed by neurones and act as chemo-
attractants for microglia (Harrison et al., 1998), which exclusively house the receptor CX3CR1). 
In fact, this is an example of the importance of chemokine signalling in neuronal-microglia 
interactions (Paolicelli et al., 2014; Eyo et al., 2016). 
 
This also points towards a neuroinflammatory role of chemokines, as dysregulation has been 
shown to play a role in pathologic, chronic inflammation in the brain, just as with cytokines 
(Ransohoff et al., 2007; Ramesh et al., 2013; Thuc et al., 2015).   
 
1.4.4 Neuroinflammation in disease 
Although inflammation is a by-product of the clearance and/or repair of damaging material, 
sometimes the inflammatory condition becomes protracted and the protective mechanism it 
serves becomes damaging. This is a known feature of many neurodegenerative disorders and 
may be the function of an exaggerated reactive state of microglia in the healthy brain, causing 
an augmented pro-inflammatory response (Godbout et al., 2005). Chronic neuroinflammation 
of this kind is a common pathology in many neurodegenerative disorders such as Alzheimer’s 
and Parkinson’s diseases.  
 
Alzheimer’s disease is a typical disease in which neurodegeneration is becoming increasingly 
related to an uncontrolled or exacerbated neuroinflammatory response (Heneka et al., 2015). 
The presence of plaques of aggregated insoluble β-amyloid, created from the improper cleavage 
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of amyloid precursor protein (APP), is a hallmark of the disease. Other features include tangles 
of the hyperphosphorylated tau protein, neuroinflammation and neurodegeneration 
(Duyckaerts et al., 2009). Amyloid plaques are associated with a pro-inflammatory response 
through activated microglia and astrocytes. TLR 2 and 4 are the pattern recognition receptors 
for β-amyloid, and their blockage (Udan et al., 2008) or knockout (Reed-Geaghan et al., 2009) 
causes a reduced inflammatory response in microglia to β-amyloid. 
 
1.4.4.1 Peripheral infiltration of immune cells 
Despite the existence of the blood-brain barrier, it is still possible for microglia to be activated 
without any physical changes to the BBB. This is triggered through direct TLR ligand or cytokine 
signalling from a peripheral immune response at regions of the brain that lack the protection of 
the tight vasculature. These areas are known as circumventricular organs and are areas where 
pro-inflammatory agents can pass more easily from the bloodstream to the parenchyma  
 
Furthermore, although microglia are the resident macrophages in the CNS, peripheral immune 
cells can be often seen in the CNS during severe peripheral infections. This infiltration is due to 
the pathological breakdown of the blood-brain barrier and is usually associated with the 
breakdown of the tight paracellular junctions than an increase in transcellular permeability 
(Stamatovic et al., 2008). Microglia are even known to increase the permeability of the BBB to 
peripheral immune cells through the release of cytokines (Prat et al., 2001). It is also possible 
that peripheral immune cells such as macrophages and T cells can interact with the healthy BBB 
themselves to enter the CNS (Daneman and Prat, 2015). 
 
1.4.4.2 Peripheral infections and neurodegeneration 
The idea that peripheral infections have some association with neurodegenerative diseases is 
well known and many studies support some sort of link, however, the cause and effect of these 
is unclear. In fact, there have been many examples linking specific pathogens with 
neurodegenerative disorders (McManus and Heneka, 2017). 
 
In patients with dementia, there are many studies reporting correlations between underlying 
illnesses and the progression of dementia. In a study of patients living with various dementias, 
patients with underlying conditions had significantly decreased cognition and general function 
scores (Hodgson et al., 2011).  
 
  55 
Illnesses, and in particular viral infections have been shown to contribute to cognitive decline in 
dementia patients (Strandberg et al., 2004). Severe infections leading to sepsis are also known 
to cause a permanent cognitive disturbance in the elderly (Widmann and Heneka, 2014). These 
infections can lead to delirium, and it has been shown that whilst patients may improve upon 
treatment of the infection, long-term the incidence and progression of dementia progression is 
far worse than in control subjects (Davis et al., 2012) 
 
This is particularly prominent when the infection causes delirium in Alzheimer’s disease patients. 
In this case, the rate of cognitive decline nearly doubles (Fong et al., 2009). To make matters 
worse, infectious diseases are more common in patients with dementia than in healthy aged-
matched controls (Natalwala et al., 2008). The related potentiation of neurodegeneration has 
been seen in to be mediated by a long-term upregulation of pro-inflammatory cytokines such as 
IL-1β and TNFα, even after the systemic infection is over (Holmes et al., 2003; Holmes et al., 
2009). 
 
Other non-dementia type neurodegenerative disorders have shown links between peripheral 
infections and their progression. The bacteria Clostridium perfringens was first seen in humans 
in the gut biota of a patient with multiple sclerosis. This bacterium releases a toxin (epsilon toxin) 
which has a 10-fold incidence in multiple sclerosis CSF samples, compared to those from healthy 
subjects (Rumah et al., 2013). Also, in mouse models of Parkinson’s disease, α-synuclein 
deposition increases in transgenic mice that are administered samples of PD patients’ gut 
bacteria. This has been shown to increase their motor deficits (Sampson et al., 2016). This 
highlights the importance of peripheral viral and bacterial infections on the brain, particularly in 
patients with genetic risk factors for neurodegenerative disorders. 
 
1.4.4.3 Investigating peripheral infection effects on brain oscillations and plasticity 
Studies investigating the effects of peripheral inflammation often use synthetic analogues of 
ligands for TLR receptors to induce an inflammatory response. This allows immune challenges 
(such as bacterial or viral infections) to be mimicked, which elicits a particular response that is 
mediated through the TLR that is targeted. It also allows the control of the strength of the 
infection through the dose of the infectious agent, and the time scale to compare acute to 
chronic or repeated infections. In this thesis, 2 models of peripheral infection are used: 
lipopolysaccharide and Poly Inosinic: Cytidylic acid administration. 
 
  56 
Lipopolysaccharide (LPS) is a large molecule on the extracellular membrane of gram-negative 
bacteria that is recognised by the immune system causing the mobilisation of a response to the 
pathogenic bacteria. Isolated preparations of LPS can be used to mimic a bacterial infection. The 
recognition of LPS is through its structure as a ligand that specifically activates TLR4 receptors, 
and it is widely used to study the effects of systemic infection on the brain. It is thought that LPS 
in the blood activates TLR4 receptors in the circumventricular organs, which leads to the 
production of tumour necrosis factor (TNF). TNF then induces the expression of NF-kB that is a 
pro-inflammatory gene transcription signaller thus perpetuating the spread of the pro-
inflammatory response throughout the brain (Nadeau and Rivest, 2000).  
 
Poly Inosinic: Cytidylic Acid (Poly IC) is another agent that is used to activate an immune 
response. It is a synthetic copy of double-stranded RNA, found in some virus structures, and as 
such can mimic the action of viral infection through the binding to TLR3 receptors.  
 
It has been shown that peripheral immune challenge with LPS causes an exaggerated pro-
inflammatory response in prion disease models compared to controls (Combrinck et al., 2002) 
as well as mouse models of Alzheimer’s disease (Sly et al., 2001; Lee et al., 2002). Also, LPS and 
β-amyloid induce a pro-inflammatory response through class-II major histocompatibility 
proteins (MHC-II) which causes cytotoxicity (Butovsky et al., 2005). For this reason, the injection 
of LPS and Poly IC are widely used to study systemic infections, as well as their knock-on effect 
on the brain. 
 
1.5 Leishmaniasis 
The peripheral models described above are quite simple versions of infectious agents. To 
validate the findings from these models this thesis also uses a ‘natural’ infectious agent related 
to the disease Leishmaniasis. Leishmaniasis is caused by a group of protozoan parasites of the 
genus Leishmania. There are 20 different species of Leishmania parasites that cause the various 
forms of the disease. Parasites are transmitted through the bite of an infected female 
phlebotomine sandfly (females blood feed only when they are producing eggs). This means that 
the global spread of Leishmaniasis centres on areas where sand-flies are common – mostly 
tropical and subtropical areas.  
 
During the initial infection stage, parasites are in their promastigote phase. The parasites in this 
phase possess long flagella which means they are highly motile. They exist as promastigotes in 
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sandfly proboscis and when injected during blood feeding they travel around the new host’s 
blood stream. The parasites are phagocytosed by host macrophages where they transform to 
their amastigote phase. In this phase, the flagellum contracts and the parasites focus on 
multiplication. Parasites build up in the macrophage before it ruptures, spreading the parasite 
in the bloodstream to be taken up by other macrophages.  
 
The disease takes three main forms: cutaneous (CL), mucocutaneous (MCL), and visceral 
(VL/kala-azar). A fourth form also exists, known as post kala-azar dermal leishmaniasis (PKDL), 
which occurs as a cutaneous presentation of VL years after treatment. Cutaneous leishmaniasis 
is the most common form, but also least severe as it only affects the skin – usually around the 
bite sites. However, CL still produces open sores and skin lesions that resemble those in leprosy. 
Visceral leishmaniasis (VL) is less common but is more dangerous than CL as it is typically fatal if 
left untreated. 
  
1.5.1 Visceral Leishmaniasis 
Although there are accounts, throughout history, of diseases that resemble what is now known 
to be CL (Steverding, 2017), the visceral form of Leishmaniasis didn’t appear until 1824 in Bengal, 
India (Gibson, 1983). At the time it was referred to as Kala-azar (or ‘black disease’) due to the 
skin discolouration it caused. Patients showed symptoms of fever, enlarged spleens and livers, 
and anaemia (Steverding, 2017).  It wasn’t until the early 20th century that the unnamed bodies 
(then thought to be trypanosomes) were discovered in patients with kala-azar (Donovan, 1994; 
Leishman, 2006). These parasites were recognised as a novel protozoan organism and found to 
cause the kala-azar disease (Ross, 1903b) and named Leishmania donovani after their initial 
discoverers (Ross, 1903a).  There are now two species of Leishmania known to cause VL, and 
their infections are geographically localised with L. infantum (aka. L. chagasi) prevalent in North 
Africa, Europe and Latin America, and L. donovani infections occurring in the remainder of Africa, 
and India and surrounding countries (Chappuis et al., 2007). It is the visceral leishmaniasis 
caused by L. donovani that is studied in this thesis. 
 
VL is the second most deadly parasitic disease in the world (after malaria) and is considered to 
be nearly always fatal in left untreated  (Desjeux, 2001). Over 90% of the occurrence of new 
cases of VL are restricted to 6 countries: Bangladesh,  Brazil, Ethiopia, India, South Sudan and 
Sudan (Alvar et al., 2012). This is due to the climatological conditions in which the sand-flies 
  58 
thrive, although there are also socioeconomic factors that are correlated to infection such as 
malnutrition, poor living conditions and lack of medical resources (Georgiadou et al., 2015). 
 
1.5.2 Leishmaniasis and peripheral neuropathy 
The list of signs and symptoms that are associated with leishmaniasis do not classically include 
neurological effects, however, emerging evidence is uncovering changes to the nervous system 
during leishmaniasis infections. It is more common for neurological effects to be present in the 
peripheral nervous system than the CNS, however, both have been recorded. 
 
Cutaneous leishmaniasis classically is only thought to affect the skin. A study of patients infected 
with the Leishmaniasis major showed that in 5% of cases, patients with cutaneous leishmaniasis 
presented with increase inflammatory cells around peripheral nerves, neuritis and even neural 
infiltration of amastigotes (Kubba et al., 1987).   
 
Peripheral neurological disturbances have also been seen in cases studies of 13 visceral 
leishmaniasis infected patients in Sudan who presented with varying neurological symptoms 
mostly affecting the lower limbs such as hyperaesthesia, impaired vibration, pain and touch, 
cranial nerve palsies and foot drop. However, malnutrition could not be ruled out as a factor in 
these symptoms (Mustafa, 1965). Further characterisation of the neurological effects of VL used 
nerve conduction studies to highlight evidence of neuronal demyelination and axonal 
degeneration in 15 patients. The recovery of neuropathy after treating the Leishmaniasis 
infection, along with tests confirming no vitamin deficiency suggest that these infections caused 
neurological problems for these patients (Hashim et al., 1995). 
 
 There have also been cases of Guillain-Barre syndrome diagnoses secondary to leishmaniasis 
infection (Prasad and Sen, 1996). Guillain-Barre syndrome occurs when the immune system 
attacks the peripheral nerves leading to muscle weakness and changes in sensation such as 
tingling and pain (Fasanaro et al., 1991; Attarian et al., 2003). It may be that a Leishmania 
infection recruits the host's immune system to attack the peripheral nerves, especially 
considering there is evidence of immune cell invasion of nerves (Kubba et al., 1987). 
 
1.5.3 Leishmaniasis in the CNS 
Although visceral leishmaniasis classically infects the spleen, liver and bone marrow, 
Leishmaniasis donovani parasites (responsible for VL) have been shown to infiltrate the brain as 
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little as 3 days after infection by intraperitoneal injection in mice (Melo et al., 2017). This is in 
tandem with increased leukocyte and macrophage presence in the brain tissue. These cell types 
could provide the route by which the intracellular parasite infiltrates the CNS. Amastigote stage 
Leishmania donovani parasites have also been found in the CSF of a human patient. The patient 
presented with pyrexia and headaches leading to a diagnosis of “leishmanial meningitis”. This 
was unresponsive to older anti-leishmaniasis drugs pentamidine isethionate and sodium 
antimony gluconate, which fail to cross the blood-brain barrier, therefore amphotericin B was 
finally able to cure the patient. It is possible infiltration to the CNS was a response to a previous 
removal of the spleen the year before (Prasad and Sen, 1996). 
 
Further case studies have found likely CNS problems in patients with visceral leishmanias. One 
patient in Kenya presented with a tremor of the torso and limbs (Chunge et al., 1985). Often 
symptoms of this nature are related to malnutrition however this was unlikely as the 
malnutrition was reversed before any improvement in symptoms. Only after treatment with the 
anti-leishmaniasis drug, sodium stibogluconate, was there any improvement and eventual 
reversal of the tremor in correlation with the parasite load being neutralised. Despite this, it is 
not clear as to the neurological cause of the tremor (Chunge et al., 1985). Another patient in 
Brazil presented with similar tremor further to VL which was alleviated with sodium 
stibogluconate treatment. Again, vitamin deficiency was possible, yet other characteristics of 
this were not seen and the patient's symptoms were reversed without any treatment with 
vitamin supplements (Diniz et al., 2010). Although by no means definitive proof of CNS effects 
of VL, several patients have also presented with mental changes or depression-like symptoms 
(Carswell, 1953; Maru, 1979). 
 
1.5.4 Leishmaniasis and neuroinflammation 
Further to showing neurological complications with both cutaneous and visceral leishmaniasis 
and the presence of Leishmania parasites in the brains, infection has also been shown to induce 
neuroinflammation. Increased levels of three cytokines associated with the initiation and 
maintenance of inflammation IL-1β, IFN-γ and TNF-α were found to be upregulated in the brains 
of VL infected dogs. The levels of these cytokines did not correlate with parasite load (Melo et 
al., 2013). 
 
Initially (3 -14 days post-infection) there is an early inflammation response with upregulation of 
certain chemokines (CCL-5, 7 & 12 and CXCL-10), chemokine receptors (CCR-1 & 2 and CXCR-3) 
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and pro-inflammatory cytokines (IL-1β, IL-6, IFN-γ and TNFα). This initial wave of inflammation 
is curtailed by anti-inflammatory cytokines (IL-10, TGF-β). However, 90 days post-infection, 
there is a re-upregulation of the proinflammatory cytokines and chemokines, with no change in 
the anti-inflammatory cytokines (Melo et al., 2017) 
 
It is clear therefore that whilst CNS system effects of leishmaniasis may be uncommon,  
Leishmaniasis may not only affect the CNS, but parasites can also overcome the blood-brain 
barrier. Whether increased neuroinflammation in these brains occurs as a spreading of 
peripheral inflammation, or infection within the brain is also unclear.  
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1.6 Aims and Objectives 
The state of the field as outlined in the chapter above shows that changes occur to synaptic 
plasticity which are related to certain brain states and electrical rhythms, and changes to 
immediate early gene expression across the sleep/wake cycle may also be related.  
 
The initial aims of this thesis are then: 
 To generate sleep and wake-related oscillations in vitro using previously optimised 
pharmacological models in slice preparations of rat neocortex. 
 To assess the effects of oscillations, generated in vitro, on neuronal activity and plasticity 
using immunohistochemistry to monitor immediate early gene expression changes. 
 To localise oscillation related immediate early gene changes across neocortical laminae 
and identify specific cell types involved. 
 
Since inflammation in the brain is a common feature in many disorders that affect normal brain 
function, and peripheral infections are known to induce neuroinflammation even in healthy 
individuals, the further aims of this thesis are:   
 To monitor the direct activity of pathogenic signals on sleep- and wake-related 
oscillations in preparations of rat neocortex by bath application of agents that mimic 
pathogenic bacterial or viral sequences (LPS or Poly I:C respectively).  
 To test the effects of the longevity of a peripheral immune response in a cohort of rats 
through a regime of dosing rats with repeated peripheral injections of LPS and Poly I:C 
for up to 28 days. Then: 
o To compare the effect of the longevity of a mimicked systemic infection on sleep 
and wake-related rhythms by generating oscillations in slice preparations of 
neocortex take from dosed animals. 
o To monitor the resulting inflammation in the brain of dosed rats through a 
multiplex cytokine panel assay to analyse pro- and anti-inflammatory cytokine 
and chemokine expression. 
 Finally, to evaluate the effect of a real-life systemic infection (visceral leishmaniasis) on 
sleep and wake related oscillations generated in slice preparations of mouse neocortex. 
Then, investigate the general effects of those oscillations on plasticity through the use 
of immunohistochemistry and seek to corroborate changes previously seen in 
immediate early gene expression in the initial investigation. 
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Chapter Two – Materials and Methods 
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2.1 Materials 
2.1.1 List of drugs and chemicals used 
The following drugs were used in experiments discussed in this thesis: 
ACSF salts Various 
Biocytin hydrochloride Sigma-Aldrich, UK 
Carbachol Tocris Biosciences, UK 
Ethanol BDH-Merck 
Fluoromount Sigma-Aldrich, UK 
Normal Goat Serum Sigma-Aldrich, UK 
Isoflurane (Vetflurane) Virbac, UK 
Kainic Acid Tocris Biosciences, UK 
LPS Sigma-Aldrich, US 
Ketamine (hydrochloride, Ketavet) Zoetis UK Ltd 
Methanol Fisher Scientific, UK 
Optimum Cutting Temperature Fisher Scientific, UK 
Paraformaldehyde Affymetrics USB, UK 
Phosphate Buffered Saline Gibco, UK 
Poly Inosinic: Cytidylic Acid  Sigma-Aldrich, US 
Potassium Acetate Sigma-Aldrich, UK 
SCH 33920 Tocris Biosciences, UK 
Sucrose Fischer Scientific, UK 
Triton X-100 Sigma-Aldrich, UK 
Xylazine (hydrochloride, Rompun) Bayer, UK 
 
2.1.2 ACSF Formulations 
Normal artificial cerebrospinal fluid (ACSF) was used in the recording chamber and holding 
chamber and consisted of (in mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 1.2 CaCl2, 10 glucose, 
24 NaHCO3.  
 
Sucrose artificial cerebrospinal fluid (sACSF) – for perfusion and cutting - was made by 
substituting the sodium chloride in the above composition above with sucrose. This reduced the 
passive influx of sodium ions which leads to cell swelling by osmosis of water into the cell which 
limits cell survival (Ting et al., 2014). Divalent cations were also present in a higher concentration 
in sACSF as they stabilise excitable cell membranes, and raise the threshold for action potentials. 
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This is thought to be because divalent cations adsorb to the negatively charged outer side of the 
membrane and create an electrical field that repels cations away from the membrane surface 
(Frankenhaeuser, 1957; Frankenhaeuser and Hodgkin, 1957). Divalent cations also bind to ion 
channels and limit the passage of ions through them, again minimising excitotoxicity (Brown and 
Ransom, 2002). Interneurons are more susceptible to damage as they are more constitutively 
active than principal cells. As interneurons are critical for oscillation generation the replacement 
of the sodium in the solutions was particularly important. Considering these points, the sACSF 
was made up (in mM) of: 3 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 10 glucose, 24 NaHCO3 and 252 
Sucrose.  
 
2.1.3 Antibodies used 
 
Primary Antibodies  Manufacturer 
Arc (Rabbit, 156003) Synaptic Systems Gmbh 
C-Fos (Rabbit, SC52) Santa Cruz Biotechnology 
Iba-1 (Rabbit, 019-19741) Wako 
GAD67 (Mouse, MAB5406) Millipore 
NeuN (Guinea Pig, ABN90) Millipore 
 
Secondary Antibodies Manufacturer 
Alexa Fluor 488 Goat Anti-Rabbit IgG (H+L) – A11008 
 
Invitrogen 
Alex Fluor 488 Goat Anti-Rabbit IgG (H+L) Highly Cross-
Adsorbed, A11034  
Invitrogen 
Alexa Fluor 546 Goat Anti-Mouse IgG (H+L) Highly Cross-
Adsorbed, A11030 
Invitrogen 
Alexa Fluor 633 Goat Anti-Guinea Pig IgG (H+L) Highly Cross-
Adsorbed, A21105 
Invitrogen 
Alexa Fluor 568 Streptavidin conjugated, S112265 Invitrogen 
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2.2 Electrophysiology 
2.2.1 Animal provision 
The experiments in this these were carried out in two different institutions. Experiments for 
Chapter 3 and 5 were carried out in the Department of Biology, University of York, UK. 
Experiments for Chapter 4 were carried out at Eisai Inc. Andover Innovative Medicines (AiM) 
Institute, USA.  
 
Adult male Wister rats used for experiments in Chapter 3 and 4 were obtained from either the 
UK or US divisions of Charles River Laboratories Inc. Mice were used for Leishmaniasis 
experiments in Chapter 5 owing to the lack of appropriate Home Office license and existing 
expertise at the University of York regarding the pattern of infection and immune responses 
observed in mouse models (Engwerda and Kaye, 2000; Bunn et al., 2014; Pinto et al., 2017). The 
mice were of C57/Bl6 background strain and were bred at the Biological Services Facility (BSF) 
at the University of York.  
 
All animals were housed in either the Biological Services Facility in the University of York or the 
Life Sciences Facility at the Eisai Inc. AiM Institute. Animals were allowed a constant supply of 
food and water and were subject to a 12-hour light-dark cycle. All animals were taken for slice 
preparation 3-4 hours into the light cycle.  
 
All animal procedures in the UK were carried out under the Animals (Scientific Procedures) Act 
1986 as approved by the Home Office and Animal Welfare and Ethical Review Body at 
the University of York. 
 
All animal procedures in the USA were carried out under the Animal Welfare Act (AWA) and PHS 
Policy on Humane Care and Use of Laboratory Animals USA and were approved by the 
Institutional Animal Care and Use Committee. 
 
2.2.2 Brain slice preparation 
Animal sacrifice was carried out slightly differently between institutions in which work was 
carried out. In particular, rats used in Chapter 4 were terminally anaesthetised without prior 
anaesthesia whereas isoflurane inhalant was used for all other experiments. 
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Rats and mice were terminally anaesthetised with a cocktail of the anaesthetic ketamine (an 
NMDAR antagonist) (Ketavet, Zoetis, 100 mg/ml) and the anaesthetic and muscle relaxant 
xylazine (an agonist for α2 adrenoreceptors) (Rompun, Bayer PLC, 20mg/ml) by either 
intraperitoneal or intramuscular injection. The routes of administration were different due to 
the difference in pre-terminal anaesthesia and efforts to minimise the suffering of the animals 
(as intramuscular injections are more painful). 
 
 
 
 
 
Once the animal no longer showed eye blink and pedal withdrawal reflexes, the abdomen was 
opened, and the rib cage and diaphragm cut, to expose the heart. An incision was made in the 
right atrium and the left ventricle of the heart was punctured with the perfusion needle. 
Perfusion with 20ml (mice) or 50ml (rats) of an ice-cold (~4°C) artificial cerebrospinal fluid 
solution containing sucrose (sACSF) was then carried out to exsanguinate the animal and protect 
the brain during the cutting process. This solution had also been oxygenated with carbogen gas 
(95% O2/5% CO2). Sucrose ACSF is explained in more detail in Chapter 2.1.2 and consists of: 3 
KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 10 glucose, 24 NaHCO3 and 252 Sucrose.  
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Once the transcranial perfusion was completed, the skull was exposed and the animal 
decapitated. The skull was cut down the midline and the bone removed to expose the brain. The 
brain was then removed and placed into the ice-cold, oxygenated sACSF. The cerebellum was 
removed and discarded, and the remaining brain was then glued onto a metal vibratome plate 
using Loctite Precision Superglue. The brain was oriented either dorsal side (for horizontal slices) 
or caudal side (for coronal slices) down. The brain was supported by a 1x1cm block of agar to 
aid cutting. The plate was attached to a Leica VT-1000S vibratome and submerged in ice-cold 
oxygenated sACSF and horizontal or coronal slices were cut to 450μm thickness. The cutting 
blade oscillated a frequency of 80Hz, with an amplitude of 0.6mm, and advanced through the 
slices at 0.15mm/s.  
 
For experiments investigating the delta rhythm, coronal sections were cut. Whole slices were 
sub-sectioned to keep primary somatosensory and secondary somatosensory cortical areas as 
well as deeper white matter and striatal structures. 
 
For experiments investigating the gamma rhythm, horizontal slices were cut. These were either 
sub-sectioned to retain the hippocampus and caudal cortical regions (to generate and record 
hippocampal oscillations) or cut to preserve the primary auditory and secondary somatosensory 
cortices for cortical gamma oscillations, with some subcortical structures retained for 
orientation (Figure 2.1). 
 
2.2.3 Slice maintenance 
 The first slices were placed on a double thickness of Whatman paper in an interface chamber 
(see Figure 2.2a) between artificial cerebrospinal fluid (ACSF) and a humid carbogen 
environment (95% oxygen, 5% carbon dioxide). Slices were left to acclimatise for 1 hour at room 
temperature and then maintained at 30-32oC thereafter. The ACSF was circulated through the 
chamber at 1.5mls/min. ACSF is explained in more detail in Chapter 2.1.2, and consists of: 126 
NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 1.2 CaCl2, 10 glucose, 24 NaHCO3. Subsequent slices were 
placed on tissue paper in a holding chamber (see Figure 2.2b). These slices were maintained at 
an interface between oxygenated ACSF and carbogen gas at room temperature and partially 
sealed with parafilm. 
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2.2.4 Oscillation induction 
Different oscillations were more robustly generated in slices of different orientations, which 
were cut as outlined below (and in Figure 2.3). To maintain slices in a viable state they were 
dissected down to reatin only the necessary areas of observation (and subcortical structures for 
orientation) – this was done as larger slices require more oxygenation. The slices were viewed 
with a light microscope to ensure correct and consistent placement of the electrodes for local 
field potential (LFP) recordings. 
 
To generate delta frequency oscillations in the primary and secondary somatosensory cortices 
of the coronal brain slices, a combination of the acetylcholine agonist, Carbachol (4 µM) and 
dopaminergic antagonist, SCH23990 (10 µM) were simultaneously added to the circulating ACSF. 
Cortical LFP recordings were made from layer 5 of the primary and secondary somatosensory 
cortex in coronal slices as previously described (Carracedo et al., 2013).  
 
To generate gamma frequency oscillations in the primary auditory and secondary 
somatosensory cortices of the horizontal brain slices, kainic acid was used (400nM). Cortical LFP 
recordings were made from layer 3 of the primary auditory and secondary somatosensory 
cortex, in horizontal slices according to the in vitro procedure already characterised (Ainsworth 
et al., 2011). 
 
Kainic acid was also used to generate hippocampal oscillations, though at a lower concentration 
(50nM). Recordings were made from the stratum radiatum of the cornu ammonis 3 (CA3) region 
of the hippocampus (see Figure 2.5 for example oscillations). 
 
2.2.5 Extracellular (LFP) Recordings 
Extracellular electrodes were made from borosilicate glass capillaries and were pulled to form a 
tip with a Model P-1000 Flaming-Brown micropipette puller. Micropipettes were then filled with 
normal ACSF and placed in pipette holders with silver wire used to form a conducting bridge 
between the ACSF and the amplifier electronics. These holders were then attached to head 
stages that could be finely moved by micromanipulators. The electrical signal from slices was 
conducted through the micropipette solution and to the silver wire. The signal was digitised at 
a sampling frequency of 2000 and filtered between 0.1 and 300Hz, before being visualised and 
saved on a computer. The hardware and software used to relay the electrical signal to the 
computer were different between institutions (see Figure 2.4). 
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In all experiments after application of drugs, slices were left for 2 hours to allow them to 
generate oscillations, and recordings were made during this time to assess the build-up of any 
oscillations seen.  
 
In Chapter 3, because IEG protein levels are thought to be at their highest at 2 hours (Morgan et 
al., 1987), final recordings were made then, and oscillating slices were then fixed for IEG 
measurements. Slices were considered to have generated delta oscillations if the peak power 
(between 0.5 and 4Hz) was above 100μV². For gamma oscillating slices the threshold for 
inclusion was a peak power of 10μV².  
 
In Chapter 4 and 5, because the oscillatory ability of slices was compared, oscillations were left 
to stabilise (>2 hours), and once the peak power did not change by more than 10% in 15 minutes. 
The oscillation was considered stable and a final recording was made. The same frequency bands 
were used for all but the chronic dosing hippocampal experiments of Chapter 4. Due to the low 
frequency of the oscillation (discussed in Chapter 4.3.2), a 20 – 50 Hz band was used. 
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2.2.6 Analysis of field potential recordings  
Data was collected through either Spike2 (Cambridge Electronic Design Ltd., UK) or Axograph 
(Axograph, USA). The recordings were filtered between 0.1 and 300Hz and the sampling 
frequency was 2000. The recorded data was exported to MATLAB (MathWorks Inc., Natick, USA) 
where bespoke programs were created to analyse certain features of the data. 
 
The LFP recordings were analysed for oscillatory activity and several characteristics of this 
activity were measured. These measures were made from the computation of an overlapping 
window Discrete Fourier Transform (DFT) using the MATLAB program ‘pwelch’, computed from 
60 seconds of data. This DFT algorithm produces a power spectrum whereby the time domain is 
converted to frequency. This is done by separating the waveform into its frequency components 
(as a mixture of sine waves) and calculating the absolute magnitude squared (power) at each of 
these frequencies.  
 
From the power spectra, measures of the frequency and modal peak power were taken. In 
addition, power was integrated from the lower to the upper boundaries of the frequency bands 
of interest to give an ‘area power’ measurement. Limits of the frequency band were set for 
calculations of power: for gamma oscillations, these were 30-50Hz, and for delta, these were 
0.5-4 Hz (Figure 2.5). These measures could then be averaged within conditions to monitor the 
changes to these properties over different conditions. 
 
Statistical analysis of the data was performed by Sigmaplot 12.3 (Systat Software Inc, Hounslow, 
UK). Data were presented graphically using Microsoft Excel (Microsoft Corp., Redmond, USA) 
 
2.2.7 Intracellular Recordings  
For intracellular experiments, sharp electrodes were made from borosilicate glass capillaries 
using the micropipette puller with a resistance of 70-200 MΩ. Electrodes were filled with a 
solution of potassium acetate (2M) and 2% biocytin hydrochloride. To make intracellular 
recordings, cells were punctured by sharp electrodes using the micromanipulator to track the 
electrode tip through the thickness of a 450µM slice. A constant hyperpolarising holding current 
(-0.2nA) was applied as well as a constant tuning step (-0.2nA at 2Hz) during this process. With 
each increment of the descent through the slice, a slight ‘buzz’ (by immediate increasing of 
capacitance neutralisation of the electrode) was applied to the electrode tip which facilitated 
the piercing of the membrane of the neuron. Once a membrane was penetrated the holding 
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current was hyperpolarised further to stabilise the cell while the membrane formed a seal 
around the penetrating tip of the electrode. This was maintained for ~5 minutes until the 
membrane had formed a seal around the electrode, allowing the cell to stabilise at its resting 
membrane potential (RMP). Cells with an RMP below -50mV with action potential amplitude 
above 60mV were considered suitably impaled for recording.  
 
To record excitatory postsynaptic potentials (EPSPs), cells were hyperpolarised to -70 mV. 
Further to this, depolarisation of the cell to -20mV, by injection of positive current prevented 
the cell from firing and allowed the IPSPs received by the cell being recorded.  
 
To visually highlight single neurons that had been previously characterised by intracellular 
recording, the cell was maintained in a slightly hyperpolarised state whilst a small amount of 
tuning current allowed the biocytin (in the electrode) to fill the cell and its projections. The cell 
was filled for 30 – 60 minutes and when complete the slice was removed and fixed in 4% 
paraformaldehyde (PFA). 
 
2.2.8 Biocytin labelling and imaging 
The fixed 450µM slices containing the biocytin labelled neurons were washed (3x 15 minutes) in 
phosphate buffer (PB) 0.1M to remove the fixative. Slices were then embedded in 10% gelatine 
on ice and then incubated in PFA for 60 minutes to fix the gelatine. A Leica VT1000S Vibratome 
was then used to slice these to 30µM (a thickness penetrable by a secondary antibody).  
 
All sub-sectioned slices were retained and taken through the staining process as the precise 
location of the biocytin labelled cell was not known. After two 15-minute washes with PB, each 
section was incubated in phosphate buffered saline (PBS) containing 0.2% Triton-X 100 (PBS-TX) 
for 10 minutes.  
 
To co-stain for the biocytin labelled cell Arc, the slices were blocked in normal goat serum (NGS) 
for 2 hours and incubated in the primary antibody overnight at 4oC (for details see Chapter 2.4.1 
below). Further to this, slices were incubated for two hours with Alexa Fluor Goat-α-Rabbit 488 
(1:500) and Alexa Fluor 568 Streptavidin conjugate (1:500). The streptavidin binds and 
fluorescently labels any biocytin that has diffused into the cell. On completion of the secondary 
incubation, slices were washed twice with TBS for 15 minutes and mounted on slides.  
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Slides were viewed using a Zeiss LSM 710 motorised confocal microscope to locate any cells or 
cell segments containing the biocytin label. Since slices were cut to 30µM, there was no 
guarantee of one section containing the entirety of the cells structures, therefore all sections 
were collected and images of multiple sections which had segments of the cell were taken. Most 
segments were imaged using an x20 objective. The cell body was imaged at x10 as well, to view 
its location within the cortex. Alex Fluor 488 (to show Arc) and Alexa Fluor 568 (to show biocytin) 
were excited using 488 and 561nm lasers respectively and the light emitted was collected in 
495-548nm and 578-735nm ranges respectively for each stain. Images at x20 had a pixel scale 
of 0.415µm x 0.415µm. Line averaging was used taking 8 passes of each scan line and averaging 
to increase signal: noise by minimising random and background fluorescence. These images 
were also taken as z-stacks with the maximum intensity projection calculated for each image 
presented. 
 
2.3. Infection and inflammation models 
2.3.1 Acute inflammation 
In Chapter 5 two different compounds were used to observe the effect of inflammatory agents 
upon in vitro models of cortical rhythms.  
 
To see whether there was any direct effect upon sleep and wake-related rhythms in acute in 
vitro brains slices, lipopolysaccharide (LPS, Sigma L4130) was used. LPS is a ligand for TLR 4 
receptors which also responds to pathogenic bacterial signals. Gamma and delta rhythms were 
generated and recorded according to the methods outlined in Chapter 2.2.4-6. Once the 
oscillations were considered stable 500ng/ml LPS was added to the bath and recordings were 
made every 15 minutes up to 1hr. The final stable recording was compared with the final 
recording 1 hour after LPS. 
 
2.3.2 Chronic inflammation 
For chronic inflammation experiments, the effect of LPS was compared to that of Polyinosinic: 
Polycytidylic Acid (Poly I:C, Sigma I3036), which is a ligand for TLR 3 receptors that also respond 
to viral infections. 
 
A dosing schedule was set up whereby rats were injected intraperitoneally with either 0.9% 
Saline (a.k.a. vehicle), 250g/kg LPS (in saline) or 6mg/kg Poly I:C. Some animals were dosed 
once, 24 hours prior to sacrifice and brain slice preparation. Others were dosed every three days 
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for 7 or 28 days, with Vehicle, LPS or Poly I:C and all animals survived the dosing regime 
(Tchessalova and Tronson, 2019). Once again, in vitro gamma or delta rhythms were generated 
(as above) and were recorded to track the build-up of the oscillations. Once the oscillations had 
stabilised a final recording was taken, and the slices immediately removed from the recording 
chamber on filter paper (to reduce injury) and put into 4% paraformaldehyde. 
 
2.3.3. Leishmaniasis Infection 
Parasites of the Ethiopian strain of Leishmaniasis donovani (LV9) were incubated in an 
immunosuppressed host male Rag1 -/- mouse, which had suppressed T cell and B cell 
maturation. Amastigotes were extracted from the spleen of the host mouse and C57/BL6 mice 
were then infected by intravenous injection of 3x107 amastigotes through the lateral tail vein. 
These mice were 5-8 weeks old at the time of injection and were then left for 33-37 days until 
sacrifice. 
 
Animals were weighed after sacrifice and brain removal and their spleens and livers were also 
isolated. These tissues were weighed separately and then cut in cross-sections to analyse 
parasite count by impression smear. Cut sections were pressed against a microscope slide which 
is then methanol fixed and stained with Giemsa reagent, which shows up nuclei. 1000 host nuclei 
were then counted along with the number of parasite nuclei in the within the 1000 nuclei. This 
number was also used to calculate the LDU (Leishmania do notani units), which is the number 
of parasite nuclei/1000 host nuclei multiplied by the organ weight in grams. These experiments 
were carried out by Najmeeyah Brown. 
 
2.4. Immunofluorescence 
2.4.1 Immediate early gene and cell marker staining 
Following the completion of the electrophysiological measurements, the 450μm brain slices 
were immediately removed from the recording chamber on filter paper (to reduce injury) and 
put into a fixative solution of 4% paraformaldehyde (PFA) in Phosphate Buffered Saline (PBS). 
Slices were left in the fixative for 24-48 hours and then cryoprotected with sucrose solutions. 
This involved a 2hr incubation in 10% Sucrose in PBS, followed by overnight incubation of 30% 
Sucrose in PBS. After fixation, slices used in experiments from Chapter 5 were stored in PBS with 
0.1% Azide and shipped to the UK where they were processed for immunohistochemistry. 
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Slices were then placed in plastic moulds before being immersed in optimum cutting 
temperature compound (OCT). The moulds and contents were then frozen in Iso-pentane (2-
Methylbutane) in dry ice. They were then re-sectioned to 30μm using a cryostat.  
 
For the immunohistochemistry, the 30μm slices were washed in PBS, and the cells membranes 
were permeabilised with PBS-TX (with 10% Methanol to permeablise the nuclear membrane for 
nuclear stains) for 10 mins. This was followed by a blocking step in 3% normal goat serum (NGS) 
for 2 hours. The serum contains albumin, antibodies and other proteins that bind to non-specific 
sites in the sample to prevent the non-specific binding of the secondary antibody and thus 
reduce background staining. The primary antibody was applied at the stated concentration 
diluted in PBS containing 1% NGS and incubated overnight at 4oC. Primary antibodies used were: 
Millipore ABN90 Anti NeuN (guinea pig, 1:500), Millipore MAB5406 Anti GAD67 (mouse, 1:500), 
Santa Cruz Biotechnology SC52 Anti c-Fos (rabbit, 1:200), Synaptic Systems Gmbh 156003 Anti 
Arc (rabbit, 1:500 rat tissue or 1:100 mouse tissue), and Wako 019-19741 Anti Iba1 (rabbit, 
1:1000). 
 
The secondary antibody incubation lasted 2 hours and was carried out at room temperature in 
PBS with 1% NGS. Secondary antibodies used were: Alexa Fluor Goat-α-Rabbit 488 (1:500), Alexa 
Fluor Goat- α-Mouse 546 (1:500) and Alexa Fluor Goat-α-Guinea Pig 633 (1:500). Slices were 
finally mounted on slides with Fluoromount and protected with coverslips. They were then 
imaged on an AxioScan Z1 machine. Tile scanned images were taken using a 20x lens, with pixel 
scaling at 0.325µm x 0.325µm per pixel. The immediate early gene was imaged as Alexa Fluor 
488 (excitation/emission 493/517), GAD67 was imaged as Alexa Fluor 546 (excitation/emission 
557/572), and NeuN was imaged as Alexa Fluor 633 (excitation/emission 631/647). 
 
Example, raw images for each of these labels are shown in Figure 2.6. Higher resolution images 
of the Arc stain were captured using a 63x lens on a Zeiss LSM 710 microscope, running Zeiss 
Zen software. Images were taken as tile scans from pia to cortical white matter using a 63x 
objective. Alexa Fluor 488 was excited with a 488nm laser and emitted light was collected was 
from 487-600nm. Resulting images had a pixel scale of 0.132µm x 0.132µm. Line averaging was 
used taking 8 passes of each scan line and averaging to collect only real staining. These images 
were also taken as z-stacks with the maximum intensity projection calculated for each image 
presented. 
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2.4.2 Image Analysis for cortical IEG profile measurement 
Images of immunofluorescent slices taken at x20 magnification with the Zeiss Axioscan Z1 slide 
scanner were manipulated in Zen 2 Lite (Blue) software, which uses ‘.czi’ files. Each of the 
intensity scales and upper/lower set limits of immediate early gene images were conserved 
across conditions to retain the original brightness of the staining and allow direct comparison 
between scans. Images were then exported as .tiff files and all subsequent image manipulation 
and analysis executed in MATLAB. The images were then flipped so that the secondary 
somatosensory cortex was on the right for the batch processing of the MATLAB programme, and 
were then converted to grayscale using the ’rgb2gray’ function to allow numeric comparison of 
pixel intensities and further manipulation of the datasets as described below. 
 
To extract the cortical regions required for analysis, the three images (one per fluorescence 
signal channel) were rotated to the same orientation so that the pia was at the very top of the 
image and layer VI of the cortex and cortical white matter were at the bottom. The NeuN image 
was used as a standard to provide the coordinates for the region to be cropped. The auditory 
cortex and secondary somatosensory cortex were identified with reference to an anatomical 
atlas (Paxinos and Watson, 1998) and a rectangular box was manually drawn around them 
(between the pia and cortical white matter) to provide coordinates by which to crop the image 
(Figure 2.7). Since, using the above method, the images from each channel of the triple staining 
all have the same dimensions. This allowed the coordinates of the cropped regions from the 
NeuN image to be then directly translated to the related GAD67 and Arc/c-Fos stained images 
(Figure 2.8).  
 
2.4.2.1 General regional IEG intensities 
Initially, to provide a general interpretation of changes in IEG expression, the c-Fos and Arc 
staining in cropped regions of neocortex were compared between delta oscillating slices and 
gamma oscillating slices. The images were processed to remove nonspecific background staining 
using a rolling kernel of 30 pixels in area.  The measure of the mean intensity of the staining in 
each region and for each condition was then calculated. 
 
2.4.2.2 Identifying neuronal cells 
NeuN is an antigen located in the nucleus and the immediately surrounding cytoplasm of 
neurons and is present in nearly all neuronal subtypes in the CNS  (with the exceptions of Cajal-
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Retzius cells, Purkinje cells, inferior olive neurons) (Gusel'nikova and Korzhevskiy, 2015). 
Antibodies to NeuN have long been used as an immunohistochemical marker of neurons.  
 
To provide a template by which to analyse the presence of Arc or c-Fos in all neurons, the IEG 
image was compared to a binary image of the corresponding NeuN stain. This was created using 
the im2bw function in MATLAB. This function requires the input of a thresholding value which 
was calculated by taking one standard deviation above the mean intensity of all pixels in the 
whole image. The resulting binary image retained all the cells in the foreground of a now ‘zero’ 
background. However, speckles were also present from less brightly stained background cells 
and nonspecific staining. These speckles were removed using the ‘bwareaopen’ function in 
MATLAB, which removed any objects in a binary image by size – in this case, any object smaller 
than 600 pixels (Figure 2.9). Each pixel of images taken on the Axioscan slide scanner is 0.325µm 
x 0.325µm, therefore 600 relates to ~65µm² which is much smaller than the average cell body 
size which ranges from 150-200µm²  
 
2.4.2.3 Identifying Interneurons 
To analyse the presence of Arc or c-Fos in all interneuron cell bodies, the IEG signal was 
compared to a binary image template of the corresponding GAD67 stain. This was created in a 
similar way to the NeuN template above. However, GAD67 antibody stained a large density of 
interneuron synaptic terminals as well as cell bodies, therefore additional steps had to be 
employed to separate cell bodies from the terminal staining for the template.  
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For this reason, the threshold value used with the ‘im2bw’ function used the 95th percentile 
rather than 1 standard deviation above the mean. Speckles smaller than the cells (<600 pixels in 
area) were again removed using ‘bwareaopen’. A further processing step removed the terminal 
staining (yet retained cell body staining) by retaining only the roundest objects in the image. This 
was done by creating a metric from the circumference and the area of each object using the 
formula (4π*area/perimeter²). Objects with a roundness metric of less than 0.25 were removed 
(an object with a roundness metric of 1 is approximately round) (Figure 2.10). 
 
2.4.2.4 Analysing IEG signals using NeuN and GAD67 Templates 
The NeuN and GAD67 templates were binary images so they were used to separate somatic 
levels of IEG from general background staining and staining in unidentified structures in the 
neuropil. Once the templates were created as described in the above two sections, the 
immediate early gene signal image was transposed onto the template only in areas that are 
positive for the cell-specific marker (NeuN+ve or GAD67+ve). The resulting image of the 
immediate early gene signal in the cell-specific marker template was then further processed by 
intensity. To retain only real cell immediate early gene staining, objects with an average intensity 
of less than the mean of all objects’ intensities, were removed (Figure 2.11). 
 
2.4.2.5 Analysing Arc in Dendrites 
Images of the Arc staining using the above template method contained signal arising only from 
the cell bodies. However, visual inspection of the raw images revealed there was also staining 
evident in dendrites traversing layers 2/3 of the neocortex. This extra-somal signal was excluded 
from the analysis which measured somatic staining using NeuN and GAD67 templates. 
Therefore, to analyse Arc in dendrites the original Arc image only was used, and the dendritic 
staining isolated. This was carried out by initially subtracting the background signal with a rolling 
kernel of 30 pixels in area. A binary image was then created of the background subtracted image 
and the threshold used was 1 standard deviation above the mean. Since the analysis only 
required information about the location of the dendrites and not the intensity of the signal, the 
binary image was then used for the final measurement.  Speckles were removed to the same 
parameters used throughout other analyses (<600 pixels in area). To attain the final dendritic 
images, the cells stained had to be removed, therefore any objects with a roundness measure 
of more than 0.15 were removed). Roundness was calculated using the same formula 
(4π*area/perimeter²) as section 2.3.2.2. (Figure 2.12). 
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2.3.2.5 The distribution of immediate early genes after image processing 
Once the template co-localisations and dendrites were isolated, the number of pixels that 
survived processing for each measurement were quantified across the width of the cortical 
regions of interest to create cortical profiles (from pia to subcortical white matter) for every 
repeat (gamma, delta, and matched controls) which were then normalised for length and width.  
 
To quantify the expression of c-Fos or Arc relative to oscillatory activity, matched slices from the 
same animal were used as a control. These control slices were processed in the same way as 
oscillating slices but were not exposed to the rhythm-generating drugs (Chapter 2.2.4). The 
mean profile of the oscillating condition minus matched controls were then calculated. These 
resulting profiles were also compared with the mean gamma vs. matched control profile being 
subtracted from the mean delta vs. matched control. 
 
Because no significant differences were seen between delta and gamma conditions when 
compared to control, the original raw data was scrutinised more thoroughly, and it was noticed 
that there was large variability in the data set. This was primarily down to a large variation in the 
staining in slices deemed ‘controls’. Therefore, direct comparisons between delta and gamma 
slices were also made to exclude the ‘control’ variability. 
 
To mathematically interrogate the difference between gene expression profiles of each 
condition without controls, the problem of multiple comparisons was encountered. Each profile 
contained 6000 data points from (pia to cortical white matter), meaning that there was a high 
possibility of encountering false detection of significance (Type 1 error). Due to the considerable 
number of comparisons carried out, a Bonferroni correction was deemed unfit as it was too 
conservative and would very likely cause the false exclusion of significant (Type 2 error). 
Therefore, a moderate post hoc test was considered, based on the false detection rate (FDR) 
(Storey and Tibshirani, 2003). Although the most overt changes appeared to be in the dendritic 
Arc signal, this method was also used to assess the direct comparison somatic c-fos and Arc in 
neurons and interneurons. 
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2.4.3 Oscillation and dendritic Arc expression correlations  
Upon creation of the cortical profile for each repeat of the experiment, the related 
electrophysiological data was used to compare with the distribution of Arc in dendrites. The 
cortical profiles were bisected tangentially, so that information regarding superficial and deep 
dendritic Arc signalling could be quantified separately. This was then compared with the area 
power, peak power, and peak frequency of the oscillation present (see Chapter 2.2.6). This was 
carried out for gamma and delta oscillating slices and included slices that were treated 
pharmacologically but did not generate an oscillation (to control, in part, for the presence of the 
drugs used to generate the oscillations).  
 
2.4.4 Tangential and radial arrangement analysis 
2.4.4.1 Radial and section analysis 
To look further at the tangential arrangement of Arc in dendrites, a bespoke MATLAB program 
was written. This took the example image of Arc staining and applied a high pass filter to remove 
any objects within the image that had a patterned separation larger than that of the visual 
dendrite clusters. After this an autocorrelation on each row of the image to visualise the average 
spatial arrangement of the dendrites. 
 
2.4.4.2 Preparation of tangential sections and analysis 
Since radial sections of the Arc stained sections spread out in the cortex, which was curved, to 
obtain tangential sections of these the brain had to be flattened out. This was done with care to 
obtain tangential sections of S2. The subcortical structures were dissected out and the cortex 
was carefully flattened and place on filter paper to hold the flattened conformation. This was 
then fixed in PFA for 24 hours. The flattened brain was then glued to a vibratome plate with the 
subcortical white matter facing downwards before being cut to 30µM on a vibratome. All 
sections were retained and sections from layers II/III were then stained with Arc as in Chapter 
2.4.1. Images were taken with a Zeiss LSM 710 motorised upright microscope with either x20 or 
x63 lens for different image resolutions. Images were taken as z-stacks and then the maximum 
intensity projection image was calculated in Zeiss Zen Software. 
 
The spatial distribution of Arc stained dendrites in the tangential plane were analysed using a 
program written in MATLAB. This involved the thresholding of the image using the MATLAB 
program ’imquantize’ and the calculation of a normalised 2-d rotational autocorrelation of the 
image which is presented as a heat map. 
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2.5 Milliplex Cytokine Panel 
2.5.1 Overview of the cytokine panel kit. 
To analyse the presence of a systemic and neuroinflammatory environment after LPS and Poly 
I:C dosing, we analysed concentrations of cytokines and chemokines in the serum and brain of 
treated rats using a Milliplex MAP Rat Cytokine/Chemokine Magnetic Bead Panel Kit. This allows 
simultaneous quantification of 27 cytokine and chemokine analytes in samples of tissue lysate 
and serum:  EGF, Eotaxin (CCL11), Fractalkine (CXC3L), G-CSF, GM-CSF, GRO/KC, IFN-γ, IL-1α, IL-
1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IL-17A, IL-18, IP-10 (CXCL10), Leptin, LIX (CXCL5), 
MCP-1 (CCL2), MIP-1α (CCL3), MIP-2 (CXCL2), RANTES (CCL5), TNF-α, and VEGF 
 
2.5.2 Milliplex sample preparation  
To prepare brain tissue for the assay, remnants of the cerebral cortex that were not used for 
electrophysiology experiments were kept in the -80°C before protein extraction. Tissue was 
defrosted to room temperature and then transferred to a 15ml tube, with 1.5ml of 
homogenisation buffer. 
 
The homogenate was transferred to a milli-tube containing an AFA fibre (Covaris, USA) these 
tubes were transferred to an E220 Focused-ultrasonicator (Covaris, USA) to lyse the tissue 
further by ultrasonication. The homogenate was then centrifuged at 4°C and 12000rcf for 5 
minutes. The supernatant was then removed and again centrifuged for 2 minutes at 2000rcf. 
 
For blood serum, 0.5 – 1ml of blood was taken from the heart immediately prior to transcardial 
perfusion. This blood was left to clot at room temperature for 30 minutes, before being 
centrifuged at 2,000 x g for 10 minutes. The supernatant serum was then collected and kept in 
the fridge for use in a cytokine panel. 
 
2.5.3 Milliplex plate setup  
To begin the assay, quality control samples (provided with the kit) were reconstituted and a 
serial dilution made of the standard solution (also provided) for comparison to allow eventual 
calculation of the concentration of cytokines/chemokines in experimental samples. The plate 
was washed with the assay buffer. Bead solution was added to every well analysed. The 
standard, quality controls and experimental samples were added to appropriate wells on the 
plate. Some wells were also left blank as a negative control. Serum matrix was added to the 
blank, standard, and quality control, and assay buffer (to make up the volume) was added to the 
samples wells and the blank. 
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The plate was then shaken for 2 hours at room temperature, after which the plate was washed 
and detection antibodies (provided with the kit) added into each well. The plate was then shaken 
for another 2 hours before adding Streptavidin-Phycoerythrin (provided with the kit) to each 
well and shaking for another 30 minutes. The plate was then washed, and sheath fluid was added 
to each well and shaken for 5 minutes before plate reading. The plate was then run on a Luminex 
200 System.  
 
2.5.4 Analysis of Milliplex assay results 
Once the samples had been read and concentrations analysed, the data went through several 
quality control steps to extract accurate results. Firstly, the assay analysed how many beads 
were counted per well. Any observed concentrations from wells where <50 beads were counted 
were discounted from analyses. Further to this, the coefficient of variation (CV) was calculated 
for each of the triplicated samples any result with a CV percentage >30% was removed from 
further analyses. The mean was found from the remaining technical replicates, to provide a 
mean concentration for each sample, which was then averaged across biological replicates. 
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Chapter Three – Plasticity related gene changes 
in sleep- and wake-related oscillations 
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3.1 Introduction 
3.1.1 Immediate early genes, plasticity, and brain states 
Immediate early genes (IEGs) are rapidly transcribed in response to certain cellular stimuli and 
can provide information about the nature of the recent cellular activity. The two immediate 
early genes of particular interest in this chapter are c-fos and ARC/Arg3.1. C-fos upregulation 
was once believed to be entirely dependent upon general levels of neuronal activity. However 
more recent evidence suggests that it may be more specifically related to the generation of new 
patterns of activity (Svarnik et al., 2013). Arc, on the other hand, has a direct, activity-dependent 
association with synaptic plasticity involving both AMPA receptor internalisation and synaptic 
stabilisation (Shepherd et al., 2006).  
 
The mRNAs for both these immediate early genes exhibit different expression patterns between 
sleep and wakefulness (Cirelli and Tononi, 2000b). This is not surprising as different networks of 
neurons fire in contrasting patterns in these brain states, and different modes of plasticity are 
dependent upon the timing of spikes that occur subsequent to different network oscillations 
(Markram et al., 2012). Delta oscillations are classically associated with deep (non-rapid eye 
movement, NREM) sleep and have been shown to associate with the consolidation of 
declarative memories, a process that requires synaptic plasticity. Cortical gamma oscillations, 
on the other hand, are associated with the processing of sensory information during 
wakefulness. The relationship between different spike timings during these oscillations and the 
type of synaptic plasticity they induce are not fully understood to date. 
 
What is known is that synaptic interconnections become stronger during novel experiences in 
the wake state – a substrate for memory (Bliss and Collingridge, 1993). This represents Hebbian 
plasticity, whereby neuronal connections are selectively modified in a use-dependent manner 
(Turrigiano and Nelson, 2000). This form of plasticity may account for increases in immediate 
early gene expression seen after learning-dependent tasks (Guzowski et al., 2001; Kelly and 
Deadwyler, 2003; Hanlon et al., 2009). For these memories to be made permanent they need to 
be consolidated during sleep (Dudai et al., 2015). This requires another plastic process which is 
thought to prune away weaker synaptic connections. This process, known as synaptic rescaling, 
has been proven on the anatomical (de Vivo et al., 2017) and molecular level (Diering et al., 
2017).  
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The pruning and depotentiation of weaker synapses, as suggested by the synaptic rescaling 
hypothesis, is not just important in memory consolidation but has also been implicated in a 
process known as synaptic homeostasis. The scaling of synaptic strengths is needed to balance 
the formation of new memories with the metabolic nutrient supply and availability of physical 
space in the neuropil for new connections. 
 
It is likely that processes underlying synaptic scaling occur during sleep as it is a state with less 
propensity for LTP. This is thought to be due to several factors: Firstly, dopamine levels need to 
be low in the brain to facilitate deep (slow-wave/delta) sleep (Dzirasa et al., 2006) and lower 
dopamine levels have a detrimental effect on long term potentiation of synaptic strengths (Li et 
al., 2003). Secondly, there is a strong diminishment (if not complete absence) of long-term 
memory acquisition during deep sleep due to the absence of sensory input (Tononi and Cirelli, 
2001). Furthermore, the amount of SWA during NREM sleep was found to be related to 
increased synaptic strength during prior wakefulness and not simply a response to increasing 
cell firing (Rodriguez et al., 2016). So, whilst NREM sleep may be the target for this synaptic 
rescaling, exactly which connections are altered, between which neuron subtypes, during NREM 
sleep is not known.  
 
3.1.2 Aims of this chapter 
This chapter aims to use immediate early gene expression changes to map the location and 
levels of cortical plasticity during rhythms associated with NREM sleep and cortical activation in 
wakefulness. For this in vitro preparations of brain tissue were used, in which pharmacologically 
induced oscillations (delta oscillations and gamma oscillations respectively) were generated to 
differentiate regional and laminar cortical changes in network dynamics associated with NREM 
sleep and cortical activation. Analyses of IEG signals in these conditions was carried out, with 
respect to specific cell subtypes and sub-compartments that contribute to these rhythms, and 
their patterned organisation. 
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3.2 Results 
3.2.1 Regional difference in overall IEG expression in different brain states  
The presence of IEG protein expression was first analysed in sub-sectioned slices of in vitro 
preparations of rat neocortex in the absence of any templates for co-expressed neuronal 
markers. This expression was compared between slices that had previously generated wake-
state (gamma) or sleep-related (delta) oscillations and those that had been left untreated with 
oscillation-inducing drugs. 
 
The overall expression of c-Fos and Arc were analysed in isolated primary sensory and secondary 
association cortical regions; the same regions were used in more detailed, further analyses using 
neuronal templates. The mean intensity of staining in each region (minus background) was 
analysed and compared between conditions and matched controls.  
 
There was no significant difference in C-fos intensity when comparing each oscillating condition 
to the matched control data (S1. Control vs. Delta, 11.64 ± 1.86 vs. 10.52 ± 0.81, T-test, p = 0. 
530; S2. Control vs. Delta, 10.95 ± 1.41 vs. 10.10 ± 0.89, T-test, p = 0.604; Au1. Control vs. 
Gamma, 9.87 ± 1.52 vs. 6.98 ± 0.94, T-test, p = 0.127; S2. Control vs. Gamma, 10.377 ± 4.95 vs. 
7.01 ± 0.98, T-test, p = 0.098). However, the mean C-fos intensity was lower in gamma oscillating 
slices compared to slices exhibiting a delta rhythm (Figure 3.1A). In the primary sensory cortex, 
the mean intensity of c-Fos staining was more from in gamma oscillating slices than delta 
oscillating slices (gamma: 7.04 ± 1.07; delta: 10.52 ± 0.81, p = 0.013, n=9/8, T-test). In the 
secondary association cortex, the mean intensity of c-Fos staining was also more (gamma: 7.11 
± 1.10; delta: 10.10 ± 0.88 in, p = 0.034, n=9/8, T-test). 
 
There was also no significant difference in Arc intensity when comparing each oscillating 
condition to the matched control data (S1. Control vs. Delta, 8.00 ± 1.64 vs. 5.66 ± 0.56, T-test, 
p = 0.162; S2. Control vs. Delta, 8.38 ± 2.15 vs. 5.68 ± 0.66, T-test, p = 0.208; Au1. Control vs. 
Gamma, 10.70 ± 2.43 vs. 7.85 ± 0.61, T-test, p = 0.320; S2. Control vs. Gamma, 11.22 ± 2.46 vs. 
7.75 ± 0.67, T-test, p = 0.195). However, there was lower overall expression seen in delta 
oscillating slices compared to those exhibiting gamma oscillations (Figure 3.1B). In primary 
sensory cortex, the mean intensity of Arc staining was lower from 7.85 ± 0.61 in gamma 
oscillating slices to 5.66 ± 0.56 in delta oscillating slices to (p = 0.024, n=7/6, T-test). Secondary 
association cortex the mean intensity of c-fos staining was less, from 7.75 ± 0.67 in gamma 
oscillating slices to 5.68 ± 0.66 in delta oscillating slices (p = 0.024, n=7/6, T- test). 
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3.2.2 Laminar, soma-specific IEG during different brain states compared to control  
Looking further into the cytoarchitectural origin of the above differences in immediate early 
gene expression, dual immunostaining was used to look at the localisation of IEG signals in cell 
bodies in certain cell types and cortical layers. C-fos expression was analysed in cells also stained 
with NeuN, a marker for neuronal nuclei and GAD67, a marker for ca. 96% of cortical 
interneurons (Sahara et al., 2012). Primary sensory and secondary association areas were 
analysed separately and the laminar distribution of c-fos in NeuN+ve cells was measured in 
oscillating slices. T-tests were run on every data point from the pia to subcortical white matter.  
 
For any points that were statistically significant a modified q value was calculated using a false 
detection rate (FDR) correction for multiple comparisons. The difference between the oscillating 
condition and untreated controls from the same animal were then compared to display the 
activity change due to the oscillation.  
 
During delta oscillations, the neuronal c-Fos expression did not show any significant differences 
across the cortex (Figure 3.2 Ai and Bi) compared to control in either the primary sensory cortex 
(biggest difference in S1 at 607.8 µm. Control vs. delta, 0.449 ± 0.276 vs. 0.996 ± 0.262, T-test, p 
= 0.2, with FDR, q = 0.9589) or in the secondary association cortex (biggest difference in S2 at 
437.8µm. Control vs. delta, 0.543 ± 0.484 vs. 1.139 ± 0.492, T-test, p = 0.4211, with FDR, q = 
0.890). During gamma oscillations the largest difference was a decrease in the mean c-Fos levels 
compared to control in superficial layers (Figure 3.2 Aii and Bii) but this was not significant in 
either the primary sensory cortex (Au1 at 710.8µm. Control vs. gamma, 1.056 ± 0.449 vs. 0.227 
± 0.071, T-test, p = 0.093, with FDR, q = 0.312) and secondary association cortices (S2 at 
1408.6µm. Control vs. gamma, 0.833 ± 0.236 vs. 0.130 ± 0.038 T-test, p = 0.0123, with FDR, q = 
0.344).  
 
To compare delta and gamma oscillating conditions, the control-subtracted profiles related to 
the gene expression gamma oscillating condition were subtracted from the delta condition 
profile (Figure 3.2 Aiv and Biv). There was an higher mean c-fos levels in NeuN+ve cells during 
delta conditions but this was not significant in primary cortex (681.5µm. Delta - Control vs. 
Gamma – Control: -0.043 ± 0.307 vs. -0.826 ± 0.510, T-test, p = 0.262, with FDR, q = 0.554) or 
secondary association cortex 607.8µm. Delta - Control vs. Gamma – Control: 0.534 ± 452 vs. -
0.427 ± 0.171, T-test, p = 0.040, with FDR, q = 0.478).  
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In line with the lack of change in c-Fos expression in NeuN+ve cells when comparing each 
oscillation, c-Fos expression in GAD67+ve cells also showed no change. Even the largest 
difference from control levels of c-Fos expression was not significant in either region during 
gamma (Figure 3.3 A/B, i&ii) (Au1 at 436.2µm. Control vs. gamma, 0.401 ± 0.238 vs.0.095 ± 
0.055, T test, p = 0.2332, with FDR, q = 0.529; S2 at 113.4µm. Control vs. gamma, 0.348 ± 0.312 
vs. 0.032 ± 0.016, T test, p = 0.331, with FDR, q = 0.712) or delta (S1 at 1279.9µm. Control vs. 
delta, 0.240 ± 0.112 vs. 0.035 ± 0.034, T test, p = 0.130, with FDR, q = 0.997; S2 at 745.2µm. 
Control vs. delta, 0.108 ± 0.071 vs. 0.260 ± 0.120, T test, p = 0.318, with FDR, q = 0.723). Even 
when directly comparing the two rhythms there were no significant differences (Figure 3.3 
A/Biv) (primary cortex, 567.5µm. Delta - Control vs. Gamma – Control: 0.055 ± 0.066 vs. -0.215 
± 0.151, T-test, p = 0.225, with FDR, q = 0.831; or secondary association cortex 113.4µm. Delta - 
Control vs. Gamma – Control: 0.000 ± 0.000 vs. -0.3162 ± 0.309, T-test, p = 0.468, with FDR, q = 
0.853). 
 
Somatic Arc expression was also measured for its presence in neurons (NeuN) and interneurons 
(GAD67). In neurons, during both gamma rhythms (Au1, 1913.0µm. Control vs. Gamma: 0.397 ± 
0.217 vs. 0.913 ± 0.309, T-test, p = 0.197, with FDR, q = 0.713; S2, 637.0µm. Control vs. Gamma: 
0.414 ± 0.175 vs. 0.082 ± 0.038, T-test, p = 0.088, with FDR, q = 0.902) and delta rhythms (S1 
1940.6µm. Control vs. Delta: 0.960 ± 0.626 vs. 0.272 ± 0.122, T-test, p values = 0.302, with FDR 
q= 0.480; S2, 1925.6µm, Control vs. Delta: 0.505 ± 0.241 vs. 0.042 ± 0.021, p value = 0.080, q 
value = 0.420) somatic ARC expression did not show any change from the untreated control 
condition. When comparing delta and gamma oscillation conditions directly, the difference in 
layer VI staining was more noticeable, and appeared only in primary cortical regions but was not 
significant (Figure 3.4 Aiv) (1ry: 1922.4µm, Delta-Control vs Gamma-Control: -0.669 ± 0.467 vs. 
0.279 ± 0.226, T-test, p = 0.092, with FDR q = 0.513). There was also no difference in somatic Arc 
distribution in secondary association regions (Figure 3.4 Biv) (2ry: 1925.3µm, Delta-control vs 
Gamma-Control: -0.459 ± 0.235 vs. 0.075 ± 0.207, T-test, p = 0.245, with FDR q = 0.999). 
  
Much like the expression of c-Fos, there was very little change in the GAD67+ve cell expression 
of Arc compared to control in any condition (Figure 3.5. A/B, i &ii) (Au1, 1163.9µm. Control vs. 
Gamma: 0.0312 ± 0.0149 vs. 0.241 ± 0.020, T-test, p = 0.321, with FDR, q = 0.4351; S2, 1269.1µm. 
Control vs. Gamma: 0.005 ± 0.004 vs. 0.139 ± 0.124, T-test, p = 0.301, with FDR, q = 0.660; S1, 
1297.1µm. Control vs. Delta: 0.147 ± 0.072 vs. 0.020 ± 0.020, T-test, p = 0.117, with FDR, q = 
0.647; S2 1623.0µm, Control vs. Delta: 0.190 ± 0.1826 vs. 0.003 ± 0.003, T-test, p = 0.326, with 
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FDR, q = 0.469). However, there was a decrease in the mean ARC expression in the superficial 
layers of primary cortical regions during delta compared to gamma, however this was not 
significant (Figure 3.5. Aiv) (1ry, 1162.2µm, Delta-Control vs. Gamma-Control: -0.012 ± 0.018 vs. 
0.207 ± 0.208, T-test p = 0.314, with FDR q = 0.388). This difference was very slight and not 
apparent in secondary association regions (Figure 3.5. Biv) (2ry, 1269.5µm, Delta-Control vs. 
Gamma-Control: -0.063 ± 0.082 vs. 0.133 ± 0.126, T-test, p = 0.217, with FDR, q = 0.697). 
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ARC is not only expressed in neuronal cell bodies, but also in dendrites. This was clear under 
visual inspection of oscillating slices in the primary sensory and secondary association cortices. 
Arc staining was visible in radially arranged dendrites/dendrite clusters that projected across 
intermediate and superficial layers. Arc staining was also apparent in some layer VI dendrites 
others of which stretched horizontally (Figure 3.6 A and B).  
 
Whilst this dendritic expression was conserved between delta and gamma, across the regions 
examined, there were large and contrasting patterns during gamma and delta rhythms. The 
largest difference in dendritic Arc staining was in superficial layers which was higher in delta 
conditions compared to gamma (Figure 3.7Ai/ii) however this was not significant (S1, 1327.0µm, 
Control vs. Delta: 27.0 ± 12.4 vs. 7.4 ± 1.5, T-test, p = 0.142, with FDR q = 0.954; S2, 33.1250 µm   
22.8 ± 5.1 vs. 47.7 ± 10.8, T-test, p = 0.0587, with FDR q = 0.486). During gamma oscillations 
dendritic ARC expression there was a mean decrease compared to control in both primary 
sensory and secondary association cortices, though this was not significant (Figure 3.7 A&Bii) 
(Au1, 659.4 µm, Control vs. Gamma: 30.7 ± 10.8 vs. 15.2 ± 3.2, T-test, p = 0.1948, with FDR q = 
0.972: S2, 225.2 µm Control vs. Gamma: 32.4 ± 12.4 vs. 14.7 ± 5.6, T-test, p = 0.2201, with FDR 
q = 0.640). 
 
Comparing between oscillation conditions there seemed to be more superficial dendritic Arc 
signalling in delta oscillations in both regions (Figure 3.7 Aiv/Biv). Only in primary cortical regions 
did there was a mean decrease in deep layers in delta compared to gamma oscillations. But 
these differences were not significant (S1, 683.5 µm Delta-Control vs. Gamma-Control:  15.2 ± 
8.2 vs. -13.2 ± 10.5, T-test, p = 0.054, with FDR q = 0.981: S2, 233.7 µm, Delta-Control vs. Gamma-
Control:  24.6 ± 12.4 vs. -16.9 ± 16.2, T-test, p = 0.0642, with FDR q = 0.129) 
 
Whilst these differences appeared to be noteworthy from visual inspection of the graphs none 
of the differences seen were significant. On examination of the raw data, the main contributory 
factor to the variability of the data set was the ‘control’ values which showed much greater 
variability (Figure 3.8 A) than the oscillatory condition (Figure 3.8 B). This added variability once 
the control data was subtracted from the oscillating profile (Figure 3.8C). This variance was 
measured with the MATLAB programme ‘var’ and the mean variance of the data sets was 
calculated (matched control vs gamma: 187.72 vs. 120.33). With the high variance in the 
matched control, this control data was therefore put aside, and the above analyses were 
repeated with a direct comparison between oscillation states. 
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3.2.3 Direct comparison of laminar IEG expression changes in different brain states  
The direct comparison of c-fos in NeuN+ve cells did not show any differences in the distribution 
of c-fos staining between gamma and delta rhythms, however there was a higher mean 
NeuN+ve cell c-fos expression during delta rhythms (Figure 3.9A), and the mean difference was 
largest in superficial layers of the primary cortex (Figure 3.9Ai). However, these differences were 
not significant (S1, 602.6 µm, Delta vs. Gamma: 0.950 ± 0.290, vs. 0.227 ± 0.090, T-test, p = 
0.0156, with FDR q = 0.2294: S2, 422.2 µm, Delta vs. Gamma: 1.199 ± 0.661 vs. 0.244 ± 0.148, T-
test, p = 0.099, with FDR q = 0.187). 
 
The c-fos expression was unchanged between delta and gamma oscillating slices in GAD67+ve 
cells (Figure 3.9B). (S1, 1740.1µm, Delta vs. Gamma: 0 ± 0 vs. 0.190 ± 0.122, T-test, p = 0.279, 
with FDR q = 0.593: S2, 1158.0µm, Delta vs. Gamma: 0.257 ±0.139 vs. 0.071 ± 0.047, T-test, p = 
0.152, with FDR q = 0.561).  
 
Directly comparing gamma and delta rhythms for somatic Arc also showed no significant 
differences between conditions (Figure 3.10A). (S1, 1912.6µm, Delta vs. Gamma: 0.258 ±0.121 
vs. 0.906 ± 0.298, T-test, p = 0.067, with FDR, q = 0.318, S2 1898.7µm, Delta vs. Gamma: 0.041 
± 0.027 vs. 0.421 ± 0.120, T-test, p = 0.009, with FDR q = 0.396). There was no significant 
difference in Arc distribution in GAD67+ve cells between conditions (Figure 3.10B). S1, 
1162.9µm, Delta vs. Gamma: 0.009 ± 0.006 vs. 0.241 ± 0.202 T-test, p = 0.274, with FDR q = 
0.453; S2 1269.1µm, Delta vs. Gamma: 0.021 ± 0.0179 vs. 0.139 ± 0.124, T-test, p = 0.362, with 
FDR q = 0.635). 
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The direct comparison of staining showed significantly more dendritic Arc in layer II/II in the 
primary sensory cortices during delta rhythms compared to gamma rhythms (Figure 3.11A) (1ry   
616.5µm, Delta vs. Gamma: 50.4 ± 7.0 vs. 11.8 ±   2.2, T-test, p < 0.001, with FDR q = 0.002). 
Despite the apparent visible difference in the secondary association cortex (with no overlapping 
errors), no significance was found in s2 (Figure 3.11B) (S2, 233.7µm, Delta vs. Gamma: 46.2 ± 
15.4 vs. 15.4 ± 6.5, T-test, p = 0.090, with FDR q = 0.3887).  
 
Whilst significant results were found, the false detection rate analysis assumes each point of 
comparison is independent of those surrounding it. This, therefore, is not an entirely valid 
analysis of these data, as it is structural in nature and therefore containing connected objects. 
To overcome this, data was binned into 20 regions (each bin is 97.5µm wide after interpolation) 
from pia to cortical white matter to allow for a lower false detection rate due to multiple 
comparisons. This also meant that a more conventional Holm-Sidak post hoc test could be used 
(Figure 3.12). With this analysis we now found several significant points of higher dendritic Arc 
in primary cortex (p values for bins are: 1 (97.5µm) = 0.048, 6 (585µm) = 0.003, 7 (682.5 µm) < 
0.001, 9 (877.5 µm) = 0.003) and secondary cortex (p-value for bin no. 7 (682.5 µm) was 0.039). 
 
3.2.4 The relationship between dendritic Arc expression and oscillatory properties. 
Considering that the ‘control’ condition slices were abandoned in these analyses owing to the 
variability of their IEG expression levels, it was important to deduce how much of the expression 
of dendritic Arc was down to the presence of either delta or gamma oscillations. Therefore, the 
analysis was carried out to assess the relationship between different features of the oscillatory 
activity generated (as measured from the power spectrum) and the dendritic Arc signal showing 
the significant differences above. Primary sensory cortices and secondary association area 
images were divided in half tangentially to compare the oscillatory characteristics with Arc 
expression with cortical layers in superficial and deeper portions of the cortex.  
 
In gamma oscillating slices dendritic expression of Arc was lower in deeper layers than in 
superficial layers. In the deeper half of the cortex, there were no significant correlations 
between Arc dendritic staining and the area power, the peak power or the peak frequency of 
the gamma oscillation. Superficial layers did display a negative correlation between dendritic 
Arc and the area power of the oscillation in Au1 (R² = 0.51) (Figure 3.13Ai). This significance was 
not conserved in S2 (Figure 3.13Bi).  
  114 
 
  115 
 
  116 
There was also no correlation between the dendritic Arc levels and the power or frequency of 
the highest peak in the power spectrum (Figure 3.13 A&B ii/iii). 
 
In delta oscillating slices the higher expression of Arc during delta (Figure 3.11 and 3.12) was 
conserved under visual comparison with the gamma condition correlation graphs (Figure 3.13 
and 3.14). Again, no correlation was seen between the dendritic expression of Arc in deeper 
layers and any measured of features of the delta oscillations. There was also no relationship 
between area power, peak power, or peak frequency in superficial layers in S1 (Figure 3.14B). 
However, in S2 a negative relationship was visible between Arc dendritic staining and area 
power (R² = 0.612).  
 
3.2.5 Identification of the cells responsible for dendritic Arc expression.  
All the data presented thus far has shown that the expression of Arc in dendrites is mostly 
confined to the superficial layers of the cortex. These dendrites would appear (from visual 
inspection) to originate in cells whose cell bodies lie in deeper layers and that project their apical 
dendrites to superficial layers as far as layer I (Figure 3.6). To identify the specific subtype of the 
cell responsible for this Arc expression intracellular electrophysiological recordings were made 
of single cells, in conjunction with biocytin filling. This allowed for the electrical characterisation 
of the cells, along with the physical characterisation and co-staining with Arc. This meant that 
the cell types contributing to the dendritic Arc signal could be revealed. 
 
These experiments ruled out Layer V regular spiking neurones as candidates as they did not 
show co-expression of Arc in their apical dendrite (Figure 3.15). Layer VI regular spiking cells also 
do not express Arc in their apical dendrite during delta oscillations (Figure 3.16). These 
intracellular experiments did however successfully show co-staining between biocytin labelled 
layer V intrinsically bursting cells and Arc (Figure 3.17).  
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3.2.6 The arrangement of Arc in dendrites in layer II/III of the cortex. 
The Arc staining was localised to the layer II/III portion of the apical dendrites of layer V 
intrinsically bursting cells. However, it was also apparent that these apical dendrites were not 
isolated but appeared to be arranged in clusters (Figure 3.6).  
 
To assess this arrangement, first a 1-dimensional autocorrelation was performed on each 
tangential image scan line from pia to subcortical white matter using the original radial sections 
(e.g. Figure 3.18 Ai). The location of positive pixels of each scan line of the thresholded image 
was compared with a copy of that line. The copy was then shifted along by one pixel and 
compared again until there was no overlap. Where there was a strong spatial pattern, a high 
correlation was revealed. This was done for each line of the image and plotted as a colour map. 
This showed a strong spatially repeating pattern in layers 2/3 with a spatial frequency of ~50 m 
(Figure 3.18 Aii).  
 
A 2-dimensional autocorrelation analysis was used on tangential slices from the secondary 
somatosensory cortex to see if this clustering extended beyond the radial plane captured in the 
original slices. This used a similar principle to the autocorrelation mentioned above but involved 
a rotational comparison. This analysis showed that there was a near-hexagonal structural 
arrangement of Arc-positive dendritic compartments, again with a spatial frequency of ~50µm 
(Figures 3.19 Ai, Bi, Ci). On closer inspection of the images, the dimensions of this spatial 
arrangement appeared to capture the interval between dendritic clusters. However, using 
higher-resolution images the second level of organisation within clusters was apparent (Figure 
3.19 Aii). Further analyses of this tangential arrangement, at the higher resolution, were also 
carried out using 2-D autocorrelations. This allowed the analysis of the relative location of each 
dendrite and dendrite cluster to its neighbours. This revealed the arrangement of dendrites 
within clusters. It showed a smaller-spatial scale (ca. 10 m) version of the hexagonal pattern 
seen between clusters was also present for individual dendrites within each cluster (Figure 3.19 
Aii/Bii). Furthermore, some evidence for the ~50µm hexagonal spatial arrangement between 
clusters was also still apparent using these higher-resolution images (Figures 3.19 Ci, Cii). 
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3.3. Discussion 
3.3.1 Summary 
In this chapter, the effect of certain brain rhythms on regional IEG changes was analysed. In vitro 
models of NREM sleep-related delta rhythm (Carracedo et al., 2013), and the wake-related 
gamma rhythm (Ainsworth et al., 2011) were used to monitor c-fos and Arc changes in response 
to due to specific network activities unconfounded by other electrical activity that would occur 
in vivo. With this technique, molecular changes were analysed within whole regions, as well as 
with laminar and cellular specificity.  
 
The summary of key findings from this investigation are:  
 The total c-Fos protein expression was elevated in slices oscillating at delta frequency 
compared to slices oscillating at gamma frequency in primary and association areas 
equally. 
 C-Fos expression in NeuN and GAD67 immunopositive somata was not affected by the 
nature of brain rhythms in any region/layer studied. 
 Total arc protein expression was diminished in slices oscillating at delta frequency 
compared to slices oscillation at gamma frequency in each area studied. 
 Arc expression in NeuN and GAD67 immunopositive somata was not affected by the 
nature of brain rhythms in any region/layer studied. 
 Arc expression in L5 IB neuronal apical dendrites was elevated in delta rhythms. 
 Dendritic Arc expression was differentially affected by gamma and delta oscillation 
power in primary and secondary neocortex respectively. 
 The spatial pattern of dendritic Arc expression corresponded to the previously described 
architecture of neocortical microcolumns. 
 
3.3.2 c-Fos is higher during sleep-related rhythms regionally but not locally 
C-Fos, a gene expressed in response to ‘new’ firing patterns in neurons (Svarnik et al., 2013), 
showed higher expression in slices oscillating a delta frequency, compared to gamma oscillating 
slices. These findings are at odds with studies into the expression of c-Fos across the sleep-wake 
cycle (Pompeiano et al., 1995; Hanlon et al., 2009). However, most of the previous evidence for 
c-Fos changes are with respect to mRNA data (Cirelli and Tononi, 2000c), and  there is known to 
be a discrepancy with translation across the sleep-wake cycle with an upregulation of protein 
synthesis during sleep (Ramm and Smith, 1990; Nakanishi et al., 1997), especially with plasticity 
dependent genes (Seibt et al., 2012).  
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Many in vivo studies also do not monitor the electrical activity of the brain during sleep, only by 
behaviour. Therefore, they do not make a statement about specific stages of the sleep-wake 
cycle above comparison of ‘wake’ versus ‘sleep’. With the in vitro models used in this thesis, 
specific rhythms related to certain brain function were generated, albeit in a more persistent 
fashion than is usually seen in vivo. It is likely that the changes seen in regional c-Fos levels were 
specific to the presence of gamma and delta rhythms.  
 
As well as neurons, c-Fos is also expressed glia (Dragunow et al., 1990) (Edling et al., 2007). 
Therefore, even with a background subtraction process to remove non-specific staining, 
comparing the gross remaining staining over the whole would also include glial c-Fos staining. 
To take this into account analyses for neuron-specific staining (NeuN co-localisation) was 
undertaken. Additionally, to investigate these regional changes further we analysed the change 
in the distribution of c-Fos throughout the cortical layers and found no difference in neuronal or 
interneuron c-fos staining in any layer of the cortex in these analyses, although the trend 
towards general higher c-fos during delta rhythms was still apparent. The specificity in these 
analyses (both cellular and laminar) is most likely the reason for the lack of significant changes 
recorded. Especially as observing c-Fos in areas of NeuN immunostaining meant that any extra-
somal staining was ignored. This is of particular importance as recently c-fos has been found in 
synaptic boutons (Nakao et al., 2002)  
 
3.3.3 ARC expression is lower regionally but not locally during delta oscillations  
Our initial experiments investigating the changes to Arc (an IEG mediator of plasticity) showed 
a regional decrease in both primary sensory cortex and secondary association cortex during 
delta rhythms compared to gamma activity. This is line with findings by Cirelli and Tononi 
(2000a) that show a global decrease in Arc in the cerebral cortex during sleep compared to 
wakefulness. This decrease in Arc expression has also been shown to occur more specifically in 
brain regions associated with task learning – compared to untrained regions - during 
wakefulness. These changes were abolished after 1 hour of sleep (Hanlon et al., 2009) and were 
related to increased slow wave activity, which suggests that looking at levels during sleep 
compared to SWS, the results are comparable. 
 
Trying to localise these sleep-related decreases, we found that the expression of Arc in neuronal 
cell bodies is similar during delta and gamma rhythms oscillations. This analyses only included 
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the cell bodies and therefore did not include any synaptic or dendritic signal. It is not surprising 
that there is little difference in Arc protein in the cell body as Arc is transcribed in the nucleus 
but is mostly shuttled to dendrites for translation (Steward et al., 1998), so it would be expected 
that the majority of Arc signal would arise from the dendrites, which is indeed the case with 
these experiments. This would also account for the similarity in the pattern of activity ARC in 
GAD67+ve interneurons as the analyses only observed changes within the locale of the soma 
rather than dendrites of interneurons. 
 
3.3.4 Arc expression was elevated in L5 IB neuronal dendrites during delta rhythms 
Contrasting the regional decreases, we found that Arc was highest in dendrites in layer II/III in 
vitro delta oscillations compared to gamma oscillations. This finding was also at odds with 
general changes seen in Arc expression over the sleep-wake cycle, in which Arc mRNA is built up 
during wakefulness and decreased during sleep in the cortex (Cirelli and Tononi, 1999; Cirelli et 
al., 2004) and hippocampus (Thompson et al., 2010). It also contrasted the gross regional 
changes which also saw a decrease in Arc signal. The gross analysis not only included the 
dendritic staining but somatic and extracellular signal. To lead to a net reduction over the whole 
area, the higher level of dendritic Arc must have a contrasting decrease in the rest of the signal.  
 
Since delta rhythms are associated with SWS, our data would suggest that processes occur 
during SWS that generally decrease the expression of Arc, but locally has a higher expression in 
distal dendrites. The mechanism by which this specific increase occurs is unclear, in that whilst 
its transcription occurs in the nucleus, its mRNA is trafficked to the dendrites where it translated 
(Steward et al., 1998). Synaptic activity is known to increase both of these processes (Steward 
and Worley, 2001), so it uncertain whether the increased level of Arc is as a result of de novo 
transcription, or the translation of already synthesised mRNA. Observing the dendritic 
appearance of Arc In the presence of a transcriptional repressor (actinomycin D) or a protein 
synthesis inhibitor (cycloheximide) would help elucidate this mechanism. 
 
Whilst the mechanism by which Arc is increased may be uncertain, the processes in which it is 
involved during delta are clearer. It is known that the landscape of synaptic plasticity during 
wakefulness is weighted towards potentiation (Bramham and Srebro, 1989), whereas synaptic 
depression (LTD) dominates sleep (Tononi and Cirelli, 2003; Shepherd, 2012).  The process of 
rescaling synapses during sleep in this way is important for the maintenance of synaptic 
homeostasis (Tononi and Cirelli, 2014).  
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These results show that Arc is implicated in this process, through its role in LTD by the 
internalisation of AMPA receptors from the postsynaptic membrane (Chowdhury et al., 2006; 
Rial Verde et al., 2006; Shepherd et al., 2006). The role of Arc in synaptic scaling is supported by 
evidence that shows that the KO of Arc prevents this process in the primary visual cortex (Gao 
et al., 2010). This endocytosis (and thus LTD) is known to increase during sleep  (Vyazovskiy et 
al., 2008; Lante et al., 2011; Diering et al., 2017) and is also supported by studies that highlight 
the electrophysiological presence of LTD in sleep too (Vyazovskiy et al., 2008; Liu et al., 2010).  
 
There is also evidence that relates the delta rhythms with LTD, as activity of the delta band 
reduces with sleep time along with the overall strength of synapses (Riedner et al., 2007). The 
influence of certain neurotransmitters during delta rhythms also points toward synaptic 
depression as dopamine (D1) receptors are blocked to enhance delta oscillations in vitro 
(Carracedo et al., 2013) and the activation of these receptors has been shown to impair LTD (Xu 
and Yao, 2010). Thus, it seems that Arc may play a critical role in this synaptic rescaling during 
SWS-related delta rhythms through the de-potentiation of synapses in layer II/III.  
 
Intracellular experiments allowed us to pinpoint the layer II/III Arc increase to the apical 
dendrites of layer V IBs. Structurally, this laminar and cellular localisation corresponds spatially 
with calcium spike initiation zones (Perez-Garci et al., 2013) which are portions of the apical 
dendrite of layer V cells that are highly innervated by inhibitory neurones and as such possess a 
high density of GABAB receptors. The activation of these receptors has been shown to decrease 
excitability by the blockage of voltage-dependent calcium channels (VDCCs) which abolishes 
calcium spikes in these dendrites (Perez-Garci et al., 2006; Breton and Stuart, 2012). 
Additionally, the GABAB mediated inhibition of layer V intrinsically bursting cells is implicated in 
synaptic depression during delta oscillations and is responsible for the separation of each active 
phase of the rhythm (Carracedo et al., 2013).  The burst firing between periods of inhibition seen 
during delta rhythms is suggested to be associated with huge calcium influx, which is ideal for 
the induction of immediate early gene expression (Buzsaki, 1998; Das et al., 2018).  
 
Increased calcium influx (following cellular activation) has been shown to be important in 
synaptic scaling, as it binds to the N-teminus of the postsynaptic density protein-95 (PSD 95) 
preventing it from anchoring AMPA receptors to the postsynaptic membrane and allowing their 
internalisation (Chowdhury et al., 2018). The actual removal of AMPA receptors requires Arc, 
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which binds interacts with endophilin and dynamin to bring AMPA receptors into endosomes 
and thus cause their endocytosis (Chowdhury et al., 2006). It may be that the calcium spike 
initiation zones afford a high degree of synaptic plasticity to apical dendrites in layer II/III and 
help ‘allocate’ synapses in a calcium-dependent manner, and Arc completes the process. 
Additionally, some AMPA receptors are permeable to calcium, and it has been shown that the 
internalisation of all these calcium-permeable AMPA receptors from the membrane of L5 
pyramidal cells occurs during sleep (Lante et al., 2011). This may serve as a negative feedback 
mechanism for synaptic rescaling.  
 
3.3.5 The arrangement of Arc stained of intrinsically bursting cell dendrites  
Not only is the nature and cellular localisation of this synaptic scaling of importance, but also 
the arrangement of cell clusters in which it occurs. We found that there was a tangential spatial 
organisation of clusters of the Arc immunopositive layer V IB apical dendrites, at a spatial 
frequency of ~50uM. This was conserved when looking at these dendrites clusters radially and 
these structures were also found to have quasi-hexagonal arrangement. Additionally, a within-
cluster analysis found this hexagonal-like arrangement to be present between the dendrites of 
each cluster. 
 
Previously, Maruoka et al. (2017) have shown a similar feature in the neocortex of mice, with a 
hexagonal arrangement (with a spatial frequency of about 30µM) in the pattern of sub-cortical 
projection neuron (SCPN) dendrites. The cells that make up these clusters were labelled by the 
injection of a tracer into the pons and were suggested to represent cortical microcolumns. The 
similar pattern of expression seen in this chapter existed in the apical dendrites of LV IB cells, 
which are known to project to the pons (Gao and Zheng, 2004) and thus correspond to the SCPNs 
of cortical microcolumns discovered the aforementioned study.  The spatial frequency disparity 
of the two findings may be a species related difference between rats and mice. Not only are 
layer V pyramidal cells known to be anatomically clustered, but they are also shown show 
correlated c-fos expression (Maruoka et al., 2011), and in many areas of the sensory cortex, they 
fire synchronously with the presentation of stimuli (Maruoka et al., 2017). If the activity of these 
dendrites is so strongly connected, the high synaptic plasticity between them is unsurprising. 
The increased change in synaptic plasticity during delta rhythms, most likely related to 
depression of synapses, occurs in dendrites that form these structures. This suggests that these 
microcolumns may be the main functional units in the neocortex in which synaptic scaling 
occurs, and thus highlights the importance of these functional units in the memory process. 
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It is suggested that whilst in less complex nervous systems single neurons act more 
independently, the neocortical microcolumn shows that neurons act much synergistically as a 
single entity in higher animals (Perin et al., 2011). Furthermore, there is a high degree of synaptic 
plasticity between pyramidal neurons in these circuits. Initially dendrites have indiscriminate 
contact with axons of other pyramidal cells, only defined by their proximity (with 50µm) 
(Kalisman et al., 2005)  This allows for the modification of synaptic weights in these contacts to 
occur due to the timing of action potentials and EPSPS (Markram et al., 1997) a preference for 
the elimination of existing weaker synaptic connections (whilst new ‘weak’ connections were 
retained at a similar rate to the remaining stronger connections)  has also been shown  (Le Bé 
and Markram, 2006). On a more microscopic level, this has also been shown to occur in dendritic 
spines during sleep, in a discriminatory fashion based on the smaller size of the spines (de Vivo 
et al., 2017). 
 
These data in combination with our work point at a system whereby synaptic connection are 
preferentially made and strengthened, as a result of wakeful experiences, in layer V pyramidal 
cells within cortical microcolumns. During SWS, Arc is upregulated, possibly by increase Ca2+ 
entry caused by burst firing of the IB cells (Williams and Stuart, 1999; Yi et al., 2017). This triggers 
the internalisation of AMPA receptors necessary for synaptic scaling required for the 
consolidation of memories the maintenance of synaptic homeostasis. 
 
3.3.6. Experimental Limitations 
One complication to the experiments in this chapter was the ‘control’ slices. These were 
quiescent slices kept in the same conditions as the experimental slices, yet in the absence of an 
oscillation generating drug and were used to represent random background activity. However, 
even when discounting slices that were obviously not truly quiescent – for instance those with 
spontaneous oscillations or epileptiform activity – slice immediate early gene expression was 
variable. This is most likely because their electrical activity was not ‘controlled’ or kept 
consistent in any way. The lower variance in the oscillatory data shows that the generation of 
the oscillation ‘clamps’ the network into a specific response mode that is consistent across slices 
and related to consistent gene expression. Furthermore, the control condition is not 
representative of an in vivo brain state and therefore may not be a reliable comparator.  
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For the analysis of the cellular signal of immediate early genes, the somatic signal of the IEG was 
overlaid to the template of NeuN/GAD67 cells. The mean of each NeuN/GAD67 cells’ average 
IEG intensity was used as a threshold by which to count pixels. This meant that the profiles 
represent counts of positively stained pixels, rather than numbers of cells. This may not be a 
problem, but it does assume ubiquity in neuronal soma size and staining across each soma.  
 
However, the thresholding method used also did not account for differences in staining intensity 
across slices or conditions. This means that the general change in IEG levels across conditions 
was not accounted for and therefore lost from the analysis. For example, even if the mean 
intensity of all the cells in one image was brighter another, the analyses would just include those 
brighter than the mean for each image independently. This means any intensity differences 
between conditions or repeats within the same condition, are lost. Furthermore, thresholding 
in this way meant that although negatively stained cells were rightly removed, also dimly stained 
cells, which may have still been classed as immuno-positive for IEG markers, would have also 
been discounted. However, this means that the analyses using this method did show the 
distribution of the brightly stained cells in each image. 
 
Setting a threshold to be used for all images across conditions, would allow for a fair comparison 
between conditions of the numbers and intensities of immunopositive cells. Furthermore, 
measuring the distribution of cell counts by a lower standard threshold along with separate 
comparisons for intensity may provide a clearer way by which to present the results and even 
highlight differences that were lost using the other method.  
 
 
 
 
 
 
 
 
 
 
 
 
  130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four – The effect of neuroinflammation 
on sleep- and wake-related oscillations 
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4.1 Introduction 
Neuroinflammation is the response in the CNS to a physical, pathogenic, or toxic insult. The 
presence of infectious or pathological material (including dead and dying neurons) leads to the 
production of proinflammatory cytokines and chemokines, which mobilise microglia (amongst 
other immune cells) to the site of damage to neutralise the threat. Neuroinflammation is usually 
transient and is curtailed by anti-inflammatory cytokines which reduce the inflammation to 
baseline levels. Unfortunately as well as offering a defence to the brain from damage, 
neuroinflammation can occur aberrantly. This is often the case with neurodegeneration, where 
there is an unnecessary or augmented pro-inflammatory response in the brain (Godbout et al., 
2005). Neuroinflammation is involved in the pathophysiology of many neurodegenerative 
disorders such as Alzheimer’s disease (Bronzuoli et al., 2016), Parkinson’s disease (Wang et al., 
2015b), motor neuron disease (Komine, 2015)  and multiple sclerosis (Bjelobaba et al., 2017).  
  
As well as triggers within the CNS, neuroinflammation can occur in cases of systemic infection 
that either spread to the brain or induce inflammation that is propagated within the CNS. 
Cytokines can spread from the periphery into the CNS via areas where the blood-brain barrier is 
compromised and even through molecular transport systems in a healthy blood-brain barrier.  
 
There are many examples where peripheral infections can affect the function of the brain and 
one particularly severe condition that highlights this is delirium. It is often seen after traumatic 
brain injury or in serious infection or sepsis (Lemstra et al., 2007; Siami et al., 2008). It is 
particularly prevalent among the elderly (Luz et al., 2003). Many studies have found 
inflammatory changes in the brain related to delirium such as increased microglia and astrocytic 
activity (van Munster et al., 2011) as well as increased pro-inflammatory cytokine signalling (van 
Munster et al., 2008). In conjunction with dementia, even less serious peripheral infections such 
as urinary tract infections have been shown to have serious cognitive effects (O'Keeffe and Ni 
Chonchubhair, 1994; Davis et al., 2012). Some studies also implicate systemic pathogens in the 
aetiology of neurodegenerative disorders (Rumah et al., 2013) 
 
Studies into the effect of systemic inflammation in the CNS often use synthetic analogues of 
ligands for TLR receptors (Lipopolysaccharide (LPS) and Poly I:C) to mimic immune challenges 
(such as bacterial or viral infections) in animal models. Intraperitoneal injections of LPS have 
been shown to change the inflammatory state of the brain in otherwise healthy animals by 
inducing the activation of astrocytes (Gautron et al., 2002), and the proliferation of astrocytes 
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and microglia (Semmler et al., 2005; Nishioku et al., 2009). LPS is also known to increase levels 
of pro-inflammatory cytokines IL1β, TNFα and the chemokine CCL2 (MCP-1) (Thompson et al., 
2008).  
 
In animal models, the peripheral administration of LPS has been shown to cause alterations in 
sleep-related brain rhythms. LPS increases delta frequency oscillation amplitude and duration, 
whilst also decreasing REM sleep (Krueger et al., 1986). The same effects have been shown 
with the administration of viable and heat killed E. coli (Toth and Krueger, 1989). Other changes 
in the brains activity after systemic LPS challenge show spike-wave discharges in the 
hippocampus, (Mamad et al., 2018). These changes may play a role in the cortical dysfunction 
seen during delirium. 
 
Associations between neuroinflammation, altered sleep patterns (Mullington et al., 2010) and 
cognitive function during wakefulness have also been highlighted in humans (Simen et al., 2011; 
Cortese and Burger, 2017; d’Avila et al., 2018). However changes to sleep-related oscillatory 
dynamics have also been suggested and are thought to arise from the activity of the autonomic 
nervous system detecting peripheral infection as opposed to pathological changes due to 
neuroinflammation, especially as excision of the vagal nerved attenuates the SWS increases 
(Opp and Toth, 1998).  
 
Whether neuroinflammation causes more direct changes to network stability in the brain, and 
subsequent modulation of synaptic plasticity markers (Chapter 3) is not known. We therefore 
examined a series of acute and chronic inflammatory challenges in brain slice models of wake 
and sleep rhythms to investigate this. 
 
4.1.2 Aims of this chapter 
This chapter aims to monitor the effect of the application of inflammatory agents 
(Lipopolysaccharide and Polyinosinic:Polycytidylic Acid) on in vitro models of oscillations 
associated with certain states (delta oscillations and gamma oscillations respectively) in acute 
preparations of brain slices. Also to investigate the effect of raising a systemic immune response 
(in rats by the intraperitoneal injection of LPS and Poly I:C) on the ability to generate cortical 
oscillations in vitro. Finally, to assess the inflammatory environment of the brain after systemic 
LPS and Poly I:C injection, by monitoring levels of cytokines and chemokines in the brain. 
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4.2. Results 
4.2.1 Acute application of LPS onto oscillating slices  
To analyse the direct effect of inflammatory agents on cortical oscillation dynamics, 500ng/ml 
LPS was added to the circulating ACSF around stably oscillating in vitro slices of rat brain. 
Oscillations were assessed 1 hour after LPS treatment. KA-induced hippocampal oscillations did 
not change in any characteristics (Figure 4.1) (KA vs KA+LPS, area power 19005 ± 14435 vs. 26977 
± 19925 µV², Paired T-test, p = 0.210; peak power 1846 ± 1496 vs. 2178 ± 1631 µV²/Hz, Paired 
T-test, p = 0.190; peak frequency 26.6 ± 1.7 vs. 26.2 ± 1.4 Hz, Paired T-test, p = 0.244). KA-induced 
cortical gamma oscillations also showed no change in oscillatory characteristics after application 
of LPS (Figure 4.2) (KA vs KA+LPS, area power 422 ± 188 vs. 455 ± 184 µV², Paired T-test, p = 
0.574; peak power 15.25 ± 8.78 µV², vs. 15.82 ± 8.22 µV²/Hz, Paired T-test, p = 0.822; peak 
frequency 31.1 ± 1.5 vs. 30.5 ± 1.8 Hz, Paired T-test, p = 0.838). The delta oscillation, induced by 
SCH23390 and Carbachol (Figure 4.3) did not show changes to area power (SCH+CCH vs. 
SCH+CCH+LPS, 1414.4 ± 522.3 vs. 1363.0 ± 610.6 µV², Paired T-test, p = 0.952) or peak frequency 
(SCH+CCH vs. SCH+CCH+LPS, 1.07 ± 0.08 vs. 1.00 ± 0.04 Hz, One-Way ANOVA, p = 0.413). There 
was a decrease in mean peak power, although this was not significant (SCH+CCH vs. 
SCH+CCH+LPS, 335.9 ± 197.1 vs. 121.3 ± 43.3 µV²/Hz, T-test, p = 0.330). 
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4.2.2 Acute and Chronic systemic infection effects on oscillations 
We investigated the effects of prior systemic infection of the animal on the ability to generate 
oscillations in in vitro brain slices. Infection was induced with 0.9% saline (which was also the 
vehicle), 250ug/ml LPS, 6mg/ml Poly I: C. Animals were dosed either once, 24 hr/1 days prior to 
sacrifice, or every three days for 7, or 28 days. All statistical analysis was carried out using a Two-
Way ANOVA with Holm-Sidak multiple comparisons procedure for significant results. However, 
the low n numbers obtained in the Poly I:C condition prevented the analysis of interactions 
between time course and inflammation in this case so only the LPS data set was analysed. 
 
In hippocampal slices, stable oscillatory activity was measured in CA3 after the bath application 
of 50nM KA. The mean area power of CA3 oscillations was lower after LPS treatment at each 
time point though this was not significant (Figure 4.4) (Area Power, Vehicle vs. LPS, 1 day: 9028.1 
± 927.0 vs. 7192.5 ± 1345.5 µV², Two Way ANOVA, p = 0.455; 7 days: 10215.7 ± 2315.1 vs 5977.4 
± 975.65 µV², Two Way ANOVA, p = 0.062; 28 days: 8604.7 ± 2315.1 vs. 3655.2 ± 2646.95 µV², 
Two Way ANOVA, p = 0.115). The mean area power was also lower in the Poly I:C treated 
condition, but again not significantly so (Area Power, 7 days: 7612.7 ± 1310.2 µV²; 28 days: 
6172.7µV², n=1).  
 
The peak power showed no significant difference between any groups (Peak Power, Vehicle vs. 
LPS, 1 day: 709.0 ± 102.22 vs. 536.0 ± 168.4 µV²/Hz, 7 days 970.0 ± 630.8 vs. 503.7 ± 148.0 
µV²/Hz, 28 days 386.7 ± 94.2 vs. 357.5 ± 301.43 µV²/Hz, Two Way ANOVA, Treatment Time, p = 
0.650, Condition, p = 0.825, Interaction = 0.789). Again, the mean peak power after Poly I:C 
treatment was closer to that of the LPS condition than control (Peak Power, 7 days: 503.7 ± 
148.03 µV²/Hz; 28 days: 438.5 µV²/Hz, n=1). The frequency of the oscillation in CA3 showed a 
bidirectional change, with an apparent increase after 1 day treatment with LPS which was not 
significant (Peak Frequency, Vehicle vs. LPS, 1 day: 23.4 ± 0.28 vs. 26.6 ± 1.2 Hz, Two Way ANOVA 
with Holm-Sidak correction, p = 0.082) but with 7 days dosing, the decrease compared to vehicle 
was significant (Peak Frequency, Vehicle vs. LPS, 7 days: 28.1 ± 1.5 vs. 24.7 ± 0.6 Hz, Two Way 
ANOVA with Holm-Sidak correction, p = 0.033). There was no significant difference between 
treatments after 28 days (Peak Frequency, Vehicle vs. LPS, 28 days: 25.0 ± 1.8 vs. 25.6 ± 0.5 Hz, 
Two Way ANOVA with Holm-Sidak correction, p = 0.751). The data for Poly I:C seemed to match 
that of LPS (Peak Frequency, 7 days: 23.7 ± 1.01 Hz; 28 days: 24.7 Hz, n = 1). Interestingly there 
was also a difference in the comparison for treatment time vehicle data between 1 and 7 days 
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(Figure 4.4C) (Peak Frequency, Vehicle, 1 day vs. 7 days: 23.4 ± 0.28 vs. 28.1 ± 1.54, Two Way 
ANOVA with Holm-Sidak correction, p = 0.030). 
 
For cortical gamma rhythms (Figure 4.5) the mean area power and peak power was higher after 
LPS treatment than in control slices after 7 days, but lower after 28 days of treatment. (Area 
Power, Vehicle vs. LPS, 7 days: 69.4 ± 8.1 vs. 101.9 ± 30.2 µV²; 28 days: 115.6 ± 17.1 vs. 51.7 µV², 
n =1, Two Way ANOVA, Treatment Time, p = 0.953, Condition, p = 0.644, Interaction = 0.185) 
(Peak Power, Vehicle vs. LPS, 7 days: 1.1 ± 0.4 vs. 1.6 ± 0.6 µV²/Hz; 28 days: 1.8 ± 0.8 vs. 1.1 
µV²/Hz, n = 1,   Two Way ANOVA, Treatment Time, p = 0.889, Condition, p = 0.925, Interaction = 
0.442). The mean frequency was lower after LPS treatment compared to control after 7 days, 
but is increased after 28 days, but this difference was not significant ( Peak Frequency, Vehicle 
vs. LPS, 7 days: 37.1 ± 2.5 vs. 33.2 ± 2.9 Hz; 28 days: 33.0 ± 6.6 vs. 38.2 Hz, n = 1,   Two Way 
ANOVA, Treatment Time, p = 0.917, Condition, p = 0.897 , Interaction = 0.343). The differences 
in all oscillatory parameters after Poly I:C treatment compared to control were not significant 
but followed the same pattern as LPS for area power (7 days: 187.11 ± 111.9 µV²; 28 days: 65.8 
± 49.1 µV²) and peak frequency (7 days: 34.7 ± 5.6 Hz; 28 days: 35.8 ± 3.9 Hz). The mean peak 
power after Poly I:C treatment increased similarly to LPS after 7 days but remained similar to 
the vehicle after 28 days (7 days: 187.11 ± 111.9 µV²/Hz; 28 days: 65.8 ± 49.1 µV²/Hz).  
 
Looking at cortical delta oscillations, the area power and peak power of the oscillations in the 
LPS treated condition did not change significantly compared to the control (Figure 4.6) (Area 
Power, Vehicle vs. LPS, 1 day: 361.8 ± 255.1 vs. 425.3 ± 113.6µV², 7 days: 1384.1 ± 449.9 vs. 
2004.6 ± 673.4 µV²; 28 days: 1854.0 ± 508.7 vs. 1169.9 ± 142.07 µV²;Two Way ANOVA, 
Treatment Time, p = 0.113, Condition, p = 0.999, Interaction = 0.535) (Peak Power, Vehicle vs. 
LPS, 1 day: 32.6  ± 18.4 vs. 74.7 ± 33.1 µV²/Hz, 7 days: 284.9 ± 127.0 vs. 632.65 ± 274.0 µV²; 28 
days: 1854.0 ± 508.7 vs. 1169.9 ± 142.0 µV²; Two Way ANOVA, Treatment Time, p = 0.142, 
Condition, p = 0.911, Interaction = 0.298). The mean peak frequency of the delta oscillations 
lower with treatment with inflammatory agents. However, extricating reliable statistical results 
from the peak frequency data was difficult due unequal variances. Therefore, separate 
ANOVA/Kruskal-Wallis tests were performed for the data in each treatment time separately.  
 
There were no significant differences found in treatment conditions that last 1 or 28 days. (Peak 
Frequency, Vehicle vs. LPS, 1 day: 1.30 ± 0.28 vs. 1.15 ± 0.06 Hz, Kruskal-Wallis ANOVA on Ranks, 
Vehicle vs LPS, p = 0.999; Vehicle vs. LPS. Vs. Poly I:C, 28 days: 1.30 ± 0.10 vs. 1.23 ± 0.12 vs. 0.86 
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± 0.269, Kruskal-Wallis ANOVA on Ranks, Vehicle vs LPS, p = 0.400). There was a significant 
decrease in the frequency of the delta rhythm after 7 day treatment of LPS, but not Poly I:C 
(Peak Frequency, Vehicle vs. LPS vs. Poly I:C, 7 days: 1.40 ± 0.08 vs. 1.18 ± 0.02 vs. 1.16 ± 0.05 
Hz, One Way ANOVA with Holm Sidak correction, Vehicle vs LPS, p = 0.47, Vehicle vs. Poly I:C = 
0.058). 
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4.2.3 The effect of chronic systemic infection on neuroinflammatory mediators 
To analyse the inflammatory environment of the brain after systemic infection, surplus tissue 
from the preparation of brains slices was taken and analysed for 27 cytokines and chemokines 
using a multiplex bead-based protein assay. This compared 7 and 28-day dosed animals to 
vehicle dosed controls for the levels of 27 different cytokine and chemokines in the cerebral 
homogenate. 
 
Six cytokines/chemokines were significantly increased after 7 days dosing with LPS (Figure 4.7). 
These were Fractalkine (Vehicle vs. LPS: 842.4 ± 100.7 vs. 1166.0 ± 64.0 pg/ml, One-Way ANOVA 
with post hoc Holm-Sidak, p-value = 0.027), IL-1β (Vehicle vs. LPS: 57.2 ± 1.7 vs. 70.0 ± 2.7 pg/ml, 
One-Way ANOVA with post hoc Holm-Sidak, p-value = 0.004), IL-4 (Vehicle vs. LPS: 80.6 ± 1.9 vs. 
63.0 ± 4.5 pg/ml, One-Way ANOVA with post hoc Holm-Sidak, p-value = 0.007), IL-13 (Vehicle vs. 
LPS: 14.1 ± 2.1 vs. 21.3 ± 0.7 pg/ml, One-Way ANOVA with post hoc Holm-Sidak, p-value = 0.014), 
VEGF (Vehicle vs. LPS: 124.1 ± 11.4 vs. 155.6 ± 6.1 pg/ml, One-Way ANOVA with post hoc Holm-
Sidak, p-value = 0.004) and RANTES (Vehicle vs. LPS: 16.3 ± 1.4 vs. 20.7 ± 0.85 pg/ml, One-Way 
ANOVA with post hoc Holm-Sidak, p-value = 0.043). Only two chemokines were increased after 
7 days Poly I:C dosing, these were IP-10 (Vehicle vs. Poly I:C: 189.4 ± 14.2 vs. 696.0 ± 198.4 pg/ml, 
One-Way ANOVA with post hoc Holm-Sidak, p-value = 0.034) and RANTES (Vehicle vs. Poly I:C: 
16.3 ± 1.4 vs. 24.3 ± 3.0 pg/ml, One-Way ANOVA with post hoc Holm-Sidak, p-value = 0.027). 
 
As for the 28-day dosing regime, only 3 cytokines were significantly changed after LPS dosing 
(Figure 4.8): IFN-γ (Vehicle vs. LPS: 673.2 ± 25.1 vs. 803.8 ± 46.4 pg/ml, One-Way ANOVA with 
post hoc Holm-Sidak, p-value = 0.048), TNF-α (Vehicle vs. LPS: 7.8 ± 0.5 vs. 11.3 ± 1.2 pg/ml, One-
Way ANOVA with post hoc Holm-Sidak, p-value = 0.029) and IL-1α (Vehicle vs. LPS: 104.6  ± 11.6 
vs. 154.0 ± 8.4 pg/ml, One-Way ANOVA with post hoc Holm-Sidak, p-value = 0.014). The only 
cytokine that was increased after 28 days dosing with Poly I:C was IL-5 (Vehicle vs. Poly I:C: 188.4 
± 5.2 vs. 168.0 ± 5.2 pg/ml, One-Way ANOVA with post hoc Holm-Sidak, p-value = 0.033)  
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4.2.4 The effect of chronic systemic infection on microglial morphology 
To further confirm the presence of inflammation in the brain, microglia were analysed. Under 
inflammatory conditions, microglia are known to retract their processes and become ramified 
in structure. The morphology was assessed following a stain for Iba1. This allowed the visual and 
analytical comparison of microglia. The area of each microglia cell was calculated and found to 
be significantly lower after 28 days dosing with LPS or Poly I:C (Figure 4.9) (Area, Vehicle vs. LPS 
vs. Poly I:C, 58.9 ± 6.0 vs. 43.8 ± 4.1 vs. 44.5 ± 3.3 µm², p values from One-Way ANOVA with post-
hoc Tukey’s Multiple comparisons procedure: Vehicle vs LPS = 0.089, Vehicle vs Poly I:C = 0.042). 
Area of a cell does not necessarily show how spread out the projections are, so a bounding box 
was fitted around each cell (the smallest rectangle that would encompass the whole object), the 
area of which gives a better indication of the amount of spread of the projections of the cell. 
This was also significantly lower in the inflammation condition meaning that the spread of the 
projections was smaller (bounding box area, Vehicle vs. LPS vs. Poly I:C, 282.3.9 ± 43.5 vs. 140.3 
± 18.1 vs. 160.0 ± 15.1 µm², p values from One-Way ANOVA with post-hoc Tukey’s Multiple 
comparisons procedure: Vehicle vs LPS, p = 0.002, Vehicle vs Poly I:C, p = 0.003). 
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4.3. Discussion 
4.3.1 Summary 
In this chapter, the effect of inflammation on in vitro models of certain brain rhythms was 
analysed. The effect of the direct application of lipopolysaccharide was monitored along with 
the changes after the systemic dosing of LPS and Poly I:C for up to 28 days. These changes were 
also related to changes to cytokine and chemokine expression as well as microglial 
morphological changes.  
 
The summary of key findings from this investigation are:  
 The direct application of LPS had no significant effect on characteristics of in vitro 
models of cortical gamma and delta oscillations, and hippocampal oscillations.  
 There was a bidirectional change in hippocampal oscillation frequency only, after 
systemic immune challenge, which is related to the longevity of the ‘infection’.  
 The systemic immune challenge did not change the area power, peak power or 
frequency of cortical gamma oscillations or delta oscillations but did reduce the 
frequency of delta oscillations after 7 days but not over 28 days.  
 The landscape of inflammatory cytokines and chemokines was different between 7 days 
immune challenge compared to 28-day immune challenge.  
 Microglia were activated upon systemic immune challenge with LPS and Poly I:C.  
 
4.3.2 A note about hippocampal gamma oscillations and temperature.  
The oscillations recorded from the CA3 region of the hippocampus were found to be between 
25 – 30 Hz. This range normally describes beta oscillations; however, it is known that slice 
preparations often have lower frequencies than in vivo. This is due to the reduction of 
temperature that in vitro slices are maintained at (compared to body temperature) so that the 
correct amount of oxygen may be dissolved. This phenomenon has been recorded in the 
carbachol-induced oscillation in the CA1 region of the hippocampus, showing a 3.3 Hz decrease 
with every 1°C decrease in temperature (Dickinson et al., 2003). This temperature relationship 
is suggested to be driven by elongated GABAergic IPSCs leading to a long latency between IPSPs, 
which set the tempo of the oscillation. It would appear that both hippocampal gamma and beta 
rhythms have a similar GABAA dependent mechanism (Tsintsadze et al., 2015). Previous research 
has accepted in vivo oscillations with a frequency as low as 25Hz as gamma oscillations (Colgin 
et al., 2009a). This, along with the temperature dependent frequency change would suggest that 
the oscillations generated may be gamma oscillations despite having a frequency below 30Hz. 
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4.3.3 The acute application of LPS onto slices  
The first studies in this chapter showed that the addition of LPS to the circulating ACSF had no 
effect on the stable in vitro hippocampal/cortical gamma oscillations. The pattern recognition 
receptor for LPS (TLR4) has been documented in neurons (Leow-Dyke et al., 2012). In cultured 
neurons, TLR4 activation (by LPS) has been shown to produce TNFα, IL-6, CXCL1 And RANTES 
(Aurelian et al., 2016). However, these experiments showed that LPS does not directly affect 
electrical activity. It also has been shown in cultured cells that LPS has no effect on neuronal 
survival in the absence of microglia. Whereas in neuron/microglia co-culture there is almost a 
complete destruction of all cells (Lehnardt et al., 2003). This shows not only that neurons do not 
possess mechanisms to induce their own toxicity after LPS application, but also, in the presence 
of microglia, toxicity occurs on a time scale of many hours to days (Rupalla et al., 1998; Rangroo 
Thrane et al., 2012). Other studies also corroborate the idea that microglia are responsible for 
stimulating neuronal apoptosis (Tseng et al., 2012; Zhang et al., 2013). This is thought to be 
through the upregulation of pro-inflammatory cytokines released by microglia such as TNFα, IL-
1β as well as iNOS. These were shown to be upregulated downstream of IFN-y (Wang et al., 
2015a) after at least 2 hours. 
 
Changes to induced hippocampal gamma oscillations in organotypic slices were seen after 
treatment with LPS, however, the time scale of the LPS treatment was to be 72 hours 
(Papageorgiou et al., 2016). Using a microelectrode array system, enhanced excitability 
generated epileptiform discharges after LPS application, though again after >6 hours (Gullo et 
al., 2014). Only a much more immediate effect has been seen in vivo, with the epi-pial 
application of LPS generating epileptiform activity within an hour of application. Although the 
concentration of LPS used was 40x that used in this thesis (Rodgers et al., 2009)  
 
4.3.4. Changes to in vitro rhythms related to longevity of immune challenge.  
The initial experiments in this chapter showed that LPS had no effect upon the oscillatory activity 
of in vitro brain slices after 1 hour. These findings (along with the studies outlined above) suggest 
that LPS driven changes to neuronal excitability occur at a timescale that is longer than 
reasonable to observe in acute brain slice preparations. Furthermore, the impact of systemic 
infection on the oscillatory activity of the brain is of particular importance, especially with 
growing research into the effects of systemic infection on neurodegenerative disorders (Perry 
et al., 2003).  
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After 24 hours, there were no significant changes to the area power, peak power, or peak 
frequency of any of the oscillations measured. This is in line with in vivo data showing that 
although initial changes to delta and gamma oscillations may occur after intraperitoneal (i.p.) 
LPS injection, these changes stabilise to control condition after 24 hours (Mamad et al., 2018).  
 
We found two significant aberrations in the oscillatory activity across the dosing regimes. 
Reductions were in the frequency of both hippocampal gamma oscillations and cortical delta 
oscillations after 7 days treatment with LPS. Poly I:C broadly followed this trend though ‘n’ 
numbers were too low for inclusion in statistical tests. The slowing of the background EEG is 
related to cerebral dysfunction and often associated with lesions, delirium and dementia 
(Britton et al., 2016). Further findings included an interesting trend in the electrophysiology 
data, with the time scale of the apparent change of the power of delta frequency oscillations 
(Figure 4.10). At one day post-infection the delta power is unchanged compared to control. 
However, after 7 days the mean delta power is increased by ~50%. This increase is reversed after 
28 days when there was an insignificant reduction compared to control. 
 
 
 
 
                           
 
Figure 4.10. The relative area power of generated rhythms compared to control  
The mean area power as a percentage of the mean control reading in LPS rats treated 
with 250ug/kg LPS for 1, 7 and 28 days, red = hippocampal gamma oscillations, Blue = 
cortical delta oscillations. 
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These data would suggest a changed propensity for sleep as SWS levels correlate with sleep 
need (Brunner et al., 1990; Rodriguez et al., 2016). Sleep changes in humans after 
neuroinflammation (especially following traumatic brain injury) are common, with increases in 
sleep need and daytime sleepiness (Imbach et al., 2015),  as well as increases in the power of 
delta rhythms during SWS, (Parsons et al., 1997). This is likely a result of the cytokine 
upregulation as cytokine i.p. IL-1β injection has also been shown to increase delta power during 
slow wave sleep in rats (Hansen and Krueger, 1997). The same is true for the cortical infusion 
and i.p. injection of TNFα (Kubota et al., 2001; Yoshida et al., 2004).  
 
In humans, many conditions related to neuroinflammation have shown an increase in delta 
oscillations, including delirium from a range of causes (Koponen et al., 1989). Increases in delta 
rhythms during wakefulness has also be seen as a result of sports-related concussion (Gosselin 
et al., 2009) and mild traumatic brain injury) (Modarres et al., 2017). Intrusions of this sort have 
also been noted in healthy rats during prolonged wakefulness and termed ‘local sleep’ 
(Vyazovskiy et al., 2011). Inflammatory cytokines may be involved in this process, as sleep 
deprivation is known to increase IL-1β (Frey et al., 2007) and TNFα (Shearer et al., 2001). It could 
follow that the sickness behaviour seen after i.p. injection of LPS (Biesmans et al., 2013) is a 
cognitive behavioural response to the sleep debt highlighted by our studies. 
 
There was also a general decrease in the mean area power of hippocampal gamma oscillations 
upon systemic LPS injection over time, compared to control (Figure 4.10). These oscillations 
were recorded from the CA3 region of the hippocampus which is known to exhibit “slow” 
gamma rhythms (~25 – 50 Hz) (Colgin et al., 2009a) and are in the range of the rhythmic activity 
seen in these experiments.  The synchrony of activity in the frequency band between CA3 and 
CA1 regions for the hippocampus is believed to be important for memory retrieval (Colgin, 
2016). Reductions in slow gamma have been shown in the hippocampus in triple mutant (Psen1, 
APPS and tau) Alzheimer’s mouse models (Mably et al., 2017) and a model of tauopathy (Booth 
et al., 2016) both of which are associated with memory loss (Jahn, 2013) (Van der Jeugd et al., 
2011). The decrease in these oscillations after chronic LPS injections suggest that the induction 
of inflammation in the brain may play a role in aberrations to gamma oscillations. 
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4.3.5 Cytokine/chemokine levels differ with duration of the immune challenge.  
It is likely that the electrophysiological changes seen in slices from animals subjected to a 
systemic immune challenge (in this chapter) were due to neuroinflammation. This was 
confirmed with experiments that showed significant changes to pro- and anti-inflammatory 
cytokines and chemokines in the brain.  
After 7 days dosing with LPS (doses occurred on day 0, 3, and 6) (Tchessalova and Tronson, 
2019) several pro- and anti-inflammatory cytokines and chemokines were found to be 
increased. These were IL-1β, IL-13, VEGF and the chemokines Fractalkine and RANTES. 
Interestingly, three cytokines classically associated with a pro-inflammatory environment 
were not changed after 7 days (TNFα, IL-1α and IFN-γ). 
The increased expression, after the inflammatory challenge, of IL-1β is unsurprising as IL-1 
interleukins are considered the archetypal pro-inflammatory cytokines. The upregulation of 
its expression is likely to be due to its secretion from microglia and astrocytes after 
inflammatory challenge (Rothwell and Luheshi, 2000). Generally, IL-1β is seen to be the more 
important IL-1 cytokine and here it is increased and IL-1α is not significantly different. 
However, this may be due to a possible redundancy mechanism in the cytokine signalling 
system whereby both IL-1α and β exert their effects through the same receptor (IL-1RI) (Sims 
et al., 1988).  
The increase in fractalkine is also indicative of a proinflammatory response as it is released 
by neurones undergoing apoptosis as a chemoattractant signal to microglia and astrocytes 
(Sokolowski et al., 2014) which exclusively house the CX3CR1 receptor – that binds fractalkine 
(Maciejewski-Lenoir et al., 1999). Through this chemotactic mechanism, fractalkine has been 
implicated in the uptake of aggregated alpha-synuclein by microglia in a mouse model of PD 
model (Thome et al., 2015) and knockout of the CX3CR1 receptor causes protracted microglial 
activation after LPS immune stimulation (Corona et al., 2010). This may be due to the lack of 
signalling to attract microglia to sites of exogenous material that requires phagocytosis. In 
our experiments, the presence of fractalkine suggest an induction of neuroinflammatory 
mechanism requiring microglial migration and phagocytosis.  
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Another chemokine showing increased expression after 7 days treatment is RANTES (CCL5). 
RANTES is a pleiotropic chemokine, probably due to its promiscuity in terms of receptor 
binding (Pease, 2006). RANTES is constitutively active in the healthy brain, having roles in 
myelination (Kadi et al., 2006), differentiation of astrocytes (Bakhiet et al., 2001) glucose uptake 
and metabolism (Chou et al., 2016). However during inflammation RANTES is generally 
considered proinflammatory as it has been shown to be expressed by T-cells, and recruits 
various immune cells to sites of inflammation (Maghazachi et al., 1996) and also mobilises 
mononuclear phagocytes and aid their BBB penetration (Sadek et al., 1998). Conversely 
RANTES has also been shown to be neuroprotective, inducing the expression of neurotrophic 
factors (Tokami et al., 2013). 
 
The increase in pro- inflammatory cytokines and chemokines (Il-1β, Fractalkine and RANTES) 
after a 7-day inflammatory challenge occurs in tandem with anti-inflammatory cytokines, 
suggesting that there is a balance immune response occurring, mediated by VEGF and IL-13. IL-
13 is considered an anti-inflammatory inhibiting the expression of other pro-inflammatory 
cytokines in monocytes such as IL-1β, TNFα and GRO in monocytes and IFN-γ (Minty et al., 
1993) In the brain IL-13 is also known to promote an anti-inflammatory phenotype in 
microglia (Chawla et al., 2011)  and contribute to the removal of pro-inflammatory microglia 
(Mori et al., 2016). These effects are seen in tandem with IL-4, which is often linked to IL-13 
due to the overlap of their biological function (Chomarat and Banchereau, 1998) and their 
ability to act through the dimerization of their receptors. (Rael and Lockey, 2011). Unusually 
however, we found that whilst IL-13 was significantly increased after 7-day immune 
challenge, IL-4 was decreased. VEGF is also suggested to be anti-inflammatory and it has been 
shown that exogenous peripheral injection with VEGF leads to decreased levels of pro-
inflammatory cytokines IL-1β and TNF-α (Xu et al., 2017) highlighting its role in the reversal of 
inflammation. 
 
However, the cytokines present in the brains of rats treated for 28 days with LPS (every 3rd day) 
reflect tipping of the balance to a more pro-inflammatory environment. The three main pro-
inflammatory cytokines IL-1a, TNFα and IFN-y are all increased with respect to the vehicle-
treated animals, all of which are known to activate microglia (Gibson et al., 2004; Kuno et al., 
2005; Rock et al., 2005).  
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4.3.6 Microglia are activated upon systemic immune challenge  
The neuroinflammatory environment of the brain, induced after 28-day treatment with LPS and 
Poly I:C was confirmed by assessing the morphology of microglia. Looking at the surface area of 
the microglia gave a good indication of their ramification and thus their status of activation. This 
is due to the fact that activated microglia retract their projections to become more amoeboid 
to facilitate phagocytosis (Dheen et al., 2007). It was not clear whether the activation of 
microglia occurred due to the infiltration of LPS or Poly I:C molecules into the brain, OR 
indirectly. However it has been shown that LPS does not readily cross the blood-brain barrier 
(Singh and Jiang, 2004), suggesting that the activation of microglia in the brain occurs through 
indirect methods either through the activation of TLR4 receptors, or cytokine receptors in 
astrocytes and microglia in the circumventricular organs (Nadeau and Rivest, 1999), or 
peripheral cytokine interacting with endothelial cells to transfer the inflammatory signal across 
the BBB. This is most likely though TNFα signalling as it is the first proinflammatory cytokine to 
be upregulated by intraperitoneal LPS treatment, shortly after IL-1β and IL-6 (Fong et al., 1989). 
All of these cytokines are likely to propagate the peripheral infection to the CNS but targeting 
receptors on the endothelium of brain capillaries, which then causes the diffusion of 
prostaglandins and NOS to the brain parenchyma (Elmquist et al., 1997).  
 
4.3.7 Experimental limitations.  
A major caveat to the results in this chapter is the low number of repeats used for the 
electrophysiology experiments. In some cases, visual trends are apparent due to the difference 
in compared means and separation of the error bars, however, there is no significant difference. 
It is not possible to know without further repeats whether these trends are legitimate. In other 
cases (especially where n numbers are particularly low) large error bars make it difficult to 
discern any trends even visually. Furthermore, it was intended that slices from the 
electrophysiology experiments would be stained for immediate early gene markers to analyse if 
changes in cortical dynamics were related to changes in synaptic plasticity. Unfortunately, the 
tissue was transported from the US to the UK for this purpose and when it was, much of it was 
not useable for immunohistochemistry, and those slices were structurally compromised. The 
example in Figure 11 shows the best example of Arc staining in the US tissue compared to tissue 
collected in the UK. This issue also affected the Iba1 staining of this tissue, which meant 
therefore that only one animal per condition was compared. This meant that whilst we could 
confirm that intraperitoneal injection of LPS and Poly I:C at the doses used was capable of 
activating microglia, it could not be confirmed for all animals tested.  
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Chapter Five – The effect of Leishmaniasis 
donovani sleep- and wake-related oscillations. 
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5.1 Introduction 
The previous chapter dealt with experimental models of systemic infection and, while revealing 
trends in oscillatory characteristics, lack of sufficient ‘n’ numbers and poor quality imported, 
matched tissue meant only suggestions of effects of neuroinflammation were possible. In this 
chapter, we switch to using a genuine pathogen to examine these suggestions further. 
 
 The parasitic disease, Leishmaniasis is a systemic disease, whereby protozoa of the Leishmania 
genus are transmitted to a host through the bite of an infected female phlebotomine sandfly 
(only females blood feed during egg production). The promastigote phase of the parasite has 
highly motility and travels in the host’s bloodstream until engulfed by macrophages. The 
parasites then enter the amastigote phase and duplicate until they rupture the macrophage and 
are engulfed by others. In this way, the infection can spread around the body.  
 
Some specific parasites stay close to the initial bite site and thus damage the cutaneous or 
mucocutaneous tissues causing cutaneous/mucocutaneous leishmaniases. The form of 
Leishmaniasis of interest in this thesis is the visceral form, which spreads around the body 
primarily affecting the liver and spleen but also invading other organs. Although visceral 
leishmaniasis classically presents with parasites infecting the visceral organs and bone marrow, 
viable Leishmania donovani (Melo et al., 2017) and L. infantum (Cardinot et al., 2016; Oliveira et 
al., 2017) parasites (responsible for VL infections) have been shown to infiltrate the brain. This 
is in tandem with increased leukocyte and macrophage presence in the brain tissue (Melo et al., 
2017). These cell types could provide the route by which the intracellular parasite infiltrates the 
CNS, and the disruption of the blood-brain barrier secondary to systemic inflammation may aid 
the infiltration of these cells (Melo et al., 2015). 
 
Visceral leishmaniasis is known to induce proinflammatory responses in the periphery, with 
increasing levels of pro-inflammatory cytokines such as IL-2 (Kaye, 1987) and TNF (Pinto et al., 
2017), which stimulate T cells to release IFNγ and causes macrophage activation (Kaye et al., 
1991) Leishmaniasis infection has also shown to upregulate proinflammatory cytokines in the 
CNS, such as IL-1β, IL-6, IFN- γ and TNFα (Melo et al., 2017). These proinflammatory changes 
engage microglia to phagocytose Leishmania parasites, whose presence is increased in tandem 
with T lymphocytes in ependymal areas of the brain, in correlation with T lymphocyte numbers 
(Melo and Machado, 2011). It has also been shown that microglia are better at dealing with 
Leishmania parasites than macrophages, showing higher levels of phagocytosis, and more 
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cytotoxicity to Leishmania parasites in vitro. This highlights the importance of microglia in the 
protection of the CNS tissues against Leishmania infection (Ramos et al., 2014).  
 
There is evidence that further to the neurological manifestation of Leishmania parasites 
neurological symptoms can develop. These include tremor, delirium, thought delusions (Chunge 
et al., 1985)  and depression-like symptoms (Carswell, 1953; Maru, 1979).  In mice, Leishmania 
infection increased anxiety behaviour and decreased locomotion (Portes et al., 2016). Whilst 
neurological presentations and cognitive symptoms of leishmaniasis are uncommon, 
neuroinflammation is known to affect the oscillatory activity of the brain (Mamad et al., 2018). 
This may also occur secondary to leishmaniasis infection and may even have a knock-on effect 
on the normal plasticity-related mechanisms that occur in a healthy brain (Chapter 3). 
 
5.1.2 Aims and objectives 
This chapter aimed to use a mouse model of the Ethiopian form of visceral leishmaniasis (caused 
by Leishmania donovani.) to assess changes to sleep and wake state related oscillations in acute 
in vitro cortical slice preparations. Further to this, the effect of the real-life systemic infection 
(with potential for CNS infection involvement), on changes to synaptic plasticity across these 
brain rhythms (shown in Chapter 3) was investigated. 
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5.2 Results 
5.2.1 Confirmation of parasitic infections 
To investigate the effects of a real-world infection on the ability of brain slices to generate 
cortical oscillation in vitro we used Leishmaniasis infected mice and uninfected control mice.  
To ensure these mice were suitably infected, they were weighed prior to sacrifice. This showed 
that the total body weight of infected mice was significantly lower than that of naïve controls 
(Figure 5.1A) (naïve vs infected, mean total body weight, 31.84 ± 0.66 vs 27.67 ± 1.08 g, T-test, 
p  = 0.009).  
 
Further confirmation of infection came from the weight of the two organs primarily infected in 
leishmaniasis, the spleen and the liver. The weight of the spleen was significantly increased in 
infected mice compared to naïve control mice (Figure 5.1B), naïve vs infected, mean spleen 
weight, 0.08 ± 0.01 vs 0.71 ±0.04 g, T-test, p values < 0.001. The liver weight was similarly 
increased (naïve vs infected, mean liver weight, 2.36 ± 0.09 vs 1.47 ± 0.05 g, T-test, p values < 
0.001). These difference were even more profound when the weight of the spleen or liver was 
taken as a percentage of the entire body weight (BW) (Figure 5.1C) (naïve vs infected, % BW, 
spleen: 2.57 ± 0.18 vs 0.26 ± 0.02 %, T-test, p values < 0.001, liver: 8.57 ± 0.30 vs 4.64 ± 0.20 %, 
T-test, p values < 0.001,). 
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To get a better picture of the infection rates in each mouse, parasite counts were undertaken. 
Again, the liver and spleen were used, and counts of parasites/1000 host nuclei (Figure 5.2) (liver 
vs spleen, parasite count/1000 host nuclei, liver: 568.5 ± 134.5 vs 240 ± 44.9, parasite counts for 
naïve controls were zero). To normalise these count numbers to the size of the organ, the 
parasite count was multiplied by the organ’s weight (liver vs spleen, LDU, liver: 1298.8 ± 281.6 
vs 161.1 ± 21.5, LDUs for naïve controls were zero). 
 
5.2.2 Effect of Leishmaniasis infection on cortical oscillations 
Having confirmed that the mice were indeed infected, in vitro brain slice preparations were 
made and the effect of the Leishmaniasis infection on the ability to generate sleep and wake-
related rhythms in these slices was investigated.  
 
Bath application of 400nM KA was used to generate cortical gamma oscillations. The mean area 
power of the gamma oscillation was lower in animals that were infected with leishmaniasis, 
although this was not significant for Au1 or S2 (Figure 5.3) (Naïve vs. Infected, Au1: 218.8 ± 46.9 
vs. 97.4 ± 29.0 µV², T-test, p-value = 0.052, S2: 223.9 ± 29.4 vs 123.1 ± 39.1 µV², T-test, p-value 
= 0.066). Peak power was similarly lower, but to a significant level in S2 (Naïve vs. Infected, Au1: 
7.4 ± 2.9 vs. 2.6 ± 0.5 µV²/Hz, T-test, p-value = 0.136, S2: 6.5 ± 1.1 vs 2.9 ± 0.9 µV²Hz, T-test, p-
value = 0.026). There was no change to the frequency of the cortical gamma rhythm in infected 
animals in either Au1 or S2 (Naïve vs. Infected, Au1: 35.2 ± 1.5 vs. 36.4 ± 1.7 Hz, S2: 35.8 ± 1.9 vs 
37.1 ± 1.4 Hz). 
 
Delta oscillations generated by the bath application of 4µM CCH 10µM SCH23990 were also 
investigated. The generation of rhythms of delta frequency 0.5– 4 Hz did not change after 
leishmaniasis infection in either S1 or S2 (Figure 5.4) (Naïve vs. Infected, Area Power, S1: 4599.4 
± 2563.0 vs. 2512.7 ± 820.8 µV², S2: 3608.23 ± 1684.9 vs. 2109.9 ± 472.0 µV², Peak Power, S1: 
294.3 ± 157.4 vs. 216.6 ± 86.6 µV²/Hz, S2: 372.0 ± 156.9 vs. 246.8 ± 87.34  µV²/Hz, Peak 
Frequency, S1: 1.01 ± 0.13 vs. 0.94 ± 0.10 Hz, S2: 0.92 ± 0.06 vs. 1.05 ± 0.08Hz). 
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5.2.3 Effect of Leishmaniasis infection and oscillation on Arc in dendrites 
Finally, to assess whether a systemic infection induced by a biological pathogen can cause 
changes to the environment of plasticity in the brain, slices used in the experiments above were 
processed and stained for Arc. The dendritic Arc signal was then analysed. We only analysed Arc 
as this was the one plasticity marker which was shown to significantly change between sleep 
and wake-related rhythms. 
 
The largest mean changes in laminar expression of Arc in dendrites in naïve mice was during 
delta rhythms (compared to gamma rhythms) in primary and secondary cortical regions. Despite 
large differences in the means there was no significant difference (Figure 5.5) (1ry, 254.8µm, 
Naive Delta vs. Gamma: 60.2 ± 12.8 vs. 16.6 ± 4.5, T-test, p = 0.013, with FDR, q = 0.400; 2ry, 
55.8 µm, Naive Delta vs. Gamma: 35.0 ± 17.7 vs. 2.2 ± 1.4, T-test, p =  0.101, with FDR q =  0.193). 
The non-significant increases during delta in superficial layers were conserved in Leishmaniasis 
infected slices however the effect was still not significant even where the difference was the 
largest (1ry, 213.9µm, Infected Delta vs. Gamma: 62.9 ± 17.3 vs. 11.3 ± 5.7, T-test, p = 0.022, 
with FDR, q = 0.358; 2ry, 229.8µm, Naive Delta vs. Gamma: 58.5 ± 14.2 vs. 25.2 ± 8.0, T-test, p =  
0.076, with FDR q =  0.502). 
 
When comparing the profile of dendritic Arc during delta rhythms in slices from naïve and 
infected mice there was no difference (Figure 5.6) (S1, 159.3µm, Delta, Naïve vs. Infected: 18.5 
± 7.1 vs. 50.5 ± 16.6, T-test, p = 0.115, with FDR q = 0.872: S2, 82.6, Delta, Naïve vs. Infected:  
37.0 ± 11.0 vs. 25.9 ± 10.8, T-test, p = 0.49, with FDR, q = 0.912). The leishmaniasis infection also 
had no overall effect on dendritic Arc expression during gamma oscillations, though individual 
significances were found at some cortical depths: Au1, 463.5µm, Gamma, Naïve vs. Infected: 
41.4 ± 5.0 vs. 16.9 ± 5.7, T-test, p = 0.012, with FDR, q = 0.999, S2: 528.15µm, Gamma, Naïve vs. 
Infected: 40.5 ± 5.1 vs. 14.1 ± 4.1, T-test, p = 0.004, with FDR, q = 0.270.  
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5.3 Discussion 
5.3.1 Summary 
In this chapter, the effect of a biological pathogen on in vitro models of certain brain rhythms 
has been investigated. The pathogen used was the parasite Leishmania donovani, which causes 
visceral leishmaniasis and is known to elicit systemic inflammation. The effect of this infection 
on synaptic plasticity in the neocortex of mice was also explored.  
 
The summary of key findings from this investigation are:  
 The injection of Leishmania donovani parasites into the tail vein successfully led to an 
infection in mice that had the characteristics of visceral leishmaniasis and lasted for at 
least 28 days.  
 There was a decrease in the peak power of cortical gamma oscillations in the secondary 
somatosensory cortex in mice infected with L. donovani.  
 There was no significant change to delta oscillation dynamics in L. donovani infected 
mice compared to naïve mice. 
 There was no significant difference in dendritic Arc expression between brain slices in 
naïve mice exhibiting gamma or delta oscillations, or between these oscillations in 
infected mice. 
 The Leishmaniasis infection caused no significant difference in dendritic Arc staining 
during either gamma or delta oscillations, compared to control. 
 
5.3.2. Leishmania donovani. IV injection causes visceral leishmaniasis in mice.  
After the intravenous injection of Leishmania donovani parasites, mice displayed many signs 
that were consistent with visceral leishmaniasis presentation in humans. Firstly, the mice 
exhibited weight loss, a symptom typical of visceral leishmaniasis in humans (Araujo Lima Verde 
et al., 2011). Unusually in humans, this symptom occurs despite no loss of appetite. 
 
The two organs known to be most affected by experimental are the spleen and the liver 
(Berman, 1997; Polley et al., 2005; Melo, 2017). The weights of the spleen and liver were tested 
in infected and naïve mice and both organs were found to be significantly increased in weight 
compared to control. This is consistent with the human disease, with splenomegaly and 
hepatomegaly being common pathologies in the disease (Melchionda et al., 2014). In patients 
with visceral leishmaniasis, parasites are seen in Kupffer cells leading to their hyperplasia, as 
well as the ‘ballooning’ degeneration of hepatocytes. There is also an increase in parasite-
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infected macrophages (el Hag et al., 1994). The hypertrophy of the spleen is known to be due to 
the build-up of histiocytes, macrophages and plasma cells. Parasite counts showed that infection 
in the liver was more pronounced than in the spleen, especially when the weight of the organ 
was taken into consideration when calculating the LDU index. Although the LDU index is 
suggested to be less sensitive than qPCR methods in quantifying parasite load (Moreira et al., 
2012), the presence of the Leishmania parasites in these organs could be reliably confirmed 
compared to uninfected naïve mice. As well as increased parasite load, studies have also shown 
that the inflammatory response to leishmaniasis infection is stronger in the liver than the spleen 
with the upregulation of IL-1β and TNFα in the liver exceeding and preceding enhanced 
expression by the spleen (Melo et al., 2013). Although we did not test serum or tissues for 
inflammatory markers, it is likely that pro-inflammatory cytokines are also upregulated in our 
models as has been shown by previous studies (Melo et al., 2017; Grano et al., 2018). To confirm 
this to be the case, an analysis of cerebral cytokines or microglial activation would show the 
inflammatory environment of the brains of these mice after Leishmaniasis infection. 
 
5.3.3. Leishmaniasis infection impacts only gamma oscillations in the neocortex.  
In assessing changes to the oscillatory activity in brain slices from naïve and L. donovani infected 
animals, the mean peak power of somatosensory gamma rhythms was significantly reduced. 
This change was partially reflected in the primary sensory cortex and decreases in mean area 
power were also seen in both regions, however these changes did not reach significance. The 
presence of oscillatory changes in the brain in these mice is indicative of a central neurological 
element to visceral leishmaniasis. This neurological alteration may have been due to 
neuroinflammation secondary to the peripheral infection (as shown in Chapter 4). This is 
corroborated by previous evidence that shows increases in proinflammatory cytokines in the 
brain (IL-1β, IL-6, IFN- γ, TNFα) in experimental leishmaniasis models (Melo et al., 2017) as well 
as leukocyte infiltration of the BBB (Melo et al., 2009), both of which are classic signs 
neuroinflammation. However, there have been reports of small numbers of parasites invading 
the CNS tissue of naturally and experimentally infected dogs, suggesting that some degree of 
primary activation of neuroinflammatory pathways may also occur (Nieto et al., 1996; Vinuelas 
et al., 2001; Tafuri et al., 2004). The number of CNS infiltrates are very small though, so if it is an 
inflammatory response leading to these oscillatory changes, it is more likely to be due to the 
propagation of the systemic immune response and this mode of cytokine production is a 
common feature of the disease (Pinto et al., 2017) (Kaye et al., 1991).  
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Gamma power decreases have previously been reported in the neocortex under 
neuroinflammatory conditions. The injection of the inflammatory cytokine IL-1β, into the 
striatum of rats, led to a decrease in the power of the stimulus-evoked gamma oscillations in 
the barrel cortex (Bray et al., 2016). Changes to oscillatory activity have also been recognised 
after systemic cytokine administration (Hansen and Krueger, 1997; Kubota et al., 2001; Yoshida 
et al., 2004), though the changes shown in these studies were largely associated with alterations 
in rhythmic activity in the delta frequency range. Unusually, there was no change in delta activity 
when comparing slices from infected and naïve mice in this thesis. This is surprising as changes 
to delta frequency rhythms are more often associated with neuroinflammation (Parsons et al., 
1997; Opp and Toth, 1998; Mamad et al., 2018), and see Chapter 4.  
 
Cytokine-driven changes to the gamma oscillations may occur through the activity of NMDA 
receptors. NMDA has been implicated in controlling the power of gamma oscillations with the 
blockage of the NMDA receptor increasing gamma power (Hakami et al., 2009). IL-1β is known 
to enhance NMDA receptor activity through (Viviani et al., 2003) the action of tyrosine kinases 
to increase intracellular calcium and through this mechanism may decrease the power of gamma 
oscillations (Debray et al., 1997). Interleukin 1β is known to be produced by macrophages and 
monocytes during Leishmaniasis infection (Sani et al., 2014) (Santos et al., 2018). If the systemic 
upregulation of this pro-inflammatory signal reaches the brain it may cause the changes to 
gamma oscillations seen through the activity of IL-1β. To test this theory, the expression of IL-
1β in the brain could be analysed after infection.  
 
5.3.4. No change occurs in dendritic Arc expression by brain rhythm or infection in mice.  
Because only dendritic Arc expression showed any significant difference in rhythm-related 
expression in Chapter 3 of this thesis, only the expression of Arc in dendrites was analysed in the 
L. donovani infected mice. Firstly, to establish whether the phenomenon discovered in rats 
previously in this thesis is conserved in mice, the dendritic Arc expression during delta and 
gamma rhythms was compared to naive mice. Despite a visible increase in dendritic Arc in 
superficial layers in mice and non-overlapping error bars, there was no significant change in the 
dendritic Arc expression between rhythms in healthy mice. The trend of an increase would 
appear to corroborate the results found in Chapter 3 albeit to a non-significant level.  
 
The visible increase in superficial dendritic Arc during delta rhythms is conserved in leishmaniasis 
infected mice, yet this difference was also not significant, despite appearing larger in infected 
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animals – especially in the primary sensory cortex. The lack of significance in the laminar 
expression of Arc is surprising due to the small error bars in the data. Indeed, some significant 
changes were seen in individual sub-laminae. However, the consideration of multiple 
comparisons by calculation of the false detection rate led to the rejection of these changes as 
significant when considering the overall expression profile. The effect of the presence of the 
systemic leishmaniasis infection on rhythm-related Arc expression was also assessed. No 
significant difference was seen in Arc signalling between naive and infected mice in either area 
of the cortex during either rhythm. This suggests that the compromised power of the gamma 
oscillation has no effect on the overall plasticity mechanism in dendrites of these cells.  
 
The lack of change to dendritic Arc signalling in response to oscillatory state or infection 
suggests that the changing landscape of synaptic plasticity is of lower magnitude in the 
neocortex of mice than in rat between wakefulness and SWS. Although there is species 
difference between these studies (this chapter and Chapter 3) the mechanisms for oscillation 
generation are largely conserved (Buzsaki and Wang, 2012; Beltramo et al., 2013). However, a 
decreased propensity for plasticity in layer V neurons has been seen between species, related 
to a decreased ratio of layer V IB cells to RS cells in mice compared to rats (Jacob et al., 2012). 
Since our previous findings have been related to the expression of Arc in these diminished 
number of IB cells this suggests that this disparity between species may account for the non-
significance of the changes.  
 
5.3.5. Experimental limitations  
Due to regulatory restrictions, availability and precedence in the literature, mice (as opposed to 
rats) were used to model visceral leishmaniasis. This added an element of complexity as the in 
vitro models of oscillations used had been established in rats rather than mice (Ainsworth et al., 
2011; Carracedo et al., 2013). Indeed, the concentrations of oscillating generating drugs - 
kainate (400nM) for gamma rhythms and carbachol (4µm) and SCH23390 (10µm) for delta 
rhythms - were optimised in rats only. These concentrations have been optimised for generating 
the most robust oscillation possible in particular regions of rat brains. Whilst the regions chose 
from mice experiments were the same, the optimal drug concentrations to generate the most 
robust oscillations may be different. Whilst these concentrations are indeed successful at 
generating gamma and delta oscillations respectively in mice, to generate the most robust 
oscillation possible in mice would require an additional survey of dose response.  
 
  172 
This species difference between this chapter and Chapter 3 may account for the lack of change 
in dendritic Arc signalling both between rhythms and as a result of infection. As mentioned 
above, the lower percentage of intrinsically bursting cells in layer V in mice may account for the 
disparity in Arc changes compared to rats.  
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Chapter Six – General Discussion                       
and Future Directions 
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6.1 Overview 
Sleep has been an area of great mystery to neuroscience for centuries. Through decades of 
research, immediate early genes have emerged as an interesting target of research concerning 
their important roles in neuronal activity (c-Fos) and plasticity (Arc). This has led to findings that 
recognise changes to IEG levels across the sleep-wake cycle. Earlier studies into these immediate 
early genes took crude samples of brains of awake and sleeping animals and noticed profound 
changes (Cirelli and Tononi, 1999; Cirelli and Tononi, 2000b). More recently, research has 
involved more regionally specific surveys and relationships between brain states and memory 
(Ribeiro et al., 1999; Hanlon et al., 2009). 
  
Still, many of the studies into gene expression changes during the sleep-wake cycle are in vivo, 
and claims relating them specific brain rhythms have mostly been correlative rather than 
mechanistic. These studies have been informative, though, and it is from them that the synaptic 
homeostasis hypothesis (SHY) was developed. However, the mechanisms through which the 
downscaling of synaptic strength occurs during sleep (as the SHY theorises) are still being 
explored, mainly in attempts to reconcile the seemingly contradictory nature of decreased 
synaptic strength correlating with increased memory performance (consolidation) – something 
that currently stands opposed to the long-standing synaptic weight doctrine for learning and 
recall (Bliss and Collingridge, 1993). One potentially critical factor here may be temporal: 
understanding how specific network activities, distributed over time in the form of brain 
rhythms, might pinpoint causative changes in engrams linked to the observed immediate early 
gene and AMPA receptor number changes.  
 
With this in mind, this thesis attempted to relate changes in c-Fos and Arc to specific sleep- and 
wake-related brain rhythms using previously characterised, pharmacologically induced in vitro 
models. Cortical gamma and delta oscillation models were compared due to their known 
importance in the formation and consolidation of memories respectively. Once gross regional 
changes had been discovered, investigations were carried out to localise the source of the 
changes on a laminar, cellular, and sub-cellular level. These changes could then reciprocally 
inform studies into the changes that occur to these cortical rhythms upon the induction of 
neuroinflammation – an insult known to have profound effects on memory - either by models 
of immune challenge or with a biological pathological infection. 
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6.2.1 Plasticity-related gene changes in cortical oscillation models 
The initial investigation compared regional changes in immediate early gene expression during 
in vitro delta and gamma rhythms. Whilst the general decrease in Arc levels during sleep-related 
rhythms was broadly in line with changes seen in previous studies (Cirelli and Tononi, 2000a), 
the increase in c-Fos opposed previous findings (Pompeiano et al., 1995; Hanlon et al., 2009). 
This opposition may be due to the mismatch between what is defined as sleep and wake, 
compared to specific network activities (gamma and delta rhythms). These in vivo studies could 
not separate SWS from REM sleep whereas the current study looked solely at SWS. In addition, 
the results may also have been complicated by extracellular and non-neuronal staining – a clear 
dichotomy was seen, for example, between gross Arc levels (Figure 3.1) and the specific 
expression in IB neuronal apical dendrites (Figures 3.11, 3.12) (see below). 
  
To hone in further on the cells responsible for these changes, the distribution of c-Fos and Arc 
stained neuron and interneuron somata was analysed. In principal cell and interneuron somata, 
whilst expression of c-Fos and Arc was apparent, there were no changes seen in either IEG in 
response to the two oscillation models. What was observed, however, was an abundance of Arc 
stained dendrites, or sections of dendrites particularly in layer II/III of the cortex. Examination 
of this dendritic staining and comparison between rhythms highlighted a phenomenon whereby 
the generation of delta rhythms in secondary- and particularly primary- sensory cortex increases 
this dendritic Arc staining above that seen during gamma oscillations. As Arc increases are linked 
to changes in many types of synaptic plasticity (both in potentiation and depression), it would 
suggest that the majority of the synaptic alterations in the cortex occur in dendrites, during slow 
wave sleep. This plasticity is likely to be in the weakening of synaptic connections as LTD is 
known to be the dominating mechanism change during sleep (Tononi and Cirelli, 2003; 
Shepherd, 2012). The mechanism through which Arc is known to induce synaptic depression is 
through AMPA receptor internalisation (Chowdhury et al., 2006), which is upregulated during 
SWS and implicated in synaptic scaling (Diering et al., 2017). 
  
Intracellular experiments identified the specific cell type in which this dendritic Arc change 
occurred as the layer V intrinsically bursting cell (IB). The layer II/III localisation of the dendritic 
signal in these IBs corresponds with calcium spike initiation zones, which are important for 
mediating Ca2+ entry to pyramidal cells (Perez-Garci et al., 2013). This Ca2+ influx is increased by 
the burst firing of pyramidal cells during delta oscillations and aids in AMPA receptor 
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internalisation through inhibition of the anchorage of the receptor to the postsynaptic 
membrane (Chowdhury et al., 2018). 
 
Further to localising the major synaptic changes related to synaptic scaling during SWS in the 
cortex, a spatial arrangement in the contributing IB cells was found. This showed that not only 
was synaptic plasticity increased in bundles of IB dendrites, but these dendrites also work as a 
unit with other cells and their arrangement in a hexagonal pattern may facilitate this 
coordination (Maruoka et al., 2017). Thus slow wave sleep appears to associate with an 
enhanced state of excitatory synaptic plasticity in modules of neocortical cells known to be vital 
for both the generation of SWS itself and for linking neocortical activity to multiple subcortical 
structures (Groh et al., 2010; Kim et al., 2015). 
 
6.3.1 The effect of neuroinflammation on cortical oscillations models. 
Following the findings of the relationship between Arc mediated plasticity and cortical oscillation 
mode, further investigations were carried out to determine if perturbation in oscillatory 
dynamics occurred after neuroinflammation and whether this was related to changes in 
impaired or altered plasticity. Studies that investigate biological changes to pathogen-related 
inflammation (in the brain or otherwise) often use LPS to mimic a bacterial infection through its 
activation of TLR4 receptors (Lund et al., 2006). 
 
We first saw no immediate effects of LPS on stable cortical oscillations. There are many 
possibilities for this lack of effect. It is known that whilst peripheral sensory neurons express 
TLR4 receptors (Leow-Dyke et al., 2012), cortical neurons do not (Lehnardt et al., 2003). This 
being the case, it is unlikely that triggering signalling pathways in other (TLR4 +ve) cell types 
would directly affect neuronal excitability at the timescale measured. In fact the timescale for 
induction of inflammatory cytokines known to cause changes to oscillatory dynamics is longer 
than the time tested (Wang et al., 2015a). 
  
Following this and with increasing awareness of the implications of systemic infection for 
neurodegenerative diseases (Perry et al., 2003), a dosing study was set up to assess the effects 
of systemic infection on the inflammatory environment in the brain and monitor the resulting 
oscillatory changes. It was also hoped that dosing with either LPS or poly I:C (an agent that 
mimics viral DNA, and ligand for TLR3 receptors) would allow the comparison of bacterial and 
viral infection changes. The chosen dosing schedule allowed the comparison of acute and 
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chronic inflammatory conditions by the recording of oscillations 24 hours after a single dose of 
LPS or after doses every 3 days for 7 or 28 days. Since the doses used were relatively low, it 
allowed the build-up of chronic inflammation, which meant that no change was seen after 24 
hours. This lack of change may also have been because the conclusion of the first ‘wave’ of 
inflammation occurs less than 24 hours after dosing (Mamad et al., 2018). 
 
The longer timescale of infection was sufficient to induce oscillatory changes, significantly in the 
frequency of hippocampal gamma oscillations and cortical delta rhythms. These changes were 
thought to be related to deficits in cognitive function (Britton et al., 2016) and specifically 
sensory/memory processing  (Jahn, 2013). 
 
Beyond these frequency changes, other differences in the oscillatory activity were apparent, 
however due to low n numbers, these were not found to be significant. The bidirectional trend 
towards changes in delta rhythms suggested changes in sleep-need depending on the nature of 
neuroinflammation present. Shorter-term dosing increases are likely to be related to changes in 
the brain after infection or TBI leading to delirium (Parsons et al., 1997) (Koponen et al., 1989), 
and may also be related to increased sleep need (Vyazovskiy et al., 2011). The trend towards a 
decrease seen over the longer term (28 days here) may be due to more serious changes in the 
cortical networks supporting these rhythms and could even be a result of neuronal cell death 
(Pevzner et al., 2016). This may also underlie the trend in decrease of the hippocampal slow 
gamma rhythms, which is a dysfunction seen in Alzheimer’s disease. These oscillatory changes 
could also be linked to changes in the neuroinflammatory state with mostly just ’classic’ 
proinflammatory cytokines upregulated after 28-day dosing, whereas after 7 days a balance 
between pro- and anti-inflammatory cytokines and chemokines was seen. This was reflected in 
the proven capability of 28 days dosing with inflammatory agents to change microglia 
morphology to their active, pro-inflammatory state. It was hoped that these changes could also 
be related to changes in plasticity mechanism, but due to available tissue integrity problems, 
this analysis was not possible during the time course of this thesis. 
  
6.4 The effect of visceral leishmaniasis on cortical oscillations and plasticity. 
Neuroinflammation is prevalent in many biological diseases, and is a growing area of research, 
particularly in neurodegenerative diseases. A mouse model of visceral leishmaniasis was used 
to assess the effects of neuroinflammation in biological disease. There is only sparse evidence 
of an association between this disease and neurological defects, particularly related to the CNS. 
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However, leishmaniasis is linked with large amounts of systemic inflammation and there is also 
evidence of upregulation of neuroinflammatory cytokines in the brain. The infection was 
incubated for 28 days (similar to the last time point described above) before experiments were 
carried out. 
 
In line with features of the infection in humans and animals, mice showed decreased body 
weight, despite increases in the size of the spleen and the liver. These visceral changes were 
related to increased parasite loads in the liver and the spleen, with the former showing a higher 
parasite load. 
 
Changes in the power of cortical gamma oscillations were observed when the characteristics of 
sleep and wake-related oscillations were compared in infected mice. These changes are likely to 
be related to neuroinflammatory effects because inflammatory cytokines have been shown to 
change cortical oscillation dynamics through interactions the NMDA receptors (Bray et al., 
2016). These changes were not matched with any aberration in delta rhythm activity, which is 
unusual as the delta rhythm is more susceptible to alterations rising from neuroinflammation. 
However, this lack of change may be due to the lack of refinement of the in vitro delta rhythm 
in mice.  
 
Finally, the dendritic distribution of Arc was compared, firstly in different rhythms in control 
mice, and then between control and infected mice. The non-significant change in Arc in 
dendrites in control mice may indicate that the phenomenon evaluated in Chapter 1 can be 
conserved in mice, albeit to a lesser extent. Additionally, it was found that infection, despite 
causing changes to cortical gamma oscillatory dynamics had no effect on the levels of plasticity 
in cortical dendrites. The importance of the delta rhythm in plasticity was highlighted, so the 
fact that the change to oscillatory dynamics in infected mice was to gamma rhythms may show 
that these have a lesser impact on affecting synaptic changes in cortical neurons. 
 
6.5 Overview 
In conclusion, this thesis shows that delta rhythms that occur during SWS induce more plasticity 
compared to wake-related gamma rhythms, through the induction of the IEG Arc. This occurred 
predominantly in layer V intrinsically bursts cells and may lead to the scaling of their synaptic 
connections in order to maintain synaptic homeostasis, consolidate network representations of 
memory and/or simply provide a feedback signal to set the duration of SWS. These changes 
occur in hexagonally organised bundles of dendrites, which are multicellular units that process 
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information together and broadcast it principally to subcortical structures. Inducing systemic 
infection, either by agents mimicking bacterial or viral infection or by infection with a biological 
pathogen, caused subtle changes to the dynamics of the observed cortical oscillations. These 
oscillatory changes are likely to be due to an inflammatory response in the brain, propagated 
from the systemic immune response. Changes to these rhythms, however, do not seem to have 
any overt effect on plasticity-related Arc expression in the neocortex.  
 
6.6 Future directions  
6.6.1 Further investigation of synaptic changes during in vitro slice oscillations 
 
The main finding in the first chapter of this thesis is with regards to the immunofluorescent 
staining of Arc. It is important to note that Arc staining is only representative of changing 
synaptic strength and does not necessarily imply a direction. Indeed Arc has been shown to be 
increased during both synaptic potentiation and depression. Although it is likely that the 
increase in Arc found in the basal dendrites of layer V IB cells synaptic scaling further 
experiments would be necessary to confirm this.  Synaptic scaling involves long term depression 
and therefore intracellular electrophysiological experiments would be require to confirm 
decreased synaptic strength. The underlying mechanism could also be further explored using 
immunohistochemistry. 
 
Intracellular recordings of layer V intrinsically bursting cells before and during the induction of 
delta and gamma oscillations would allow for the comparison of EPSPs and EPSCs in terms of 
amplitude or time course. These recordings could be taken naturally during the oscillations, or 
as part of a stimulus response curves after oscillatory activity. This would be done by recording 
from IB cells and stimulating presynaptic neurons with increasing voltages. Currently changes to 
these parameters have already been shown in layer V cells after evoked bursting activity 
(Czarnecki et al., 2007). These experiments may require recordings to be made from the apical 
dendrite at layer II/III which adds a level of complexity due to the small size compared to the cell 
soma. 
 
Structural investigations of IB cell synapses may also be useful in providing evidence of LTD. 
Since LTD is associated with the internalisation of AMPA receptors, immunohistochemical 
analysis of the relative presence of full AMPA receptors or their subunits (GluA 1-4) could 
provide evidence of this. This would need to be done in conjunction with intracellular 
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experiments to electrophysiologically characterise IB cells, and highlight them with biocytin. It 
may be possible however to use dual immunohistochemical staining to show up layer V cell 
bodies (such as CTIP2) (Brunjes and Osterberg, 2015) as well as dendrites (βIII tubulin). It would 
then be required to distinguish IB cells based on their cell body location and morphology, which 
would add a level of subjectivity avoided by electrophysiological characterisation. However if 
this technique were to successfully highlight IB cells then it would be easier to analyse more cells 
for the presence of AMPA subunits at the layer II/III level of the apical dendrites. This could be 
compared between gamma and delta conditions to see if endocytosis does occur during delta 
rhythms. Much more coarsely, the general AMPA level could be compared across the layer II/III 
level between conditions. 
 
To compare this to the human condition (and perhaps even uncover something more profound 
regarding the function of sleep) in vivo measurements of AMPA receptors in humans would be 
vital. There is current research regarding the development of positron emission tomography 
(PET) tracers that recognise AMPA receptors to enable this to occur (Takahata et al., 2017; Chen 
et al., 2018; Fu et al., 2018). Once valid tracers are available, it would be possible to compare 
the levels of AMPA receptors before and after sleep, however this may not be successful for 
subtle changes. 
 
Monitoring the number and possibly the size of dendritic spines in layer V IB cells, would also 
give an indication of changes in plasticity in these neurones. Several immunohistochemical 
markers, such as PSD95 and drebrin, could be used to monitor changes in dendritic spines. These 
highlight synapses and would allow the number of dendritic spines and possibly also the size of 
those spines to be analysed (though this would require imaging at very high magnification and 
resolution). An alternative way to measure the surface area and contact of dendritic spines 
would be through scanning electron microscopy to reconstruct axon-spine interface (de Vivo et 
al., 2017). 
 
Although it is clear that ARC is upregulated during delta rhythms in this thesis, the mechanism 
by which this occurs is uncertain. ARC mRNA can be translated distally from the cell soma in the 
dendrites (Steward et al., 1998). It is therefore unclear whether the ARC induced by in vitro delta 
rhythms is representative of upregulated translation of the protein, or downstream in the de 
novo synthesis at the level of the mRNA. This could be tested by inducing cortical rhythms, but 
in the presence of a transcriptions blocker (actinomycin D) or a protein synthesis inhibitor 
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(cycloheximide). However this may mean that it is not possible to induce oscillations, or even be 
sure that any effects that are see are related specifically to ARC as opposed to ‘dirty’ off targets 
effects of blocking overall transcription or translation. Another way to answer the question 
however would be to look at the relative expression of RNA and protein during delta and gamma 
conditions. A process similar to immunohistochemistry that allows localisation of specific RNA 
sequence is in situ hybridisation. This could be employed to see if there are also alterations in 
ARC RNA levels in neurons and also indicate their location in the cell. 
  
One feature to note is that in the Arc immuno-stained tissue, there was rarely continuity 
between the dendrite and the soma in terms of the presence of Arc. This meant that it was not 
always possible to match up dendrites to specific soma. Carrying out the immunohistochemistry 
with the presence of a marker to highlight the whole neuronal cell (MAP2) would help show 
whether there is tandem staining in the soma and the dendrites. Dual staining of RNA and 
protein is possible with certain in situ hybridisation techniques (Turkekul et al., 2017) which 
would also allow full observation of the relative abundance of Arc at different stages in its 
synthesis within one neuron. 
 
6.3.2 Further investigation into the effect of neuroinflammation on cortical oscillations 
 
LPS does not cause changes to neuronal network activity changes when applied to acute slices 
of rat brain. To investigate further whether there are any direct effects of neuroinflammation 
on neuronal activity, similar experiments could be carried out using cytokines. This would 
involve the bath application of pro-inflammatory cytokines after the generation of an oscillation. 
Of particular importance are Il-1α and β, IL-6 (Dinarello, 2011) and TNFα (Probert, 2015) which 
are known to have neuronal receptor expression. 
 
To have a better understanding of the effect of in vivo induction of inflammation it would be 
important to repeat the dosing experiments and subsequent recordings in this thesis to increase 
the sample size. This would avoid Type I or Type II errors and increase the statistical power of 
tests employed to analyse the results of the dosing study. Further analyses of these experiments 
could also be carried out to assess the state of neuroinflammation at different time points. Since 
the dose used was subchronic, it may also be interesting to see what effect a higher dose of the 
infections agents had. Monitoring the rats for sickness behaviour may also be useful to better 
relate the level of illness caused by the dosing of LPS and Poly I:C to levels of infection likely to 
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cause neurological changes in humans. Often measures of food and water intake, body 
temperature and activity (Barrientos et al., 2009b) as well as body weight (Kon Kim et al., 2013), 
and anxious and depressive behaviours as shown by maze and open field tests (Sulakhiya et al., 
2016). 
  
Further effects of peripheral infections on neuroinflammatory state of the brain could be done 
by analysis of different populations of cells in the brains. Simple analyses of microglia were 
carried out in this thesis which showed evidence of microglial activation, however these only 
compared LPS and control. Furthermore these only looked at crude measures of microglia 
morphology, where a more involved measurements such as a Scholl analysis to quantify the 
ramification index size would be more sensitive. Also no measurement was taken as to the 
number of microglial cells which is an indication of neuroinflammation. Astrocyte proliferation 
is also a sing of neuroinflammation and can be investigated by the simple immunostaining for 
GFAP. 
  
Another simple immunohistochemistry experiment that could start to link neuroinflammation 
and changes to the electrical activity of the brains would be to stain for NeuN. This is a marker 
of neuronal cells and its use would allow for a comparison of cell numbers in the cortex and 
hippocampus at different dosing time scales, to see if there is significant cell death. Interneurons 
are more sensitive to changes in their local environment and are more susceptible to 
excitotoxicity, so monitoring GABA or GAD+ve cell numbers would show if neuroinflammation 
is more likely to lead to interneuron cell death. The presence or lack of cell death would highlight 
whether changes to electrical activity are driven by reduced populations of cells or failure of 
synaptic communication. The latter could be further investigated in a manner similar to that 
outlined in Chapter 6.6.1. 
 
Indeed, the initial intention of this thesis was to analyse the state of synaptic plasticity in the 
brain after peripheral infection, similarly to the analysis carried out in Chapter 3. However due 
to problems of tissue integrity this was not possible. This would still be very interesting to 
investigate, not least to shed more light on the link between memory deficits and 
neuroinflammation. In fact there have already been some studies linking neuroinflammatory 
factors like TNFα and synaptic plasticity markers like AMPA (He et al., 2012).  
 
6.3.3 Further investigation into the effect of visceral leishmaniasis on cortical oscillations 
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Many of the further experiments suggested in the previous section (6.3.2) would also be 
applicable to the work on Leishmaniasis. Especially including the measurement of: sickness 
behaviour, microglial/astrocyte number and morphology, and neuronal cell death. However 
since these two chapters were carried out of different animal models it would also be interesting 
to compare inflammation induced in the same way between mice and rats. This is particularly 
important as previous studies have shown differences in neuroinflammation between species in 
vitro (Lam et al., 2017) and in vitro (Potter-Baker et al., 2014). 
 
In Chapter 5 no measurement of neuroinflammation (or even peripheral inflammation signals) 
were taken. Despite precedence in the literature (Melo et al., 2017), it is necessary to confirm I 
this is the case in our mouse model. To do this (further to microglia and astrocyte analysis) a 
cytokine panel could be employed (as in Chapter 4), to monitor pro- and anti-inflammatory 
cytokines and chemokines in the brain following the parasitic infection.  
In Chapter 5 only experiments monitoring peripheral populations of parasites were carried out. 
Since there is previous evidence of migration of parasites into CNS tissue, it would be important 
to confirm whether parasites make it into the brain. If this were the case it could bring into 
question whether any neuroinflammation caused was a propagation of the peripheral 
inflammation signalling or due to parasitic presence in the brain. 
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